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Abstract 
Obesity is a disease that has reached epidemic proportions across the world. 
Many types of treatments have been used to combat obesity including using 
synthetic drugs such as sibutramine and orlistat. However, the high cost and 
potentially hazardous side-effects of anti-obesity drugs have led many 
researchers to turn to naturally occurring compounds obtained from fruits, 
vegetables, herbs and plants for the treatment of obesity. In our study, the anti-
obesity effects of S. crispus crude extract (SCE) and individual polyphenols 
(EGCG, Resveratrol, Phloridzin, Quercetin and Verbascoside) found in fruits, 
vegetables and herbs have been investigated. 
The effects of S. crispus extract (SCE) in vivo were tested on high fat-induced 
obese LDLr KO mice maintained on high fat diet (HFD) or switched to low fat diet 
(LFD). All mice were HFD for 25 weeks to induce obesity, after which half were 
maintained on the HFD and half switched to LFD. At the same time, mice were 
given normal water or 0.1% (w/v) SCE in water at Week 0-4 which was increased 
to 1% (w/v) at Week 5-10. Oxygen consumption (VO2), CO2 production (VCO2), 
RER, locomotor activity (LMA) and heat production (HP) were measured at Week 
0, 5 and 10. Food intake, water intake and body weight was measured weekly. 
Plasma glycerol (PG) and abdominal adipose tissue (AAT) weight were 
determined at Week 10. Mice switched to LFD lost weight (p< 0.001), mainly due 
to decreased energy intake (p<0.001). They also had lower AAT weight and PG 
concentration (all p<0.001). SCE had no effect at either dose on body weight, 
VO2, VCO2 or LMA, but significantly reduced respiratory exchange ratio (RER) 
(p=0.034) and increased HP at Week 4 (P=0.048), without altering food or water 
intake (p=0.1, p=0.222). PG concentration were also increased in SCE treated 
mice (p=0.032). 
 
The effects of SCE and individual polyphenols in vitro were tested on rat 
epididymal and human omental adipose tissue explants and results were 
compared with with the results from the pig perirenal adipose tissue explants. 
SCE does not appear to have any direct effect on lipolysis in the rat epididymal 
adipose tissue explants and human omental adipose tissue explants. EGCG was 
found to consistently inhibit lipolysis in rat, human and pig adipose tissue 
explants and the effects were greatest at 100µM. The effects of Phloridzin in 
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human, rat and pig fat explants were inconsistent as it was found to either 
increase or decrease lipolysis with different treatments. In all experiments, when 
Isoproterenol (IP) was present Resveratrol inhibited lipolysis and was 
independent of adenosine deaminase (ADA), with greater inhibition found at 
100µM compared with 50µM Resveratrol. The effects of Resveratrol on lipolysis 
in the human adipose tissue explants was found to be different when compared 
with the effects found in the pig and rat adipose tissue explants when incubated 
for 24 and 26hr. The effects of Resveratrol on lipolysis in the human adipose 
tissue itself are also dependent on the presence and absence of ADA and IP.  
Subsequent experiments were carried out where basal lipolysis and effects of the 
presence and absence of ADA were also investigated. Basal lipolysis was found 
to be higher in pig adipose tissue explants (Headland, 2007) than in human 
adipose tissue explants, but lower than rat adipose tissue explants. This is also 
true for the IP stimulated lipolysis in pig perirenal adipose tissue explants, but not 
in the pig subcutaneous adipose tissue explants, where IP stimulated lipolysis 
was similar to that in human omental adipose tissue. As expected, the presence 
of adenosine does have an effect on the lipolysis rate in rat, human and pig 
adipose tissue explants, since the addition of ADA (to metabolise/remove 
adenosine) increased basal lipolysis. However, only in the pig perirenal adipose 
tissue explants was IP stimulated lipolysis found to be increased with ADA. In the 
human omental adipose tissue explants, we also found that although BMI and 
age had weak negative correlations with lipolysis, these were not statistically 
significant (P=0.097 for BMI, P=0.48 for age). However, the trend suggests that 
IP stimulated lipolysis decreased with increased BMI. 
Thus, SCE appeared to induce lipolysis and body fat oxidation in vivo but no 
direct effect on lipolysis were found in vitro. Resveratrol is the most promising 
polyphenol to induce lipolysis based on the studies across the rat, human and pig 
species compared with quercetin, EGCG and Phloridzin. The consistent effects of 
EGCG on lipolysis inhibition however, might also be an anti-obesity effect through 
the mechanism of adipocyte apoptosis which requires further study. 
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Chapter 1 - Introduction  
 
 
1.1 Obesity  
 
1.1.1 Definition and prevalence 
Obesity is defined medically as a state of increased body weight, more 
specifically adipose tissue, of sufficient magnitude to produce adverse health 
consequences (Spiegelman & Flier, 2001). Bray (2004b) described obesity as a 
chronic disease in the same sense as hypertension and atherosclerosis. 
According to the World Health Organization (WHO, 2008), an adult is classified as 
being overweight if the Body Mass Index (BMI) is more than or equal to 25kg/m2 
and obese if their BMI is more than or equal to 30 kg/m2. BMI is calculated as 
weight in kilograms divided by height in metres squared (kg/m2). However, on the 
basis of available data in Asia, the WHO expert consultation (Yajnik & Yudkin, 
2004) concluded that Asians generally have a higher percentage of body fat than 
white people of the same age, sex, and BMI. They also found that the proportion 
of Asian people with risk factors for type 2 diabetes and cardiovascular disease is 
substantial even below the existing WHO BMI cut-off point of 25kg/m2.  
 
It is generally agreed that obesity has reached epidemic proportions across the 
world, although there is still some argument about its extent and effects (WHO, 
2000, Jeffery & Sherwood, 2008; Basham & Luik, 2008). In 2005, WHO estimates 
that there were about 1.6 billion overweight adults aged 15years and above and 
at least 400 million adults are obese worldwide. The prevalence of obesity 
continued to rise in many parts of the world. There was an increase in the 
average annual change ranging from 0.2% to 18.5% in developed countries and 
0.1% to 35.3% in developing countries (Low et al., 2009). The UK government 
has recently started to consider how society might deliver a response to obesity in 
England over the coming decades (Butland et al., 2007; Cross Government 
Obesity Unit, 2008) as obesity and overweight are still rising in England across all 
ages (Howel, 2010). According to the International Obesity Task Force (IOTF) it 
was estimated that the prevalence rate of obesity could reach 45% to 50% in the 
USA, 30% to 40% in Australia, England and Mauritius and more than 20% in 
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Brazil by 2025 (IOTF, 2008). Although obesity was initially most visible in 
developed countries, principally in the United States, it gained traction in many 
developing countries. As developing countries have become wealthier, adopted 
increasingly Westernized lifestyles characterized by increases in energy intake 
and reductions in energy expenditure and witnessed massive migration from rural 
to urban areas, obesity inevitably followed in the wake of these developments 
(Ford & Mokdad, 2008). 
 
1.1.2 Health Impact and Treatments 
The complications associated with obesity contribute to the 100,000 to 400,000 
deaths per year (Mokdad et al., 2001). This is because obesity increased the 
prevalence of many health hazards such as coronary artery disease, type 2 
diabetes (Willet et al., 1999), hypertension (Wilson et al., 2002), dyslipidemia 
(Grundy & Barnett, 1990), osteoarthritis (Hart & Spector, 1993), obstructive sleep 
apnea (Gami et al., 2003) and depression (Dixon et al., 2003). In order to 
GHWHUPLQHDQLQGLYLGXDO¶VULVNUHlating to obesity, WHO and the National Institutes 
of Health (NIH) has identified categories of BMI and the magnitude of potential 
health risk (Figure 1.1). Formal classification of severe obesity facilitates its 
conceptualization as a chronic disease. 
Extensive data have demonstrated that with weight loss, obese patients can 
UHYHUVH WKH KDUPIXO KHDOWK UHODWHG HIIHFWV DWWULEXWHG WR H[FHVV ZHLJKW 2¶%ULDQ
2010; Klein et al., 2004). Diet, exercise, pharmacotherapy, behavioural therapy, 
and lifestyle modification can each produce modest weight loss in the severely 
obese (Kissane & Pratt, 2011). Pharmacotherapy, in addition to diet and 
exercise, has been demonstrated to facilitate weight loss of 10% at 1 year 
(Eisenberg et al., 2006). Behavior therapy is a useful adjunct to planned 
adjustments in food intake and physical activity. Specific behavioral strategies 
include: self-monitoring, stress management, stimulus control, problem solving, 
contingency management, cognitive restructuring and social support (Latner et al, 
2002). Long-term maintenance of significant weight loss, however, continues to 
be the most challenging problem in the medically based treatment for obesity 
(Kissane & Pratt, 2011).   
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Figure 1.1 BMI cut-off points for public health action (Yajnik & Yudkin, 2004). 
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1.2 Adipose Tissue 
1.2.1 Physiology and The Adipocyte Life Cycle 
To understand more about obesity, we have to understand what is happening at 
the cellular concentration particularly in the adipose tissue. Adipose tissue is an 
organ that stores energy in the form of triglycerides synthesized from the excess 
of ingested fats and carbohydrates. The most important function of adipose tissue 
is for energy storage, mechanical and thermal protection for other organs, 
production of hormonal and metabolically active substances and protection 
against fat accumulation in other body organs (Svacina, 2008). Adipose tissue 
contains different cell types. Only one third of the tissue is constituted by 
adipocytes and the rest is represented by fibroblasts, macrophages, stromal 
cells, monocytes and preadipocytes (Geloen et al., 1989). Hormonal activity and 
transcription factors are responsible for differentiation of preadipocytes to 
adipocytes (Farmer, 2006). The biologic events leading to obesity are 
characterized by changes in cell properties of adipocytes and may include an 
increase in the number or size or both (Flier, 1995).  
 
Adipocytes are derived from mesenchymal stem cells, which have the potential to 
differentiate into myoblasts, chondroblasts, osteoblasts or adipocytes (Rayalam 
et al., 2008a). The adipocyte life cycle includes alteration of cell shape and 
growth arrest, clonal expansion and a complex sequence of changes in gene 
expression leading to storage of lipid and finally cell death (Figure 1.2). 
Mesenchymal stem cells are the precursors of several different types of cells, 
including myoblasts, chondroblasts, osteoblasts and preadipocytes. Once pre 
adipocytes are triggered to mature, they begin to change shape and undergo a 
round of cell division known as clonal expension, followed by initiation of the 
genetic program that allows them to synthesize and store trigylcerides. Mature 
adipocytes can continue storing lipid when energy intake exceeds output, and 
they can mobilize and oxidize lipid when energy output exceeds input. Mature 
adipocytes can also undergo apoptotic cell death under certain conditions 
(Rayalam et al., 2008a). 
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Figure 1.2 Adipocyte Life Cycle (Rayalam et al., 2008b) 
 
 
Mesenchymal stem cells are the precursors of several different types of cells, including myoblasts, chondroblasts, osteoblasts and preadipocytes. Once 
preadipocytes are triggered to mature, they begin to change shape and undergo a round of cell division known as clonal expansion followed by initiation of the 
genetic program that allows them to synthesize and store triglycerides. Mature adipocytes can continue storing lipid when energy intake exceeds output, and they 
can mobilize and oxidize lipid when energy output exceeds input. Mature adipocytes can also undergo apoptotic cell death under certain conditions. 
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1.2.2 Endocrine Organ 
Adipose tissue has been considered as an endocrine organ because of its 
capacity to secrete hormones and cytokines. It secretes a variety of factors in a 
manner dependent upon its metabolic state such as the release of tumor necrosis 
factor-Į71)-Įfrom macrophages and the release of leptin adipocytes (Ailhaud 
2006). These factors include proteins, metabolites and hormones. Thus, adipose 
tissue is not only known for its capacity to store excess dietary energy but also 
recognized as a fundamental participant in the control of energy metabolism. A 
growing number of adipocyte-derived factors have been described and their 
contribution to the pathophysiology of the metabolic syndrome, characterized by 
central adiposity, insulin resistance, dyslipidemia, hypertension, chronic 
inflammation and a prothrombotic state, is being investigated (Gimeno, 2005). 
 
1.2.3 Lipogenesis 
Most energy reserves in the human body are stored in adipocyte as triglycerides 
(TG) through the process of lipogenesis. Lipogenesis is the synthesis of fatty 
acids (FA) which form TG from carbohydrates or other energy sources in the diet 
(Figure 1.3). Lipid accumulation in adipose tissue depends on circulating FA 
uptake (Zechner et al., 2000). Adipose tissue exerts a buffering activity by 
increasing plasma TG clearance and suppressing the release of non-esterified 
fatty acids (NEFA) into the circulation (Frayn, 2002). TG arise in the adipocyte 
from two major routes: de novo lipogenesis from non-lipid precursors or uptake of 
FA from the plasma. In humans, the major source for adipocyte TG comes from 
chylomicrons and very-low-density lipoproteins (VLDL). VLDL and chylomicron 
particles, too large to penetrate the endothelial lining of adipose tissue capillaries, 
must be processed in the luminal space (Lafontan & Langin, 2009).  
 
TG in the lipoprotein particles are hydrolyzed by lipoprotein lipase (LPL) 
originating from adipocytes. LPL is synthesized and secreted by the adipocytes 
and is translocated into the lumen of capillaries. There, it binds to the luminal 
surface of endothelial cells by interacting with cell-surface glycosaminoglycans, 
especially heparin sulphate proteoglycans (HSPG)(Lafontan & Langin, 2009). 
Non-esterified fatty acids (NEFA) released from TG by LPL activity move through 
the endothelial lining to the adipocytes, where they are taken up, though some of 
them escape being trapped by the adipocytes, and are transported by albumin to 
other tissues. Specific NEFA-transporting proteins have been described (Frohnert 
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& Bernlohr, 2000; Hajri & Abumrad, 2002; Pohl et al., 2004). Once taken up by 
the fat cells, NEFAs are esterified to TG. 
 
1.2.4 Lipolysis 
FA and TG availability in non-adipose tissues depends on the activity of lipolytic 
enzymes present in adipose tissue (Figure 1.3). The principal role of adipose 
lipolytic enzymes is to provide other tissues with FA in case of energy demand. 
TG stored in the lipid droplet are first hydrolyzed by the enzyme adipose 
triglyceride lipase (ATGL), also known as desnutrin, releasing a diacylglycerol 
moiety and FA (Villena et al., 2004. This enzyme is induced under fasting 
condition and repressed after feeding and is downregulated in ob/ob and db/db 
mice (Villena et al., 2004). There are other enzymes that can hydrolyze TG such 
as triglyceride hydrolase (TGH) and adiponutrin, but their role in adipocyte 
lipolysis is secondary (Jenkins et al., 2004; Lake et al., 2005; Soni et al., 2004).  
 
After hydrolysis by ATGL, diacylglycerols are then hydrolyzed sequentially by the 
hormone-sensitive lipase (HSL) and monoglyceride lipase (MGL), producing 
FFAs and glycerol (Fredrikson et al., 1986; Holm, 1986). Different lipases gain 
access to the lipid droplet when proteins that coat the vesicle (perilipins) are 
phosphorylated. Perilipin A normally prevents lipolysis of TG by surrounding the 
lipid droplet, preventing the access of lipases (Brasaemle et al  ȕ-
adrenergic stimulation of adipocytes and the subsequent protein kinase A-
dependent phosphorylation of HSL and perilipin trigger the translocation of HSL 
from the cytoplasm to the lipid droplet and induce neutral lipid hydrolysis (Egan et 
al., 1992). 
 
During fasting, glucagon and catecholamines stimulate lipolysis in the adipocytes 
by activating several lipases via PKA, resulting in a mobilization of FFA from the 
adipocyte to the circulation, which are then bound to albumin and transported to 
muscle, liver, heart and other tissues for oxidation or re-esterification (Lafontan et 
al  ȕ-adrenergic receptors induce lipolysis, whereas Į2-adrenergic 
receptors inhibit lipolysis. For example, visceral fat cells are more responsive to 
b-adrenergic receptors in comparison to subcutaneous adipocytes. This explains 
why visceral fat is more easily mobilized (Deshaies & Despres, 2000). In fact, 
moderate weight loss induced by a low-energy diet is associated with an increase 
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in ȕ-adrenergic receptor sensitivity. In the postprandial state, high plasma insulin 
concentrations inhibit lipolytic enzymes, decreasing lipid mobilization from 
adipose tissue. These effects are mediated by the activation of 
phosphodiesterase 3B that degrades cAMP, preventing the stimulation of several 
lipases, and by activating protein phosphatase-1 that causes dephosphorylation 
of HSL, in both instances reducing the rates of lipolysis (Langin, 2006; Ragolia & 
Begum, 1998). 
 
Nevertheless, during obesity, excess FA release from adipose tissue increases 
deposition in muscle and liver, contributing to the development of insulin 
resistance. Furthermore, FA release is also associated with hypertriglyceridemia, 
failure in insulin clearance by liver, and impaired insulin secretion by ȕ cells in the 
pancreas (Cases & Barzilai, 2000). 
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Figure 1.3 Lipogenesis and Lipolysis (Frigolet Vásquez-Vela, 2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipogenesis and lipolysis. Glucose is transported into the adipocyte by the insulin sensitive transporter GLUT4. This glucose is oxidized via glycolysis to acetyl-
CoA  and then converted into fatty acids, which arethen esterified to glycerol  in the endoplasmic reticulum (ER) to form triglycerides (TG). These are then 
translocated into the lipid droplet. Fatty acids (FA) obtained from lipoproteins, through the action of lipoprotein lipase (LPL) are also esterified into TG and stored. 
Under fasting conditions, lipolysis is activated by G-protein-coupled receptors resulting in an increase in cAMP. This initiates aprotein kinase cascade that results 
in the phosphorylation of the protein perilipin located in the membrane of the lipid droplet. This cascade  also phosphorylates the hormone-sensitive lipase (HSL) 
and  triggers its translocation from the cytoplasm to the lipid droplet this enzyme catalyses the hydrolysis of diglycerides (DG) produced by the adipocyte 
triglyceride lipase (ATGL) to form monoglycerides (MG). MG are then further hydrolysed to release free glycerol. The fatty acids generated are released to 
nonadipose tissues, mainly for energy purposes.
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1.3 Medicinal plants 
1.3.1 Introduction 
Medicinal plants and plant extracts represent the oldest and most widespread 
form of medication. At least 25% of the active compounds present in currently 
prescribed synthetic drugs were first identified in plant sources (Balandrin et al., 
1985). Although some of the therapeutic properties attributed to plants have 
proven to be erroneous, medicinal plant therapy is based on the empirical findings 
of hundreds and thousands of years. The first records, written on clay tablets in 
cuneiform, are from Mesopotamia and date from about 2600 BC; among the 
substances that were used were oils of Cedrus species (Cedar) and Cupressus 
sempervirens (Cypress), Glycyrrhiza glabra (Licorice), Commiphora species 
(Myrrh) and Papaver somniferum (Poppy juice), all of which are still in use today 
for the treatment of ailments ranging from coughs and colds to parasitic infections 
and inflammation (Gurib-Fakim, 2006).  
The search for obesity treatments became popular in the mid-19th century where 
industrialization made obesity a prevalent problem (Mermel, 2004). Vinegar and 
cabbage soup became one of the earliest widely touted obesity cures with the 
common rationale that the acidic makeup of these foods literally chewed up fat 
although their success as weight management agents has more to do with the 
psychological phenomena than any unique chemical properties of the individual 
foods (Mermel, 2004). Today, health functions of well-known micronutrients are 
studied as well as traditional ethnic plant foods and herbal extracts towards the 
development of functional, health promoting foods which includes the treatment of 
obesity. Although not designated as vitamins, there is a large group of 
compounds in fruits and vegetables, teas and herbal extracts which might not be 
essential throughout life or cause clinically manifested deficiencies, but are 
essential for health and well-being in adulthood and in the elderly population 
(Holst & Williamson, 2008). These compounds are called phytochemicals and 
when consumed in the diet, they may reduce the risk of age-related chronic 
diseases.  
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1.3.2 Anti-obesity Effects 
At present, because of dissatisfaction with high costs and potentially hazardous 
side effects of anti-obesity drugs, the potential of natural products for treating 
obesity is under exploration, and this may be an excellent  alternative strategy for 
developing future effective, safe anti-obesity drugs (Mayer et al., 2009; 
Nakayama et al., 2007; Park et al., 2005). Although weight loss and weight 
control drugs are becoming extremely common in today's society, the remedies 
provided by the diet industry have failed in the long-term maintenance of weight 
loss in obese patients (Wadden, 1993). Moreover, it has been estimated that 
more than 90% of the people who lose weight by dieting return to their original 
weight within 2±5 years (Stern et al., 1995). For the treatment of obesity, natural 
products have been known to act as lipase inhibitors, metabolic stimulants, 
appetite suppressants, starch blockers/nutrient absorption inhibitors, 
glucose/insulin metabolism regulators, lipid metabolic regulators, adipogenesis 
inhibitors, apoptosis inducers, lipolysis inducers and energy expenditure 
stimulators (Rayalam et al., 2008a; Yun, 2010). During my PhD studies, I have 
focused on the effect of Strobilanthes crispus extract (SCE) as an energy 
expenditure stimulator and the effect of individual polyphenols as lipolysis 
inducers. 
 
Numerous naturally-occurring compounds have been proposed as treatment for 
weight loss via enhanced energy expenditure including caffeine (Dulloo, 1993; 
Racotta et al., 1994), capsaicin (Rayalam et al. b), 2008; Kawada et al., 1986) 
and catechins such as epigallocatechin and epigallcatechin gallate (EGCG) 
(Wolfram et al., 2006; Moon et al., 2007). Natural products have also been found 
to have the potential for mobilizing lipids by stimulating lipolysis in adipocytes 
ZKLFKFDQ OHDG WR ZHLJKW ORVV LQSHRSOH ZLWKREHVLW\ 3ULQV	2¶5DKLOO\ 
Sorisky et al., 2000). Lipolysis in adipocytes has been found to be increased by 
docosahexaenoic acid (DHA) in fish oil (Kim et al., 2006) and raspberry ketone 
from red raspberry (Morimoto et al., 2005). 
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1.4 Strobilanthes crispus 
1.4.1 Introduction 
The Strobilanthes crispus ZII 109 (L.) Bremek or Saricocalyx crispus ZII 109 (L.) 
Bremek (Acanthaceae) plant is native to countries from Madagascar to Indonesia, 
DQG LV FRPPRQO\ NQRZQ DV µGDXQ SLFDK EHOLQJ¶ LQ -DNDUWD RU µHQ\RK NHOR¶
µNHFLEHOLQJ¶ RU µNHMLEHOLQJ¶ LQ -DYD 6XQDUWR  ,W ZDV ILUVW UHFRUGHG E\
Thomas Anderson (1832-1970) who classified the plant under Spermatophyta 
(Flowering Plants and Gymnosperma)(Brummit & Prowell, 1992).  
Strobilanthes (cone head) was named from the combination of strobilos, which 
means flower (Plowden, 1968), and crispus, which is phyllostachyus or spike-like 
leaf (phyllo means leaf, and stachyus means spike)(Jackson, 1960). The 
conjunction of the names leads to the meaningful definition of the physical plant 
(Figure 1.4). This bush-like plant can be found on riverbanks or abandoned fields; 
some Javanese use this plant as fence hedges. The leaves are oblong-
lanceolate, rather obtuse, and shallowly crenate-crispate (Backer & Bakhuizen, 
1963). Top surfaces of the leaves are darker green in color and less rough 
compared with the below surface (Sunarto, 1977). The leaves are very scabrid on 
both surfaces and covered with short hairs, whereas the flowers are short, dense, 
and are panicled spikes (Heyne, 1987). The plant can be easily propagated by 
using the stacks (Sunarto, 1977). 
 
Figure 1.4 Strobilanthes crispus Plant and Leaves 
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1.4.2 Composition 
Soediro and colleagues (1983) isolated and identified an ester glycosidic 
compound of caffeic acid, a verbascoside in the leaves, by using thin layer 
chromatography (TLC) techniques. This compound is known to have analgesic 
effects internally, and antifungal and antibacterial effects when used externally. 
/DWHU VHYHQ SKHQROLF DFLGV ȡ-K\GUR[\O EHQ]RLF ȡ-voumaric, caffeic, vanillic, 
gentinic, ferulic and syryngic acid ± were also identified by TLC, paper 
chromatography and UV spectrophotometric techniques (Soediro et al., 1987).  
Studies done by Ismail and colleagues (2000) compared the chemical 
composition and total antioxidant activity between Strobilanthes crispus tea to 
Green tea, Yerbamate tea and Black tea (Table 1.1). It was found that the dried 
leaves of Strobilanthes crispus contained a high amount of minerals including 
potassium (51% of total mineral), calcium (24% of total mineral), sodium (13% of 
total mineral), iron (1% of total mineral) and phosphorus (1% of total mineral). 
High content of water-soluble vitamins (C, B1 and B2) contributed to high 
antioxidant activity of the leaves. Catechins of Strobilanthes crispus leaves 
showed highest antioxidant activity when compared with Yerbamate and vitamin 
E.  
 
1.4.3 Health Benefits 
Although there is very little record of this plant being used for medicinal purposes, 
an infusion of the dried leaves of Strobilanthes crispus have been used as an 
antidiabetic, diuretic, antilytic, and laxative in Indonesia (Sunarto, 1977). A study 
also indicated that the water extract of Strobilanthes crispus contained 
compounds with very high affinity to protein molecules, which may bind the active 
sites of reverse transcriptase, therefore inhibiting the proliferation of retroviruses ± 
agents in viral diseases such as acquired immuno deficiency syndrome and adult 
T-cell leukemia (Kusumoto et al., 1992). A recent study done by Rahmat (2006) 
showed that Strobilanthes crispus leaves may have potential effect as anticancer 
agent.   
There are not many studies done to investigate the potential of Strobilanthes 
crispus leaves as medicinal plant. The local consumption of Strobilanthes crispus 
as tea have sparked the possibility that the leaves of this plant may have the 
health-promoting potentials of conventional tea especially as an anti-obesity 
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agent. This is supported by the fact that other types of tea has been found to have 
an effect in preventing a positive energy balance and obesity (Choo, 2003; 
Westerterp-Plantenga et al., 2006; Yang et al., 2001; Wang et al., 2003, Khan & 
Mukhtar, 2007). 
 
 
Table 1.1 Chemical composition of Strobilanthes crispus, Yerbamate, 
Green and Black teas (Ismail et al., 2000) 
 
 
S. crispus Yerbamatea Green 
teab 
Black 
teab 
   Moisture content (%) 69.3 ± 0.1 9.0 -c 3.9±9.5 
   Total ash (%) 21.6 ± 0.1 6.7 6.1±9.2 4.9-6.5 
      Water-insoluble ash (%) 13.8 ± 1.0 - 5.2-7.2 - 
      Water-soluble ash (%) 7.9 ± 1.0 2.3 1.6-2.6 3.0-4.2 
   Extractivities (%) 6.7 ± 0.4 33.1 33.0-45.0 30.0-50.0 
   Protein content (%) 13.3 ± 0.9 9.8 - 5.0-6.2 
   Total carbohydrate (%) 4.3 ± 0.7 - - - 
   Crude fiber (%) 13.9 ± 0.6 15.5 9.0-15.0 - 
   Caffeine (%) 0.01 0.6-1.4 1.5-4.3 10.0-11.0 
   Tannin (%) 1.0 ± 0.3 9.8 - - 
   Alkaloid (%) 3.2 ± 0.6 4.4 - - 
   Catechin (%) 1.18 ± 0.08 0.9 5.8 - 
Each value represents the mean ± SD of 6 determinations. 
a: Hart and Fisher (1971). b: Pearson (1976) c:shows no studies have been done 
 Value refers to values on a wet weight basis 
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1.5 Polyphenols 
 
1.5.1 Introduction and Classification 
Plants produce polyphenols as secondary metabolites involved in diverse 
processes, such as growth, lignifications, pigmentation, pollination and resistance 
against pathogens, predators and environmental stress (Duthie et al., 2003). 
Edible plants provide the human diet with more than 8000 different polyphenols 
(Fraga et al., 2010). Previously, most of the nutritional interest in polyphenolic 
compounds was in the effects of certain polyphenols to bind and precipitate 
macromolecules such as dietary protein, carbohydrate, and digestive enzymes, 
thereby reducing food digestibility (Bravo, 1998). However, interest in food 
phenolics have increased greatly because of the properties associated with some 
phenolics and their potential effects on human health (Rawel & Kulling, 2007; 
Finley, 2005; Khan & Mukhtar, 2007; Hooper & Cassidy, 2006). 
The polyphenols may be classified into different groups as a function of the 
number of phenol rings that they contain and the structural elements that bind 
these rings to one another. Distinctions are thus made between the phenolic 
acids, flavonoids, stilbenes and lignans (Figure 1.5). The flavonoids, which share 
a common structure consisting of 2 aromatic rings (A and B) bound together by 3 
carbon atoms that form an oxygenated heterocycle (ring C), may themselves be 
divided into 6 subclasses as a function of the type of heterocycle involved: 
flavonols, flavones, isoflavones, flavonones, anthocyanidins and flavonols 
(catechins and proanthocyanidins) (Figure 1.6). The main subclasses that are 
important from a human health perspective are the flavones, flavonols, flavan-3-
ols, isoflavones, anthocyanidins and lignins (Hooper & Cassidy, 2007). 
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Figure 1.5 Chemical Structures of Polyphenols (Manach et al., 2004) 
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Figure 1.6 Chemical Structures of Flavonoids (Manach et al., 2004) 
 
 
 
1.5.2 Anti-obesity Effects 
A wealth of information indicates that there are numerous bioactive components 
derived from nature, which are potentially useful as obesity treatments. This 
includes polyphenols which have been reported to prevent and ameliorate the 
effect of obesity and related metabolic syndrome.   
Recent research findings include the discovery of licorice flavonoid oil, which was 
found to decrease abdominal adipose tissue in diet-induced obese rats by 
decreasing the enzymatic activities of fatty acid synthase and increasing the 
enzymatic activity of acyl-CoA dehydrogenase, the rate limiting enzyme in the 
fatty acid oxidative pathway (Kamisoyama et al., 2008; Aoki et al., 2007). 
Oligonol, a new lychee fruit-derived polyphenol was found to enhance lipolysis in 
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primary adipocytes through the activation of the ERK1/2 pathway (Ogasawara et 
al., 2009).  
In the widely consumed green tea, epigallocatechin-3-gallate (EGCG), the 
polyphenol considered to be the most bioactive component of green tea (Wolfram 
et al, 2006), was found to increase weight loss and decreased body fat in obese 
subjects through many mechanisms (Figure 1.7) that lowered energy intake and 
increased energy expenditure (Thielecke & Boschmann, 2009; Rains et al., 
2011). Moreover, EGCG and other individual polyphenols, resveratrol and 
quercetin were found to activate adenosine monophosphate-activated protein 
kinase (AMPK) which can induce adenosine triphosphate (ATP) generation 
WKURXJKSDWKZD\VVXFKDVJO\FRO\VLVDQGȕ-oxidation (Hwang et al., 2009).  
Most recently, aques rooibos (Aspalathus linearis) extract which contained 
25%w/w of total polyphenol content was found to reduce adipocyte size and 
number as well as prevent dietary-induced hepatic steatosis in LDLr KO mice fed 
a high fat, high cholesterol diet (Beltrán-Debón et al., 2011).  
From the examples above, we can conclude that dietary polyphenols provide a 
wide spectrum of biological actions potentially beneficial for obesity and these 
biological actions, involve different mechanisms. 
 
1.5.3 Bioavailability 
To exert their biological properties, polyphenols have to be available to some 
extent in the target tissue. Polyphenols that are the most common in the human 
diet are not necessarily the most active within the body, either because they have 
a lower intrinsic activity or because they are poorly absorbed from the intestine, 
highly metabolized, or rapidly eliminated. Therefore, it is important to know the 
factors that determine their release from food, their extent of absorption in the gut 
(bioaccessability), metabolism, and bioavailability.  A general view of the different 
aspects which are involved in the bioavailability of polyphenols is given in Figure 
1.8. In order to reach the target tissues, the polyphenols have to pass multiple 
barriers and are exposed to numerous metabolic processes. The result of this is 
that the target tissues are exposed to not only the ingested polyphenol, but rather 
to a complex mixture of metabolites from various origins. 
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Figure 1.7 Mechanisms by which EGCG may decrease energy intake, increase energy expenditure, and reduce adipose 
tissue mass and prevent or treat obesity and its associated diseases, diabetes and hypertension (Thielecke & Boschmann, 
2009) 
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Figure 1.8 Different factors influencing the bioavailability of polyphenols 
(Possemiers et al., 2011) 
 
A part of the ingested fraction may be absorbed from the small intestine and may be conjugated 
with glucuronic acid or sulfate during absorption and in the liver. It can further be metabolized, 
circulate in the bloodstream or enter into enterohepatic circulation. The fraction of the ingested 
polyphenols which reaches the colon directly or indirectly can be exposed to the intestinal 
microbiota and its extensive metabolic pathway. Despite the high initial structural variations, 
overlapping pathways result in the production of a relatively small number of metabolites. 
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1.5.3.1 Bioaccessability 
Bioaccessibility is defined as the amount of a food constituent that is present in 
the gut, as a consequence of the release of this constituent from the solid food 
matrix, and may be able to pass through the intestinal barrier (Saura-Calixto et 
al., 2007). Only polyphenols released from the food matrix by the action of 
digestive enzymes (small intestine) and bacterial microflora (large intestine) are 
bioaccessible in the gut and therefore potentially bioavailable. Therefore, 
polyphenols have to be bioaccessible in order to be bioavailable to the cellular 
metabolism 
 
Soluble aglycones or glycosides may be bioaccessible in the small intestine. The 
large intestine is however, an important site in the gastrointestinal tract where 
polyphenols become bioavailable. This is where polyphenols associated with the 
indigestible fraction of the food reach the colon, where they become fermentation 
substrates for bacterial microflora along with the non-digestible food constituents 
(Saura-Calixto et al., 2007). The abundant microflora in the colon plays a critical 
role in the metabolism of polyphenols. After microbial enzyme metabolism of any 
polyphenols that reach the colon, there are two possible routes available, namely 
absorption of intact polyphenols through the colonic epithelium and passage into 
the bloodstream or breakdown of the original polyphenol structures into 
metabolites (Williamson & Manach, 2005). Also, unabsorbed polyphenols that 
reach the colon may counteract the effects of dietary pro-oxidants in the colon 
produced during colonic bacterial metabolism. Meanwhile, one crucial additional 
aspect of bacterial metabolism of polyphenols should be taken into account, i.e. 
the huge interindividual variation in the rate and extent of intestinal microbial 
metabolism. The consequence is therefore that the final circulating metabolite 
patterns can highly vary in both concentration and composition, resulting in highly 
varying bioactivity in different individuals (Possemiers et al., 2011). 
 
Colonic metabolism of dietary polyphenols has been extensively studied and 
associations between urinary excretion of simple phenolic structures, such as 
hippuric acid derivatives and bacterial polyphenol degradation was shown in 
many studies (Gao et al., 2006; Gonthier et al., 2003; Mulder et al., 2005; Olthof 
et al., 2003). It is clear that the metabolites are formed by microbial action, as 
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lower recovery was found in human and animal studies where antibiotics were 
dosed prior to flavonoid uptake (Kohri et al., 2001; Gott & Griffiths, 1987).  
 
 
1.5.3.2 Bioavailability of Catechins                                                                                                        
One of the polyphenol groups with high bioavailability is the catechins. This is 
confirmed by Stalmach and colleagues (2009) after they studied the absorption of 
flavan-3-ol monomers which are highly available in the Choladi green tea 
(648µmol/500 mL) when ingested by 10 human volunteers. Unmetabolised (±)-
epigallocatechin-3-gallate (EGCG) and (±)-epicatechin gallate were found in the 
circulatory system together with glucuronide, methyl and sulphate metabolites of 
(epi)catechin and (epi)gallocatechin with Cmax values ranging from 25 to 126 nM 
and Tmax values of 1.6±2.3 h. Cmax refers to the maximum concentration that a 
type of catechin achieved in the circulatory system after it has been administrated 
and prior to the administration of a second dose. Tmax is the time at which the 
plasma concentration is maximum for each dose interval. These Tmax values 
indicated the rate of absorption in the small intestine. The appearance of 
unmetabolised flavonoids in plasma is unusual compared with other polyphenols. 
The passage of the EGCG and (±)-epicatechin-3-gallate through the wall of the 
small intestine into the circulatory system without metabolic modification could be 
a consequence of the presence of the 3-O-galloyl moiety, as gallic acid per se is 
readily absorbed with a reported urinary excretion of 37% of intake (Shahrzad & 
Bitsch, 1998; Shahrzad et al., 2001) . 
 
1.5.3.3 Bioavailability of Quercetin                                                                                                        
Quercetin which is ubiquitous in plants and plant-derived materials especially 
onions is present as various glycosides. The bioavailability of the flavonol 
quercetin was also found to be high based on the study by Hollmann and 
colleagues (1997). In their study, nine subjects were fed a single large dose of 
onions, which contained glucose conjugates of quercetin, apples, which contain 
both glucose and non-glucose quercetin glycosides, or pure quercetin-3-
rutinoside, the major quercetin glycoside in tea. Plasma concentrations were then 
measured over 36 h. Results showed that the dietary antioxidant quercetin was 
found in the circulation after the consumption and a considerable fraction of the 
absorbed quercetin was present in plasma throughout the day. The bioavailability 
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of quercetin was confirmed later by a similar study by Krogholm and colleagues 
(2010). Even though the uptake of quercetin in the diet is in the form of 
glucosides, when it reaches the enterocyte, the glucoside is hydrolysed by 
intracellular cytosolic b-glucosidase activity which leaves quercetin to act as a 
bioactive compound in the cellular system (Jan et al., 2010). 
 
1.5.3.4 Bioavailability of Phloridzin 
Phloridzin, the glucoside conjugate of phloretin, is the major polyphenol found in 
apples. Similar to quercetin glucosides, phloridzin is thought to be hydrolyzed by 
lactase phloridzin hydrolase, and phloretin aglycone is taken up by the intestinal 
cells (Boyer & Liu, 2004). When rats were fed phloridzin and phloretin, their 
plasma contained glucuronidated and sulfated phloretin but no phloridzin (Crespy 
et al., 2002). This supports the theory that phloridzin is hydrolyzed prior to uptake 
and further glucuronidation by intestinal epithelial cells. 
 
1.5.3.5 Bioavailability of Resveratrol 
Resveratrol is another dietary polyphenol, found in grapes, red wine and peanuts 
(Jang et al., 1997). Meng and colleagues (2004) investigated the bioavailability of 
resveratrol in humans after oral ingestion of grape juice preparations and found 
that the plasma and urine of humans yielded detectable concentrations of 
resveratrol and their derivatives after 24hrs. They also found that at a low dose 
(0.03mg/kg), more than half of the ingested resveratrol was recovered in the 
urine in 24hrs, whereas at a higher dose (1mg/kg), only a quarter of the 
administered dose could be recovered during the same period. The presence of 
trace amounts of unchanged resveratrol in the human plasma and urine after 
dietary consumption of resveratrol was also confirmed by Walle and colleagues in 
another study (2004). 
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1.6 Hypotheses and Aims  
The hypotheses to be tested in this project are as follows: 
x S. crispus extract (SCE) will reduce abdominal adipose tissue weight and 
improve the lipid profile of treated mice similar to the results found in a 
previous experiment using Sprague-Dawley rats. 
x Application of SCE will result in an enhancement of lipolysis in rat and 
human adipose tissue explants. 
x The effects of individual polyphenols on rat adipose tissue explants are 
similar to that found in the pig adipose tissue explants and other studies 
using rat adipocytes or cell lines. 
x The human adipose tissue explants will have similar responses towards 
individual polyphenols as found in the pig adipose tissue explants 
(Headland K., 2007). 
x Basal and stimulated lipolysis in rat, human and pig adipose tissue 
explants are different to each other. 
 
The aims of the project were to: 
- Investigate the anti-obesity effects of S. crispus crude extract (SCE) in 
mice in vivo. 
- Establish a rat adipose tissue explants system for in vitro 
measurement of lipolysis. 
- Establish a human adipose tissue explants system for in vitro 
measurement of lipolysis. 
- Investigate the effects of SCE and individual polyphenols on lipolysis 
in the rat adipose tissue explants. 
- Investigate the effects of SCE and individual polyphenols on lipolysis 
in the human tissue explants. 
- Compare the effects of individual polyphenols on lipolysis between the 
pig (Headland, 2007), rat and human adipose tissue explants. 
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Chapter 2 ± Analysis of S. crispus 
 
 
2.1 Introduction 
Any living organism, like plants, may be considered to be a biosynthetic 
laboratory for chemical constituents such as biopolymers (proteins, nucleic acids, 
carbohydrates and lipids), primary or basic metabolites and secondary natural 
substances (Nyiredy, 2004). These chemical compounds give plants their 
therapeutic properties. 
The determination of phenolic compounds in plants is influenced by many factors. 
The principal factors includes: heredity (genetic composition), ontogeny (stage of 
development) and environment (eg. climate, soil, method of cultivation)(Nyiredy, 
2004). Variables in the extraction method (sample particle size, storage time and 
conditions, presence of interfering substances) and the chemical nature of plant 
phenolics which varies from simple to highly polymerized substances that include 
varying proportions of phenolic acids, phenylpropanoids, anthocyanins, tannins 
etc. also influence the type and amount of phenolic compounds derived from 
plants (Naczk & Shahidi, 2004). Furthermore, phenolic compounds may also 
exist as complexes with carbohydrates, protein and other plant components 
which are also sensitive to the method of extraction used. 
 The Strobilanthes crispus Bremek or Saricocalyx crispus Bremek (Acanthaceae) 
plant is native to countries from Madagascar to Indonesia, and is commonly 
known aVµGDXQSLFDKEHOLQJ¶LQ-DNDUWDRUµHQ\RKNHOR¶µNHFLEHOLQJ¶RUµNHMLEHOLQJ¶
in Java (Sunarto, 1977). Description and health benefits of the plant can be found 
on section 1.4. Extraction using Supercritical Fluid Carbon Dioxide (SFE CO2), 
Soxhlet and solvent methods have been done by Md Salleh and colleagues 
(2007) in which they identified catechin, epicatechin, rutin, quercetin, naringin 
and kaempferol to be present in the S. crispus.  
2.2 Aim 
In this study, the aim was to measure the total polyphenol content in S. crispus 
extract and determine the best chloroform-extraction procedure to be used later 
in the in vivo and in vitro studies.  
 26 
 
2.3 Methodology  
All of the chemicals used were of analytical grade and purchased from Sigma-
Aldrich (Dorset, UK), Fisher Scientific (Leicestershire, UK) or BDH (Dorset, UK) 
unless stated otherwise 
 
2.3.1 Polyphenol Extraction 
Phenolics are not uniformly distributed in plants at the tissue, cellular and 
subcellular concentrations (Naczk & Shahidi, 2004). Insolube phenolics are the 
components of cell walls, while solube phenolics are compartmentalized within 
the plant cell vacuoles (Pridham, 1960). Solubility of phenolic compunds is 
determined by the type of solvent (polarity) used, degree of polymerization of 
phenolics, as well as interaction of phenolics with other constituents and 
formation of insoluble complexes.  
 
Therefore, there is no uniform or completely satisfactory procedure that is 
suitable for the extraction of all phenolics or a specific class of phenolic 
substances from plant materials. Methanol, ethanol, chloroform, acetone, water, 
ethyl acetate and, to a lesser extent, propanol, dimethylformamide, and their 
combinations are frequently used for the extraction of phenolics (Antolovich et al., 
2000). Prior to extraction, S. crispus leaves purchased from Cedar Biotea Sdn. 
Bhd. (Malaysia) were  oven dried (40ºC, 12hours) and ground into a powder 
using a coffee grinder (CG100, Kenwood, Hampshire, UK). 
 
2.3.1.1 Diethyl Ether Extract 
This method was developed by D. Cook (unpublished method) from School of 
Biosciences, University of Nottingham. 70% methanol was used as a solvent for 
extraction at 30ºC. Following this, free phenolics were extracted with diethyl ether 
from the acidified aqueous suspension of phenolic extract. The extract was 
treated with anhydrous MgSO4 under nitrogen to liberate insoluble-bound 
phenolic acids (refer to Figure 2.1). This extract was used for analysis using 
HPLC. 
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Figure 2.1 Scheme for Diethyl Ether Extract of Polyphenol from S. crispus  (Method by D. Cook) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Extraction mixture was transferred 
quantitatively to round bottomed flask and 
connected to a rotary evaporater to evaporate 
the methanol at 30°C until there were 
approximately 60ml of aqueous solution. 
15g of S. crispus powder was 
transferred into a round bottomed flask. 
200ml of 70% methanol (aq) was 
added and extraction mixture was 
stirred with magnetic stirrer for 2 hrs. 
Extraction mixture 
was filtered under 
vacuum through 
Whatman GF/A 
paper (No. 4) 
50ml of NaOH  (2N) was 
added and solution was 
left  to hydrolyse 
overnight at room 
temperature. 
Solution was transferred quantitatively 
into 3 centrifuge tubes (50ml). Tubes 
were spun at 3200rpm for 15mins to 
separate the supernatant from pellet. 
Pellet was discarded. 
Supernatant was transferred to a 
separating funnel, and 80ml of diethyl 
ether was added and shaken vigorously. 
The aqueous extract (bottom layer) was 
removed. This was repeated 3 times.  
Aqueous extract was 
acidified to pH 1.5 with 
concentrated HCl by 
stirring with magnetic 
stirrer and measuring 
the pH at the same 
time. Extract was then 
filtered with Whatman 
No. 4 filter paper 
The ether extract 
was then added 
with MgSO4 
(anhydrous) until 
MgSO4 is not 
solid. Extract was 
then filtered with 
Whatman No. 4 
filter paper. 
Filtered extract was then 
transferred to another round 
bottom flask and connected 
again to a rotary evaporator 
to evaporate all but a few ml 
of ether.  This took 
approximately 5 minutes. 
Extract was then dried 
under a stream of N2 and 
stored at -40 ºC before use. 
Extract was 
transferred to a 
separating funnel and 
80ml diethyl ether was 
added. Mixture was 
shaken vigorously.  
The ether extract (top 
layer) was removed. 
This step was 
repeated for 3 times. 
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2.3.1.2. Chloroform-Methanol Extract 
This method was developed by Maznah I (unpublished method) from the Faculty 
of Medicine and Health Sciences, Universiti Putra Malaysia. For extraction, 100g 
of powdered leaves were soaked and stirred continuously with chloroform-
methanol (5:3, 500 ml of chloroform and 300 ml of methanol) for 12 hours. This 
mixture was then filtered with Whatman filter paper No.4 and solvent mixture 
containing the extract was collected into a round bottomed flask. The flask was 
then connected to a rotary evaporator (Rotavapor R-3000, Buchi, Switzerland) 
with water bath set at 37ºC to remove the majority of solvents, until the volume 
reached approximately 50ml. To evaporate the remaining solvents, crude extract 
was then divided into 2 pre-weighed conical tubes and dried under a continuous 
flow of nitrogen gas. Further drying of the extract was done in an air oven 
overnight at 37ºC to make sure that all solvents had evaporated. Green coloured 
extract in the form of a paste was obtained. To prepare the extract in water, 
distilled water was added to the extract paste.  
 
2.3.1.3 Hot Water extract 
0.2g of dried S. crispus leaves were weighed and added to 50ml of boiling 
milipore water, and left to boil for 5mins. Tea infusions were then left to cool to 
25-30oC. Hot water extracts were then filtered with Whatman fiter paper (No.4) 
into 50ml tubes and filtered again with a syringe-filter (0.4µm) into 15ml tubes.  
Samples were stored at -40oC for further analysis. The same method was done 
for preparation of Green tea (Camellia sinensis) (Boh Sdn. Bhd, Malaysia). 
 
2.3.2 Preparation of Sample for Total Soluble Phenolic Content 
Chloroform-methanol extract of S. crispus were subjected to different preparation 
conditions before the analysis of Total Soluble Phenolic Content in order to 
identify the best condition that provided the highest phenolic content. All samples 
were initially extracted using the chloroform-methanol extraction method 
described in section 2.2.1.2 and shaken vigorously for 2 minutes after being 
diluted in distilled water. After that, samples were either filtered at 0.45µm with a 
filter unit (MILLEX®HA from MILLIPORE, Ireland), sonicated for 15mins or 
centrifuged at 3000rpm for 15mins. Measurement of Total Soluble Phenolic 
Contents (section 2.2.3) was done in triplicate. 
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2.3.3 Total Soluble Phenolic Content 
The total soluble phenolic assay, more commonly known as the Folin-Ciocalteu 
assay, was used for determination of the total phenolic content of extracts. Folin-
Ciocalteu reagents are not specific and detect all phenolic groups found in 
extracts, including those in the extractable proteins (Naczk & Shahid, 2004). In 
this assay, 5mg gallic acid was dissolved in 1ml ethanol and made up to 50ml 
with water to give a standard stock solution with a final concentration of 
0.1mg/ml. A standard curve of gallic acid ranging from 20ug/ml to 100µg/ml was 
prepared from the stock solution. In a cuvette, 0.25ml of water (control) or each 
standards or sample (all in duplicates) was mixed with 0.25ml Folin reagent 
(diluted to 50% with water). Finally, 0.5ml of saturated sodium carbonate was 
added to the mixture and left to stand at room temperature for 30 minutes. 
Absorbance was read immediately at 750nm using an Ultrospec III UV/VISIBLE 
spectrophotometer (Pharmacia LKB, USA). 
 
2.3.4 Reversed Phase High-Performance Liquid Chromatography (RP-
HPLC) with Diode Array Detector 
The equipment used for RP-HPLC was a Perkin Elmer 200 series (Supelco, 
Bellefonte PA, USA) equipped with a pump, an autosampler, as well as a variable 
wavelength diode array detector. The HPLC-system was interfaced with a 
personal computer powered with Perkin Elmer Totalchrom software. RP-HPLC 
analyses were performed using a 5 µm C18 column, 15cm long, 4.6mm internal 
diameter (Discovery C18, Sigma, USA) at 25°C column temperature and an 
injection volume of 10 µl. The solvent system  were run under the following 
conditions: equilibration to starting conditions 80% 0.02M sodium phosphate 
buffer pH 2.4: 20% methanol for 15min at 1ml/min, then changing to 80% 
methanol: 20% buffer on a linear gradient over 25min at 1ml/minute. Ultraviolet 
(UV) detection was recorded at 280 nm wavelength. For compound identification, 
retention time and peaks of standard individual polyphenols were compared with 
those found in the extract. 
 
2.3.5 Statistical Analysis 
Values for gallic acid equivalent (µg/ml) were expressed as means ± SEM. The 
data were analyzed using the statistical software Genstat 10.0. General Analysis 
of Variance with No Blocking was used. Significance was taken as p<0.05. 
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2.4 Results 
2.4.1 Total Polyphenol Content in Chloroform-Methanol Extract 
Figure 2.2 shows the Total Soluble Phenolic Content (section 2.2.3) of S. crispus 
extract after the various preparations (section 2.2.2). Samples prepared with only 
the sonication method were found to have the highest phenolic content (P<0.001) 
compared with other preparation methods with and without sonication. Filtering 
reduced the phenolic content detected (P<0.001) while centrifugation did not 
affect the presence of phenolic content in the extract (P=0.557). 
 
 
 
Figure 2.2 Polyphenol Content of Chloroform-Methanol Extracts After 
Treatment with Different Conditions 
 
  Sonication increased total phenolic content (P<0.001) while filtration decreased total phenolic 
content (P<0.001). Centrifugation did not affect total phenolic content (P=0.557). 
 
 
a 
c 
c 
b 
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2.4.2 Total Polyphenol Content in Hot water extract 
Figure 2.3 shows the total polyphenol content of S. crispus and Green hot water 
extracted using the hot water extraction method described in section 2.2.1.3. 
Phenolic contents were adjusted to phenolic concentration in a gallic acid 
standard. S. crispus tea was found to have a significantly lower total phenolic 
content than green tea (P<0.001). 
 
 
Figure 2.3 Polyphenol Content of Hot water 
extracts
 
S. crispus tea has significantly lower total phenolic content compared with green tea 
(P<0.001). 
 
 
 
 
 
 32 
 
2.4.3 HPLC Analysis of Various S. crispus Extract 
S. crispus hot water extract (section 2.2.1.3), diethyl ether extract (2.2.1.1) and 
chloroform-methanol extract (section 2.2.1.2) were analyzed by HPLC (section 
2.2.4) at 280nm and results (Figure 2.4, 2.5 and 2.6) were compared. 
 
Figure 2.4 HPLC Analysis of S. crispus Hot water extract  
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Figure 2.5 HPLC Analysis of Chloroform-methanol Extract  
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Figure 2.6 HPLC Analysis of Diethyl-ether Extract  
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2.5 Discussion 
2.5.1 Total Polyphenol Content in Chloroform-Methanol Extract 
Results suggest that a chloroform-methanol extract prepared by sonication with 
distilled water alone had the highest total phenolic content and filtration reduced 
this content significantly. This indicates that most phenolic substances in the 
extract existed as substrates bigger than 0.45µm. Thus, this preparation method 
was used subsequently to prepare the extract for the in vivo study (Chapter 3). 
 
2.5.2 Total Polyphenol Content in Hot water extract 
S. crispus tea and green tea were prepared under the same conditions and yet 
the total polyphenol content in green hot water extract was 7 times higher. 
However, we have to note that harvest season, age of the plant, climate, 
environmental conditions and processing conditions are some variables that 
could affect the values found in our study, as mentioned by Lin and colleagues 
(2003). Furthermore, the most common polyphenols in the human diet are not 
necessarily the most active within the body, either because they have a lower 
intrinsic activity or because they are poorly absorbed from the intestine, highly 
metabolized, or rapidly eliminated (Holst & Williamson, 2008).  
 
2.5.3 HPLC Analysis of Various S. crispus Extract 
Phenolics are not uniformly distributed in plants at the tissue, cellular and 
subcellular concentrations. Insoluble phenolics are the components of cell walls, 
while soluble phenolics are compartmentalized within the plant cell vacuoles 
(Pridham, 1960; Beckman, 2000). Extraction of phenolic compounds from plant 
materials is influenced by their chemical nature, the extraction method employed, 
sample particle size, storage time and conditions, as well as presence of 
interfering substances (Naczk & Shahidi, 2004). From the results obtained in this 
study, we can verify that the phenolic compounds of S. crispus extract may vary 
depending on the method of extraction and sovents used. It was also noted that 
the separation of chemical compounds in the chloroform-methanol extract was 
much better compared with other extraction methods. This is because solubility of 
phenolic compounds is governed by the type of solvent (polarity) used, degree of 
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polymerization of phenolics, as well as interaction of phenolics with other 
constituents and formation of insoluble complexes (Naczk & Shahidi, 2004). 
However, the number of chemical compounds detected by chloroform-methanol 
extract was very low compared with other extraction methods. Therefore, there is 
no uniform or completely satisfactory procedure suitable for extraction of all 
phenolics or a specific phenolic substance in plant materials.  
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2.6 Conclusion 
S. crispus hot water extract had a very low content of total polyphenols compared 
to the chloroform-methanol extract. Detection of chemical compounds using 
HPLC confirmed that the chloroform-methanol extract of S. crispus was found to 
clearly separate some compounds compared with other extraction methods. 
Furthermore, a high total phenolic content was measured particularly when the 
extract was sonicated in distilled water. For this reason, the chloroform-methanol 
extract preparation method was chosen for the subsequent study to investigate 
the effect of the the extract in vivo. 
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Chapter 3 ± In vivo effects of S. crispus Extract 
(SCE) 
 
 
3.1 Introduction 
 Previous research done during my MSc studies in Malaysia (Zawawi, 2007) 
showed that obese Sprague-Dawley rats fed a normal chow diet and treated with 
1% S. crispus extract (in drinking water ± approx. 1g/kg BW/day) for 14 weeks, 
reduced body weight, adipose tissue and liver weights and tended to lower body 
weight gain, plasma leptin and fasting glucose concentrations compared with 
control obese rats fed the same normal chow diet. They also had improved liver 
colour and reduced hepatic steatosis. There was no difference in food intake 
between the groups, suggesting that the S. crispus extract was not inducing a 
general malaise, but might be increasing energy expenditure. The lipolysis rate 
(plasma glycerol per gram abdominal fat) in the treated group was also found to 
be higher. This suggested that the extract was inducing lipolysis in the treated 
rats.  
 
The first low-density lipoprotein receptor (LDLr) knockout (KO) mouse model was 
developed by Ishibashi and colleagues (1993). The mice were found to have 
moderate hypercholesterolemia (total cholesterol ~250 mg/dl) on a chow diet with 
lipoprotein profiles similar to humans (i.e. elevated LDL cholesterol). On a high-
fat  KLJK FKROHVWHURO µ:HVWHUQ-W\SH¶ GLHW FRQWDLQLQJ  IDW DQG  DGGHG
cholesterol, LDLr KO mice developed severe hypercholesterolemia and extensive 
atherosclerosis (Ishibashi et al., 1993). Furthermore, when LDLr KO mice were 
placed on a diet with greater than 20% fat content they also became obese and 
insulin resistant (Wu et al., 2006). This is similar to one of the most severe forms 
of human hyperlipidemia, familial hypercholesterolemia, which occurs due to 
mutations in the LDLr gene, resulting in elevated concentrations of the 
atherogenic LDL cholesterol (Kennedy et al., 2010). Thus, the LDLr KO mouse 
model is useful when studying diet-induced obesity and associated diseases. 
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3.2 Hypothesis and Aim 
The hyphothesis of this study was that the SCE will reduce abdominal adipose 
tissue weight and improve the lipid profile of the treated group similar to the 
results found in a previous experiment using Sprague-Dawley rats. Therefore, the 
aim was to investigate the effect of SCE on LDLr KO mice that had been made 
obese by feeding a high fat (60%kcal) diet and then either maintained on the high 
fat diet or switched to a low fat diet. The changes in feeding behaviour, physical 
activity and energy expenditure were measured throughout 48hr periods at Week 
4 and 9 of treatment with SCE using an Oxymax Comprehensive Lab Animal 
Monitoring System (CLAMS). 
 
 
3.3 Methodology  
3.3.1 Preparation of S. crispus Extract in Water 
S. crispus leaves (oven dried at 40ºC overnight) were bought from Cedar Biotea 
Sdn. Bhd. (Penang, Malaysia). Leaves were ground to powder using a coffee 
grinder (CG100, KENWOOD, UK). Powdered leaves were stored in glass bottles 
and kept at -Û& EHIRUH XVH For extraction, 100g of powdered leaves was 
soaked and stirred continuously with chloroform-methanol (5:3, 500 ml of 
chloroform and 300 ml of methanol) for 12 hours. This mixture was then filtered 
with Whatman filter paper No.4 and solvent mixture containing the extract was 
collected into a round bottomed flask. The flask was then connected to a rotary 
evaporator (Rotavapor R-3000, Buchi, Switzerland) with water bath set at 37ºC to 
remove the majority of solvents, until the volume reached approximately 50ml. To 
evaporate the remaining solvents, crude extract were then divided into 2 pre-
weighed conical tubes and dried under a continuous flow of nitrogen gas. Further 
drying of the extract was done by drying the extract in an air oven overnight at 
37ºC to make sure that all solvents had evaporated. Green coloured extract in the 
form of a paste was obtained. The conical tubes containing the extract were kept 
at -40ºC until further use. 
 
To prepare the extract in water, distilled water was added to the extract paste and 
the mixture was then sonicated to increase polyphenol content (see chapter 2). 
Further dilution was done with more distilled water to give the concentration 
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needed (0.1% or 1%), before being given as drinking water to the mice 
(approximate dose was 1g/kg BW/day, assuming a mouse drinks 10ml/100g/day). 
 
 
3.3.2 Experimental Design 
Obesity was induced in 39 LDLr KO mice by giving high-fat (HF) diet (60% kcal 
fat, 5.24kcal/g, Research Diets D12492) for 24wks (Week -26 to Week -2). In 
addition 10 LDLr KO mice were given low-fat (LF) diet (normal chow, 17% kcal 
fat, 3.3kcal/g Harlan Teklad 2018) as control.  These were provided by RenaSci 
(Biocity, Nottingham, UK). At Week -2 (Baseline), 7 mice given the HF diet and 
10 mice given the LF diet were culled to obtain basal organ weights, plasma lipid 
concentrations and liver lipid concentrations. The remaining mice were 
individually housed and acclimatized for one week (Refer to Figure 3.1).  
At Week 0, animals were randomly allocated into one of four treatment groups: 
the H2O HFD group (n=8) were maintained on the HF diet and given normal 
drinking water; the SCE HFD group (n=8) were maintained on the HF diet and 
given 0.1% S. crispus extract (SCE) in their drinking water for Weeks 0-5 
followed by 1% SCE for Weeks 5-10; the H2O LFD group were switched to the LF 
diet and given normal drinking water; and the SCE LFD group (n=8) were 
switched to the LF diet and given 0.1% SCE in their drinking water for Weeks 0-5, 
followed by 1% SCE for Weeks 5-10 (Figure 3.1).  
An Oxymax Comprehensive Lab Animal Monitoring System (CLAMS) was used 
on Weeks -1, 4 and 9 of the study to measure 24hr profiles of oxygen 
consumption (VO2), carbon dioxide production (VCO2), respiratory exchange ratio 
(RER), food intake and physical activity. Food intake, bodyweight and water 
intake were also measured weekly in the home cages.  
All animal procedures were approved by the University of Nottingham Local 
Ethical Review Committee and were carried out in accordance with the UK 
Animals (Scientific Procedures) Act 1986. 
3.3.3 Comprehensive Lab Animal Monitoring System (CLAMS) 
The CLAMS (Columbus Instruments, Ohio, USA) is a system for measuring 
oxygen consumption, carbon dioxide release, heat produced, physical activity 
and feeding behaviour (see Figure 3.2) 
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Figure 3.1 Experimental Design for In vivo Study 
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Figure 3.2 Comprehensive Lab Animal Monitoring System (CLAMS) 
 
 
 
 
 
 
 
 
 
 
3.3.3.1 Oxygen Consumption and Carbon Dioxide Production 
The following equations were used to calculate oxygen consumption (VO2) and 
carbon dioxide production (VCO2). The oxygen consumption was calculated by 
taking the difference between the input oxygen flow and the output oxygen flow. 
Similarly, the carbon dioxide production was calculated by taking the difference 
between the output and input carbon dioxide flows. The consumption and 
production values have the units of milliliters per hour (ml/hr).  
VO2 = Vi O2i -Vo O2o  Vi and Vo are the input and output ventilation rates 
(litres per minute), O2i and O2o are oxygen fractions 
at the input and output 
VCO2 = VoCO2o -ViCO2i  Vi and Vo are the input and output ventilation rates 
(litres per minute), CO2i and CO2o are carbon 
dioxide fractions at the input and output 
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3.3.3.2 Respiratory Exchange Ratio (RER) 
The respiratory exchange ratio (RER) is simply the ratio between the carbon 
dioxide production and the oxygen consumption. This value is a ratio and thus 
does not have any units. The RER ratio was calculated before any units 
conversion, weight normalization, or effective mass correction. 
RER = VCO2 
VO2 
 
3.3.3.3 Heat Production 
Oxymax will calculate heat with one of two methods. Both methods calculate the 
heat before the application of any normalization or correction and, thus, reflect 
the exact heat of the subject. The method used here is termed Internal and will 
derive a calorific value (CV) based on the observed respiratory exchange ratio. 
This calorific value is then used with the observed oxygen consumption (VO2) to 
calculate heat. The equations are: 
Heat = CV × VO2 
CV = 3.815 +1.232 × RER 
More detail explanation of the equations are described in Appendix A. 
 
3.3.3.4 Locomotor Activity 
CLAMS is configured with double axis detection of animal motion using IR 
photocell technology (refer to Figure 3.3). Interruption of an IR beam accrued one 
³FRXQW´&RYHUDJHLQDVLQJOH plane was implemented with IR photocells located 
in the X direction. The height of these beams is such that they intersect the 
animal midway vertically. Placement of IR photocells at a height above the animal 
detected rearing or jumping (Z-axis). 
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Figure 3.3 IR Photocells for Detecting Locomotor Activity 
 
 
 
3.3.4 Animal Monitoring in the Cage 
The 49 male LDL-receptor knockout (LDLr KO) mice aged 35 weeks were kindly 
donated by RenaSci (Biocity, Nottingham, UK) and housed individually on a 12 hr 
day-night cycle (lights off 19:00, on 07:00). The temperature was set to a 
constant 27ºC. Mice had been fed either a HF diet (n=39, 60%kcal from fat, 
Research Diets D12492) or a LF diet (n=10, 17%kcal from fat, normal chow, 
Harlan Teklad 2018) for approximately 5 months. Individual mouse food (g/day) 
and water/ extract (ml/day) intakes were measured once a week. The body 
weight of each mouse was measured once a week. 
 
3.3.5 Sample Collections and Preparations 
After 10 weeks, all mice were killed by the administration of pentobarbitone. 
Abdominal fat pads, heart, kidney and liver were removed and weighed, then 
immediately snap frozen in liquid nitrogen before being stored at -80ºC. The rest 
of the carcass was also kept at -80 ºC for later determination of carcass lipid 
content. Blood samples were collected into heparin following cardiac puncture, 
centrifuged at 12500rpm for 1 hour at 4 ºC and the plasma stored frozen at -80 
ºC prior to determination of total cholesterol, triglyceride and glucose 
concentrations.  
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3.3.6 Liver Lipid Extraction 
This method was adapted from Hara and Radin (1978). Frozen livers were 
crushed using a biopulverisor while maintaining freezing temperature by adding 
liquid nitrogen to the sample in the biopulverisor.  
Crushed liver samples (300-350mg) were weighed into 15ml tubes containing 
5.4ml of hexane:isopropanol (3:2, v/v) and homogenized using the Polytron 
Homogenizer (PT2100, Kinematica, Switzerland). Homogenized sample was 
then poured into another 15ml tube containing 1.6ml sodium sulphate,vortexed 
for 30 seconds and then centrifuged at 3000rpm for 5 minutes at room 
temperature. The supernatant was then transferred to another 15ml tube and 
dried under a stream of nitrogen on a heating block until all the solvent had 
evaporated. 3ml of hexane was added around the sides of the tubes to wash 
them and stored at -20ºC until needed. After taking the sample from storage, 
150ul of each sample was removed and dried under nitrogen gas, before adding 
50ul of isopropanol. 
 
3.3.7 Triglyceride and Glycerol Quantification 
Plasma and liver triglyceride and plasma glycerol were measured using a Serum 
Triglyceride Determination Kit (TR0100, Sigma, Missouri USA). The procedure 
involves enzymatic hydrolysis by lipase of the triglycerides to glycerol and free 
fatty acids. The glycerol produced was then measured by coupled enzyme 
reactions.  
Triglycerides are first hydrolysed by lipoprotein lipase to glycerol and free fatty 
acids. Glycerol was then phosphorylated by adenosine-¶-triphosphate (ATP) to 
form glycerol-1-phosphate (G-1-P) and adenosine-¶-diphosphate (ADP), 
catalyzed by glycerol kinase (GK). G-1-P was then oxidized by glycerol 
phosphate oxidase (GPO) to form dihydroxyacetone phosphate (DAP) and 
hydrogen peroxide (H2O2). Peroxidase (POD) catalysed the coupling of H2O2 with 
4-aminoantipyrine (4-AAP) and sodium N-ethyl-N-3(3-sulfopropyl) m anisidine 
(ESPA) to produce a quinoneimine dye with an absorbance maximum at 540nm. 
A standard curve was present on each 96 well plate to enable calculation of the 
amount of glycerol present. 200µl of Triglyceride Reagent Blank (prepared 
DFFRUGLQJ WR PDQXIDFWXUHUV¶ LQVWUXFWLRQV ZDV DGGHG WR  O RI VDPSOH RU
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standard solution in each well. After incubation of the 96 well plate at 37°C for 
10mins, absorbance was measured at 550nm using a microplate reader (680XR, 
BIO-RAD, USA).The increase in absorbance is directly proportional to the free 
glycerol concentration of the sample.  
 
 
Figure 3.4 Triglycerides and Glycerol Assay Enzymatic Reactions 
 
                               Lipoprotein Lipase 
       Triglycerides    Glycerol + Fatty acids 
                                              GK 
       Glycerol + ATP                                         G-1-P + ADP 
 
                                         GPO 
       G-1-P + O2                                                DAP + H2O2 
 
                                                POD 
       H2O2 + 4-AAP + ESPA                             Quinoneimine dye + H2O 
 
 
 
3.3.8 Cholesterol Quantification 
Plasma and liver cholesterol was measured using Infinity Total Cholesterol 
reagent (TR13421, Thermo Scientific, UK). Cholesterol esters were enzymatically 
hydrolysed by cholesterol esterase to cholesterol and free fatty acids. Free 
cholesterol, including that originally present, was then oxidized by cholesterol 
oxidase to cholest-4-en-3-one and hydrogen peroxide. The hydrogen peroxide 
combines with hydroxybenzoic acid (HBA) and 4AAP to form a chromophore 
(quinoneimine dye), which absorbs at 550nm. A standard curve using Cholesterol 
Standard (TR13923, Thermo Scientific, UK) was present on each 96 well plate to 
enable calculation of the amount of cholesterol present. 190µl of reagent was 
added to 10 µl of sample or standard solution in each well. After incubation of the 
96 well plate at 37°C for 10mins, absorbance was measured at 550nm using a 
microplate reader (680XR, BIO-RAD, USA). 
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Figure 3.5 Cholesterol Assay Enzymatic Reactions 
                                           Cholesterol Esterase 
       Cholesterol Esters    Cholesterol + Fatty acids 
                                           Cholesterol Oxidase 
       Cholesterol + O2                                                 Cholest-4-en-3-one + H2O2 
 
                                                 Peroxidase 
       2H2O2 + HBA + 4AAP                                         Quinoneimine Dye + 4H2O 
 
 
 
3.3.9 Glucose Quantification 
Plasma glucose was measured using Infinity Glucose Oxidase reagent 
(TR15221, Thermo Scientific, UK). Glucose was oxidized by glucose oxidase to 
gluconic acid and hydrogen peroxide. The hydrogen peroxide reacts in the 
presence of peroxidase with HBA and 4-AAP forming a red quinoneimine dye. 
The intensity of the colour formed is proportional to the glucose concentration 
and can be measured photometrically at 550nm. A standard curve using Glucose 
Oxidase Standard (TR15103, Thermo Scientific, UK) was present on each 96 
well plate to enable calculation of the amount of glucose present. 250µl of 
reagent was added to 10 µl of sample or standard solution in each well. After 
incubation of the 96 well plate at 37°C for 10mins absorbance was measured at 
550nm using a microplate reader (680XR, BIO-RAD, USA). 
 
Figure 3.6 Glucose Assay Enzymatic Reactions 
 
                                            Glucose Oxidase 
       Glucose + O2 + H2O                                              Gluconic Acid + H2O2 
 
                                                 Peroxidase 
       H2O2 + HBA + 4-AAP                                             Quinoneimine Dye + H2O 
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3.3.10 Total Carcass Lipid Extraction 
To measure total lipid contents, individual mice carcasses were weighed in 
aluminium containers (with lid) and freeze dried, before frozen carcasses were 
put into individual clear plastic bags and crushed repeatedly with a hammer until 
only small pieces remained. Samples were then thoroughly mixed with a metal 
spoon and then transferred to smaller plastic bags before being stored at -40ºC 
until further extraction. 
For lipid extraction, 2g of each sample was weighed onto 11cm qualitative grade 
filter paper, then loosely folded to fit down to the bottom of a thimble. Samples 
were placed into a thimble and then covered with a plug of cotton wool. A flask 
containing 3 anti-bump stones was weighed and 155ml of petroleum ether added. 
The thimble was then placed into the flask which was then fastened to a Gerhadt 
Soxtherm (Gerhardt, UK) with an automated Rapid Soxhlet Extraction system run 
according to the official method of AOAC for determination of crude fat (991.36) 
with some minor modifications described below.  
Hot extraction process followed an AOAC approved method and consisted of 3 
steps: extraction, rinsing and drying. During extraction the petroleum ether, 
sample and flask was heated up, then, the flask was washed with petroleum 
ether before being evaporated, condensed, collected beneath the condenser and 
transferred to the solvent tank for reuse in each cycle. During each cycle, a 
portion of the non-volatile compound dissolves in the solvent. After many cycles 
the desired compound will be concentrated in the flask. After extraction the 
solvent was removed by drying the flask in an oven at 103ºC for 1 hour and then 
the flask was cooled down in a dessicator before being weighed.  
 
Calculation:                  Total lipid (%) = Weight of extract (g) X 100 
                                                                Sample weight (g) 
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3.4 Results 
3.4.1 Bodyweight Changes 
Figure 3.7 shows the changes in bodyweight from the start of treatment with HF 
diet and after treatment with SCE (0.1 and 1%) with or without the LF diet. The 
bodyweight of the HF diet groups significantly increased with time (P<0.001) 
compared with the LF diet group, such that at Week -1 the HF diet fed groups 
were 1.5 fold heavier than the LFD fed group. There were no significant 
differences  (P=0.327) in bodyweights at week -1 between the groups given HF 
diet and then divided into H2O, HFD, SCE, HFD, H2O LFD and SCE, LFD groups. 
 At Week 0 half the mice were switched to the LF diet and this significantly 
decreased bodyweight, whereas the mice maintained on the HF diet continued to 
increase in bodyweight  (P<0.001for time x diet interaction). Treatment with SCE 
tended to increase bodyweight, but this was not statistically significant (P=0.072). 
Data for Weeks 5 and 10 were not included in the statistical analysis, as 
bodyweights of all animals were found to be reduced after the 48hrs in the 
CLAMS.  
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Changes in bodyweight of LDLr KO mice fed either a high (HF) or low (LF) fat diet, before and after treatment with SCE. There were no significant differences in bodyweight at 
week -1 between all HF diet fed groups (P=0.327). After week 0, the mice switched to the LF diet decreased in bodyweight, whereas the mice maintained on the HF diet 
continued to increase bodyweight (P<0.001 for diet x week interaction). SCE treatment tended to increase bodyweight (P=0.077). 
Figure 3.7 Bodyweight Increase Before and After Treatment with SCE 
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3.4.2 Food Intake 
Figure 3.8 shows the mean food intake (g/week) consumed in the home cages. 
Data at Weeks 5 and 10 was not included because after animals were housed in 
the CLAMS at Weeks 4 and 9, their food intake was reduced the following week. 
There were significant effects of Week (P<0.001) and Diet (P<0.001), but no 
interaction (P=0.118). Intakes of LF diet were higher than the intakes of HF diet, 
with mean food intake in the HFD group across all weeks being 23.28g, whereas 
the mean intake in the LFD group across all weeks was 27.8g. SCE treatment 
had no effect on food intake (P=0.13). 
 
 
Figure 3.8 Mean Food Intake (g/week) 
 
Significant effects of Diet and Week were found (P<0.001 for both), but there was no interaction 
(P=0.118) and no effect of SCE treatment (P=0.13). 
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3.4.3 Energy Intake 
Figure 3.9 shows the mean energy intake (kcal/week) from diet consumed in the 
home cages. Data at Weeks 5 and 10 were not included because after animals 
were housed in the CLAMS at Weeks 4 and 9, their food intake was reduce the 
following week. There was a significant interaction between Week and Diet 
(P=0.012) where energy intake was found to be gradually increased from Week 4 
to Week 8, particularly in the HFD groups, before coming down at Week 9. LF 
diet clearly reduces the energy intake (P<0.001). Mean energy intake in the HFD 
group was 17.19kcal/week, whereas the mean energy intake in the LFD group 
across all Weeks was 12.88kcal/week. SCE treatment tended to increase energy 
intake slightly (P=0.082). 
 
 
Figure 3.9 Mean Energy Intake (kcal/week) 
  
Significant interaction between Week and Diet was found (P=0.012) and SCE tended to increase 
energy intake (P=0.082). 
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3.4.4 Feed Efficiency 
Figure 3.10 shows the mean feed efficiency (bodyweight gain (g)/food intake (g)) 
in all groups. Data at Weeks 5 and 10 was not included because after animals 
were housed in the CLAMS at Weeks 4 and 9, their body weight and food intake 
was reduced the following week. There was a significant interaction between 
Week and Diet (P<0.001). LF diet clearly reducedthe feed efficiency (P<0.001) 
particularly between Weeks 1 and 6. Mean feed efficiency across all weeks in the 
HFD group was 0.04g/g, whereas the average of LFD group across all weeks 
was -0.03g/g. SCE treatment did not have any effect on feed efficiency 
(P=0.701). 
 
 
 
Figure 3.10 Mean Feed Efficiency (g/g) 
 
 
 
 
 
 
 
 
 
 
LF diet reduced feed efficiency, particularly between Weeks 1 and 6 (P<0.001 for interaction), but 
there was no effect of SCE treatment (P=0.701) 
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3.4.5 Water Intake 
Figure 3.11 shows the mean SCE or water intake (ml/week) consumed in the 
home cages of each group. Data at Weeks 5 and Week 10 were not included 
because after animals were housed in the CLAMS at Week 4 and 9, their water 
intake was inaccurate the following week. No significant effect of Diet (P=0.495) 
was found on water intake. However, there was a significant Week x Extract 
interaction (P=0.025) on water intake, indicating that mean water intake was 
higher in the SCE groups at the start of the study, but lower at the end. This may 
cause the treated animals to receive less of the n 1%(w/w) SCE after the dose 
was increased at Week 5. 
 
 
 
 
Figure 3.11 Mean SCE or Water Intake (ml/week) 
 
A significant interaction between Week and Extract was found (P=0.025), but there was no effect of 
Diet (P=0.495) 
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3.4.6 Oxygen Consumption in the CLAMS 
Figures 3.12, 3.13 and 3.14 show the changes in oxygen consumption (VO2, 
ml/kg metabolic weight/hr) at Weeks -1, 4 and 9 observed over 24hrs. No 
significant effect of diet or extract was found at Weeks -1, 4 and 9. There was a 
significant effect of time of day at all weeks (P<0.001), as oxygen consumption 
was found to be higher at night when all the mice were awake and active, 
indicating the expected circadian rhythm. 
 
3.4.7 Carbon dioxide Production in the CLAMS 
Figure 3.15, 3.16 and 3.17 shows the changes in carbon dioxide production 
(VCO2, ml/kg metabolic weight/hr) at Weeks -1, 4 and 9 observed over 24hrs. 
There were no significant effects of diet or extract at Week -1, but there was a 
significant effect of time of day (P<0.001) indicating a circadian rhythm, with more 
carbon dioxide released at night when all the mice were awake and active. At 
Week 4, mice given the LF diet significantly increased (P=0.021) their carbon 
dioxide production and there was a significant time x diet interaction (P=0.025), 
indicating that at some timepoints, animals given the LF diet had higher carbon 
dioxide production than animals given HF diet. At Week 9, the effect of LF diet in 
increasing carbon dioxide production was even more significant than at Week 4 
(P<0.001), with no time x diet interaction, indicating carbon dioxide production 
was higher in the LF diet group at all timepoints. No significant effects of SCE 
were found at Weeks 4 or 9 (P=0.755 and P=0.134 respectively). 
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Figure 3.12 Mean Oxygen Consumption in the CLAMS at Week -1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.135) or Extract (P=0.984) on oxygen consumption, but a significant effect of Time of day (P<0.001) was found 
indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase 
(19:00-07:00, 12hrs).  
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Figure 3.13 Mean Oxygen Consumption in the CLAMS at Week 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.46) or Extract (P=0.356) on oxygen consumption, but a significant effect of Time of day (P<0.001) was found 
indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase 
(19:00-07:00, 12hrs).  
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Figure 3.14 Mean Oxygen Consumption in the CLAMS at Week 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.573) or Extract (P=0.574) on oxygen consumption, but a significant effect of Time of day (P<0.001) was found 
indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase 
(19:00-07:00, 12hrs).  
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Figure 3.15 Mean Carbon Dioxide Production in the CLAMS at Week -1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.056) or Extract (P=0.931) on carbon dioxide production , but a significant effect of Time of day (P<0.001) was found 
indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase 
(19:00-07:00, 12hrs).  
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Figure 3.16 Mean Carbon Dioxide Production in the CLAMS at Week 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was a significant Time of day x Diet interaction (P=0.025), but SCE had no significant effect on carbon dioxide production (P=0.755). White box indicates 
light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase (19:00-07:00, 12hrs).  
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Figure 3.17 Mean Carbon Dioxide Production in the CLAMS at Week 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LF diet significantly increased carbon dioxide production (P<0.001), but SCE had no significant effect on carbon dioxide production (P=0.134). A significant effect 
of Time of day (P<0.001) was found indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and 
black box indicates dark phase (19:00-07:00, 12hrs).  
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3.4.9 Respiratory Exchange Ratio (RER) in the CLAMS 
Figures 3.18, 3.19 and 3.20 show the changes in respiratory exchange ratio 
(RER) at Weeks -1, 4 and 9 observed over 24hrs. At Week -1, as expected, there 
were no effects of Diet (P=0.592) or Extract (P=0.693) on RER, but there was a 
significant effect of time of day (P=0.001). The range for RER values at Week -1 
were 0.73 to 0.83 for all groups. At Week 4 there was a significant Diet x Time of 
day interaction (P=0.013), with LF diet increasing the RER and reducing the 
circadian rhythm, but no effect of extract on RER was observed at this stage 
(P=0.111). At Week 9, there was no longer an effect of time of day on RER 
(P=0.225), but there were significant effects of Diet (P<0.001) and Extract 
(P=0.011), with RER being increased by LF diet, but reduced by SCE. 
 
3.4.9 Locomotor Activity in the CLAMS 
Figures 3.21, 3.22 and 3.23 show the changes in locomotor activity (successive 
beam breaks/9 minutes) at Weeks -1, 4 and 9 observed over 24hrs. As expected, 
there were significant effects of Time of day at Weeks -1, 4 and 9 (all P<0.001), 
indicating the expected circadian rhythm as mice were more active during the 
dark phase. No significant effects of Diet or Extract were found at any Week 
(P>0.1 for all). 
 
 
 63 
 
Figure 3.18 Respiratory Exchange Ratio in the CLAMS at Week -1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.592) or Extract (P=0.693) on respiratory exchange ratio, but a significant effect of Time of day (P<0.001) was found 
indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase 
(19:00-07:00, 12hrs).  
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Figure 3.19 Respiratory Exchange Ratio in the CLAMS at Week 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was a significant Time of day x Diet interaction (P=0.013), but SCE had no significant effect on respiratory exchange ratio (P=0.111). White box indicates 
light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase (19:00-07:00, 12hrs).  
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Figure 3.20 Respiratory Exchange Ratio in the CLAMS at Week 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LF diet significantly increased respiratory exchange ratio (P=<0.001) and SCE significantly decreased respiratory exchange ratio (P=0.011). There was no effect 
of Time of day (P=0.225). White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase (19:00-07:00, 12hrs).  
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Figure 3.21 Locomotor Activity in the CLAMS at Week -1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.351) or Extract (P=0.824) on locomotor activity, but a significant effect of Time of day (P<0.001) was found 
indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase 
(19:00-07:00, 12hrs).  
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Figure 3.22 Locomotor Activity in the CLAMS at Week 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.191) or Extract (P=0.843) on locomotor activity, but a significant effect of Time of day (P<0.001) was found 
indicating the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase 
(19:00-07:00, 12hrs).  
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Figure 3.23 Locomotor Activity in the CLAMS at Week 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.147) or Extract (P=0.846) on locomotor activity, but a significant effect of Time of day (P<0.001) was found indicating the 
presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase (19:00-07:00, 12hrs).  
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3.4.10 Heat Production in the CLAMS 
Figures 3.24, 3.25 and 3.26 show the heat produced in the CLAMS (kcal/hour) at 
Weeks -1, 4 and 9 observed over 24hrs. At Week -1, as expected, there were no 
effects of Diet (P=0.059) or Extract (P=0.086) on heat production, but there was a 
significant effect of time of day on heat production (P<0.001). The range for heat 
production values at Week -1 were between 0.6 to 1.05 for all groups. At Week 4 
there were significant effects of Extract (P=0.048), Diet (P<0.001) and Time of 
day (<0.001). Extract was found to increase heat production, while LF diet 
decreased heat production and the effect of Time of day indicated the presence 
of a circadian rhythm. At Week 9, there was no longer an effect of Extract on heat 
production (P=0.193), but there were significant effects of Diet (P<0.001) and 
Time of day (P<0.001), with heat production being reduced by LF diet and a 
circadian rhythm being observed. 
 
3.4.11 Meal Frequency in the CLAMS 
Figures 3.27 and 3.28 shows the frequency of meals in the CLAMS measured as 
number of meals at Weeks -1, 4 and 9 observed for 24hrs (7hr light phase and 
7hr dark phase). The number of meals was recorded in the CLAMS each time the 
mice returned to the feeding trap (Figure 3.2). The data for Week 4 was missing 
as a result of an equipment problem. There was a similar problem with the 
measurements at Weeks -1 and 9, such that only data for the last 24hrs was 
available, meaning that the data are presented slightly differently in terms of the 
light;dark cycle.  No significant effects of diet or extract were observed at both 
Week -1 (P=0.199, P=0.349) and Week 9 (P=0.35, P=0.939). However, as 
expected, there was a significant effect of Time of day on meal frequency at 
Week -1 (P=0.004) and Week 9 (P<0.001), the number of meals being higher 
during the dark phase when the animals were awake compared with the light 
phase when animals were asleep or resting. 
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Figure 3.24 Heat Production in the CLAMS at Week -1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.059) or Extract (P=0.086) on heat production, but a significant effect of Time of day (P<0.001) was found indicating 
the presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase (19:00-07:00, 
12hrs).  
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Figure 3.25 Heat Production in the CLAMS at Week 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were significant effects of Diet (P<0.001). Extract (P=0.048) on heat production. Significant effect of Time of day (P<0.001) was also found indicating the 
presence of a circadian rhythm. White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase (19:00-07:00, 12hrs). 
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Figure 3.26 Heat Production in the CLAMS at Week 9 
 
 
 
 
 
 
 
 
 
 
 
  
There were significant effects of Diet (P<0.001) and Time of day (P<0.001) on heat production indicating the presence of a circadian rhythm. No effect of SCE was 
found (P=0.193). White box indicates light phase (11:00-19:00, 8hrs and 07:00-11:00, 4hrs) and black box indicates dark phase (19:00-07:00, 12hrs). 
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Figure 3.27 Meal Frequency in the CLAMS at Week -1 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.199) or Extract (P=0.349) on meal frequency, but a significant effect of Time of day (P=0.004) was found indicating the 
presence of a circadian rhythm. White box indicates light phase (07:00-19:00, 12hrs) and black box indicates dark phase (19:00-07:00, 12hrs). 
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Figure 3.28 Meal Frequency in the CLAMS at Week 9 
 
 
 
 
 
 
 
 
 
 
 
 
There were no significant effects of Diet (P=0.35) or Extract (P=0.939) on meal frequency, but a significant effect of Time of day (P<0.001) was found indicating the 
presence of a circadian rhythm. White box indicates light phase (07:00-19:00, 12hrs) and black box indicates dark phase (19:00-07:00, 12hrs). 
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3.4.12 Plasma Glucose and Lipid Concentrations 
Plasma glucose and lipid concentrations were analyzed from plasma obtained at 
Baseline (Week -2) and at the end of the study (Week 10). For data at Baseline 
(Table 3.1), samples were taken from control obese mice (n=7) given HF diet and 
control lean mice (n=10) given LF diet for 25 weeks. For data at Week 10 of 
treatment (Table 3.2), samples were taken from the diet and SCE treated groups.  
At Baseline (Table 3.1), HF diet was found to have significantly increased plasma 
glucose, total cholesterol and glycerol concentrations (all P<0.001) compared 
with LF diet. Plasma triglyceride concentrations were numerically higher in the HF 
diet, but this was not statistically significant (P=0.376). At Week 10 of treatment 
(Table 3.2), LF diet was found to significantly reduce plasma glucose, total 
cholesterol, glycerol and triglyceride concentrations (all P<0.001). There was a 
significant interaction between diet and extract (P=0.013) on plasma total 
cholesterol concentrations, due to SCE increasing the total cholesterol 
concentrations, but only in the HF diet group. SCE also significantly increased 
(P=0.032) plasma glycerol concentrations in both HF and LF diet groups. 
 
3.4.13 Liver Lipid Content 
Liver lipid contents were analyzed from livers obtained at Baseline at the end of 
the study (week 10 of treatment), which were homogenized in isopropanol. For 
data at Baseline (Table 3.1), samples were taken from the livers of control obese 
mice (n=7) given HF diet and control lean mice (n=10) given LF diet for 25weeks. 
For data at Week 10 of treatment (Table 3.2), samples were taken from diet and 
SCE treated groups.  
At Baseline (Table 3.1), significant increases in liver triglycerides and cholesterol 
content (all P<0.001) were found in the HF diet group and this was maintained at 
Week 10 of treatment (Table 3.2, all P<0.001). SCE increased liver cholesterol 
contents (Table 3.2), but only in the HF diet group (P=0.032 for Diet x extract 
interaction). 
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3.4.14 Carcass Lipid, Bodyweight and Organ Weight 
At Baseline and at the end of the study (Week 10 of treatments), mice were 
weighed, culled and then their abdominal fat, liver and heart were dissected out 
and weighed and the remaining carcasses were homogenized and analyzed for 
total lipid content. For data at Baseline (Table 3.1), samples were taken from 
control obese mice (n=7) given HF diet and control lean mice (n=10) given LF 
diet for 25weeks. For data at Week 10 of treatment (Table 3.2), samples were 
taken from the diet and SCE treated groups.  
At Baseline (Table 3.1), HF diet was found to significantly increase body weight 
(P<0.001), abdominal fat weight (P=0.002), carcass lipid content (P<0.001), liver 
weight (P<0.001) and heart weight corrected for bodyweight (P=0.022).  Similarly, 
at Week 10 (Table 3.2), HF diet significantly increased body weight (P<0.001), 
abdominal fat weight (P<0.001), % abdominal fat (P<0.001), carcass lipid content 
(P<0.001), liver weight (P<0.001), % liver weight (P=0.001) and % heart weight 
(P=0.022) compared with LF diet.  The only significant effects of SCE were to 
increase liver weight (P=0.019) and% liver weight (P=0.029), to decrease % heart 
weight (P=0.047) and a tendency to increase body weight (P=0.072) and 
abdominal fat weight (P=0.079). 
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Table 3.1 Plasma and Liver Contents, Carcass Lipid and Organ Weights at 
Baseline 
Diet High Fat 
(n=7) 
Low fat 
(n=10) 
SED P-value 
Weights and % 
Body weight (g) 48.84 36.48 1.859 <0.001 
Abdominal fat wt (g) 3.43 2.29 0.312 0.002 
% Abdominal fat (g/100g 
BW) 
7.03 6.15 0.639 0.191 
Carcass lipid (% dry wt) 71.5 54.0 2.27 <0.001 
Liver wt (g) 2.328 1.697 0.1194 <0.001 
% Liver wt (g/100g BW) 4.773 4.643 0.1785 0.478 
Heart wt (g) 0.2023 0.1853 0.0161 0.308 
% Heart wt (g/100g) 0.412 0.514 0.0398 0.022 
Plasma concentrations 
Glucose (mg/ml) 3.386 2.389 0.158 <0.001 
Total Cholesterol (mM) 25.1 10.8 2.77 <0.001 
Triglycerides (µg/ml) 2637 2178 502.7 0.376 
Glycerol (µg/ml) 1510 375 186.3 <0.001 
Liver contents 
Triglycerides (µmol/g) 245.1 44.0 19.58 <0.001 
Cholesterol (µmol/g) 15.19 10.16 1.135 <0.001 
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Table 3.2 Plasma and Liver Contents, Carcass Lipid and Organ Weights at 
Week 10 of Treatments 
Diet (D) High Fat Low fat  P- values: 
Extract (E) Cont 
(n=8) 
SC 
(n=7) 
Cont 
(n=8) 
SC 
(n=8) 
SED D E D x E 
Body weight (g) 
 52.8 58.4 40.03 42.53 2.63 <0.001 0.072 0.413 
Abdominal fat wt (g) 
 3.51 3.99 2.01 2.22 0.27 <0.001 0.079 0.493 
% Abdominal fat wt (g/100g BW) 
 6.65 6.86 4.99 5.12 0.47 <0.001 0.607 0.909 
Carcass lipid (% dry wt) 
 71.64 78.16 59.62 61.77 4.50 <0.001 0.117 0.407 
Liver wt (g) 
 2.96 3.81 2.03 2.23 0.298 <0.001 0.019 0.134 
% Liver wt (g/100g BW) 
 5.52 6.50 5.03 5.19 0.35 0.001 0.029 0.108 
Heart wt (g) 
 0.200 0.191 0.186 0.176 0.020 0.327 0.536 0.967 
% Heart wt (g/100g) 
 0.382 0.323 0.464 0.420 0.035 0.001 0.047 0.761 
Plasma Glucose (mg/ml) 
 3.28 3.50 2.26 2.52 0.288 <0.001 0.249 0.923 
Plasma Cholesterol (mM) 
 27.24 36.90 11.07 12.56 2.167 <0.001 0.001 0.013 
Plasma Triglycerides (µg/ml) 
 2463 2817 1224 1516 301.3 <0.001 0.141 0.884 
Plasma Glycerol (µg/ml) 
 1602 2324 189 428 300.5 <0.001 0.032 0.266 
Liver Triglycerides (µmol/g) 
 317 416 76 174 3807 <0.001 0.001 0.979 
Liver Cholesterol (µmol/g) 
 17.64 23.81 11.68 10.58 2.276 <0.001 0.127 0.032 
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3.5 Discussion 
3.5.1 HF Diet Induced Obesity in LDLr KO mice  
Traditionally, leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice 
have been used for studies of obesity but their utility in studying atherosclerosis is 
limited (Coenen & Hasty, 2007). On the other hand, the LDLr KO mouse has 
been used extensively as a research model to investigate pathways involved with 
lipid metabolism and as an in vivo model for atherosclerosis (Kennedy et al., 
2009; Lewis et al., 2009; Wouters et al., 2005). On high fat or high cholesterol 
µ:HVWHUQW\SH¶GLHWs containing 21% fat and 0.15% added cholesterol, LDLr KO 
mice develop severe hyperlipidemia and extensive atherosclerosis (Ishibashi et 
al., 1993). Furthermore, LDLr KO mice have also been reported to exhibit diet-
induced weight gain with high fat diet feeding (Wu et al., 2006) making it viable to 
use as a model for obesity research (Coenen et al., 2007; Merat et al., 1999; 
Bernal-Mizrachi et al., 2003; Schreyer et al., 2003; Towler et al., 1998). Thus, in 
this study, the LDLr KO mouse model was used to study the effect of SCE (0.1 
and 1%w/w) on diet-induced obesity in the presence of hyperlipidemia.  
HF diet feeding allows the characterization of obesity development and the 
evaluation of anti-obesity interventions in an in vivo experimental setting that is 
pathophysiologically similar to the human disease (Buettner et al., 2007). We 
found many attributes of obesity in the HF diet-fed group at Baseline, before any 
treatments were started.  
Hence, the HF diet was found to induce obesity. After 25weeks of feeding the HF 
diet, bodyweights were found to be significantly higher (P<0.001) than the LF 
diet-fed control group, with the HF diet-fed group increasing their bodyweight by 
127%, while the LF diet-fed group only increased their bodyweight by 70% 
(Figure 3.2). As a rule, experimental animals eating LF diets do not become 
obese (Bray et al., 2004). Development of obesity in animals eating HF diets is 
the expected outcome (Bray et al., 1990; West & York, 1998). It has also been 
studied by Cha and colleagues (2001) that when animals are exposed to several 
concentrations of dietary fat, there is a dose-response curve with a threshold at 
about 25% dietary fat. This suggests that the concentrations of dietary fat need to 
exceed 25% in the diet before obesity develops. In our case, the 34.9(% per g) or 
60%kcal of fat in the HF diet successfully induced obesity.  
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The abdominal and carcass fat and liver weights of HF diet-fed groups had 
increased, and their plasma glucose, total cholesterol and glycerol concentrations 
were also higher than the LF diet-fed controls (Table 3.1). Liver triglycerides and 
cholesterol had also risen above the concentrations in LF diet-fed group (Table 
3.1). In humans, these attributes contribute to health related problems such as 
diabetes, cardiovascular disease (CVD), non-alcoholic fatty liver disease 
(NAFLD), osteoarthritis and sleep apnea (Bray, 2004). 
Mice have been the predominant model of energy homeostasis and obesity in 
humans (Thibault et al., 2004), because of the attributes of diet-induced obese 
mice as a result of excessive energy intake and weight gain induced by the use 
of energy-dense foods, which is similar to human subjects. However, it must be 
noted that the environment of the mice studied is fully controlled (they are 
individually housed in cages that limit physical activity, in rooms controlled for 
temperature and humidity with food available nearby). Human obesity is a more 
complex multifactorial condition that has been related to excessive food 
consumption, low energy expenditure, genetics, gender, age, socio-economic 
status, ethnicity, educational concentration, smoking status and many other 
factors (Thibault et al., 2004). Thus, while controlled conditions in the diet-
induced obese mice were necessary to enable experimental control, they do not 
necessarily mimic the normal human condition. 
 
3.5.2 Change to a Low Fat Diet Reduces Obesity in LDLr KO Mice 
LF diets were given to LF groups at Week 0, after they were taken out of the 
CLAMS, together with the first treatment of 0.1% (w/w) SCE. Effects of 
treatments on bodyweight, food intake, energy intake, feed efficiency, feed 
energy efficiency, water intake, were measured weekly in their home cage, while 
effects on oxygen consumption, carbon dioxide production, respiratory exchange 
ratio, locomotor activity, heat production and meal frequency were measured in 
the CLAMS at weeks -1, 4 and 9. Finally, organ weights, plasma glucose and 
lipid concentrations and liver and carcass lipid contents were measured after 
death at the end of the experiment (week 10). 
In the homecages, the bodyweights of LF groups (LFD, H2O and LFD, SCE) 
immediately decreased after 1 week consumption of LF diet and continued to 
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decrease until Week 5 when their bodyweights became stabilized (Figure 3.2). 
The loss of bodyweight was as a result of reduced total body fat, liver and heart 
weights (Table 3.2). Even though food intake was found to be significantly 
increased by the LF diet (refer to section 3.3.2), the total energy intake of LF diet-
fed groups was significantly lower than the HF diet-fed groups (refer to section 
3.3.3) and this resulted in decreased feed efficiency (refer to section 3.3.4) which 
contributed to the decrease in bodyweights. LF diet was also found to improve 
(reduce) plasma glucose and lipid concentrations and also liver lipid contents 
(Table 3.2). Plasma glucose, total cholesterol, trigylcerides and glycerol 
concentrations were all decreased in LF diet-fed groups. Similarly, liver 
triglyceride and cholesterol contents were also reduced by LF diet. Only water 
intake was not altered by LF diet (refer to section 3.3.6).   
                                                                                                                                                               
In the CLAMS, LF diet was found to have no significant effect on oxygen 
consumption (refer to section 3.3.7), but carbon dioxide release was found to be 
increased at some timepoints at Week 4 and became significantly increased at all 
timepoints at Week 9 (refer to section 3.3.8). Since RER is the ratio of VCO2 
(total carbon dioxide production) to VO2 (total oxygen consumption), obviously the 
increased VCO2 at Weeks 4 and 9 lead to the significant increase of RER by LF 
diet. The RER value is used to indicate nutrient utilization (Westerterp, 1993). 
When the RER value is shifted closer to 1, this indicates reliance on carbohydrate 
as the major energy substrate. On the other hand, if the RER value is shifted 
closer to 0.7, this indicates a major reliance on fat oxidation (McNeill et al., 1988). 
In our study, when HF diet was switched to LF diet which had 40% higher 
calories from carbohydrate, the RER increased indicating that the animals 
increased their utilization of carbohydrates. LF diet was found to have no effect 
on the frequency of meals taken by the animals at Week 9 even though their food 
intake was increased in the home cages. Unfortunately a technical problem 
meant that the data at Week 4 were lost. 
It is well known that when obese subjects (rodents and humans) are given a LF 
diet ad libitum, it is effective in inducing weight loss and improves plasma lipid 
profile (Astrup et al., 2000a; Astrup et al., 2000b; Schaefer et al., 1995; Harris et 
al, 1986; Uhley & Jen, 1989) and our findings confirm this. However, weight 
reduction does not always reverse obesity condition (Bray et al., 2004). Previous 
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research confirmed that both mice and rats increase their number of fat cells after 
eating a HF diet for an extended time and these cells remain after dietary fat is 
reduced (Lemmonier, 1972; Faust et al., 1978; Hill, 1990; Hill et al., 1992; Rolls et 
al., 1980).  
Interestingly, locomotor activity did not increase after the diet was switched to LF 
diet although three main factors appear to participate in body-weight 
maintenance: metabolic utilization of nutrients, dietary habits and physical activity 
(Martinez, 2000). Energetic cost of physical activity was found to be one of the 
major components of energy expenditure that may influence body weight and 
composition (Tremblay & Almeras, 1996; Westerterp & Goran, 1997). In our 
study, after HF diet was switched to LF diet, the mice consumed less energy and 
their metabolic utilization changed towards carbohydrate, but their food intake 
increased, possibly to compensate for the reduced energy intake. However, their 
frequency of meals and locomotor activity were not affected, indicating that lower 
energy intakes were enough to decrease body weight and improve the blood lipid 
profile in obese LDLr KO mice. 
 
3.5.3 S. crispus Extract Decreased RER Without Altering Food Intake or 
Other Variables in LDLr KO Mice 
S. crispus leaves have been claimed to have many health benefits. In the 
previous chapter, we found that S.crispus crude extract contains polyphenols and 
HPLC analysis showed that chloroform-methanol extract clearly separated one 
particular polyphenol although the specific type of polyphenols is yet to be 
identified. In 1983, Soediro and colleagues discovered verbascoside (an ester 
glycosidic compounds of caffeic acid) and in 1987 they found 7 more phenolic 
acids (p-hydroxy benzoic, p-voumeric, caffeic, vanillic, gentinic, ferulic and 
syryngic) in extracts of S. crispus. In this study, we sought to find out whether a 
chloroform-methanol extract of S. crispus (SCE) had any antiobesity effect in 
obese LDLr KO mice. 
Results from the data taken in the homecages indicate that SCE did not have any 
significant effect on bodyweights, food or water intake (refer to section 3.3.1, 
3.3.2, 3.3.6), but was found to significantly increase the percentage of liver and 
heart weights and increased plasma glycerol and liver triglyceride content (refer 
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to Table 3.2). Plasma and liver cholesterol concentrations were also increased, 
but only in the HF diet fed groups. The LF diet decreased the cholesterol 
concentrations, with no effect of SCE observed. From these results, we suggest 
that SCE may induce adipose tissue lipolysis (increased plasma glycerol), though 
not at a high enough concentration to significantly reduce adipose tissue weights 
or total body fat content at the time measured. However, the increase in plasma 
and liver cholesterol could contribute to the development of arteriosclerosis.  
In the CLAMS, SCE was found to significantly decrease the RER value at Weeks 
4 and 9. The decreased RER suggests that SCE increased lipid oxidation, which 
may be a positive effect. Concomitantly, heat production was found to increase at 
Week 4 but the effect was diminished at Week 9. One possible reason for the 
diminished effect is tolerance towards SCE over a longer period of time. From the 
view of homeostatic control mechanisms, the brain is charged with maintaining 
body weight (or fat mass or energy content) at a given value (the set point), 
opposing change, and restoring it following any significant deviation (Fernstorm & 
Choi, 2008). Hence, when the heat production increased, the brain might sense 
change and oppose it by attempting to restore body weight to the set point value, 
perhaps by down-regulating the function of receptors involved. Although the 
volume intake of 1%(w/w) SCE was decreased 20-30% compared with earlier 
volume intake (section 3.3.5), this would not be account for the diminished effect, 
as the dose would only decrease between 20-30% leading to the consumption of 
0.7 to 0.8%(w/w) of SCE. The reason for the decreased intake of SCE at 
1%(w/w) may be due to a less acceptable taste of the more concentrated SCE.  
 
Most weight loss agents fall broadly into two biological effect areas: those that 
affect energy intake (appetite suppressants and malabsorption agents) and those 
that affect energy expenditure (Clapham & Arch, 2011). In this case however, 
although the energy expenditure was  increased due to the increased heat 
production via the decrease of RER value, these effects were not enough to 
reduce adiposity in the obese LDLr KO mice and thus were not sufficient to 
VXJJHVW LWV¶ XVH LQ WUHDWLQJ REHVLW\ $QRWKHU FRPSDUDEOH VWXG\ ZKLFK XVHG
molokheiya leaves (Corchorus olitorius L.) to reduce diet-induced obesity in HF 
diet fed LDLr KO mice had more convincing results, with body weight gains and 
epididymal adipose tissue and liver weights being reduced, as well as plasma 
glucose and triglyceride concentrations lowered and activation of beta oxidation 
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was detected although the experiment is not exactly similar as the mice in this 
study were not obese at the start of the experiment at treatments were only done 
for 8 weeks  (Wang et al., 2011).  
 
 
3.6 Conclusion 
Obesity was successfully induced in LDLr KO mice, with many attributes of 
obesity comparable with that of human obesity. LF diet successfully improved the 
obesity condition, by lowering energy intake but without increasing energy 
expenditure and heat production. SCE was found to increase lipolysis, heat 
production and fat oxidation in obese LDLr KO mice, but not enough to be 
suggested as an anti-obesity agent. However, tolerance towards heat production 
might be masking the real effects and so the measurements for adipose tissue 
weights, lipid and liver lipid contents might be different if it were to be measured 
at Week 4. The hypothesis was not met as effects of SCE on obese LDLr KO 
mice was found to be different to those found in diet-induced obese Sprague-
Dawley rats (Zawawi, 2007), where adipose tissue weight was lowered and blood 
lipid profile was found to be improved. The effect of genetic background 
especially on the bioavailability of across different species and different response 
to different SCE doses might be responsible for the differences in the results 
found. In vitro adipose tissue explant studies will be carried out next, to establish 
whether the increased plasma glycerol concentrations in LDLr KO mice are due 
to a direct lipolytic effect of SCE on adipose tissue. 
 
 
 
 
 
 
 
 85 
 
Chapter 4 - In vitro effects of SCE in the Rat and 
Human Adipose Tissue Explants 
 
4.1 Introduction 
Adipose tissue contains different cell types. Only one third of the tissue is 
constituted by adipocytes and the rest is represented by fibroblasts, 
macrophages, stromal cells, monocytes and preadipocytes (Geloen et al, 1989). 
The decrease of adipose tissue mass that occurs with weight loss may involve 
the mobilization of lipids through lipolysis, inhibiting adipogenesis or the loss of 
PDWXUHIDWFHOOVWKURXJKDSRSWRVLV3ULQV	2¶5DKLOO\6RULVN\et al., 2000). 
Preadipocytes do not have lipolytic activity until they are differentiated to mature 
adipocytes (Hauner et al., 2001). Thus, most studies that investigate the direct 
effect of treatments on lipolysis will usually involve a unipotential cell line (e.g. 
3T3-L1) that can only give rise to mature adipocytes (Frigolet Vasquez-Vela et 
al., 2008). However, mature adipocytes lack other constituents found in the 
normal adipose tissue in vivo. The advantage of using whole tissue explants 
instead of isolated adipose cells is that the tissue contains cells at all stages of 
differentiation, including pre-adipocytes, immature adipocytes and mature 
adipocytes, which are known to secrete different hormones at different stages of 
differentiation. A number of studies have used cultured adipose tissue explants to 
more closely mimic the adipose tissue in the body and measure glycerol release 
into the medium as a quantitative measure of lipolysis (Lanna et al., 1995; Porter 
et al, 2002; Baldwin et al., 2007). Early studies often used whole epididymal fat 
pads from rats (Vaughan, 1961; Vaughan, 1962; Rodbell, 1960). 
 
4.2 Hypothesis and Aim 
As seen in the previous chapter, SCE induced fat oxidation and increased 
glycerol concentration in the blood. In this study, we hypothesized that 
application of SCE will result in an enhancement of lipolysis in rat and human 
adipose tissue explants. The aim was to optimize the method for measuring 
lipolysis in rat fat explants, based on the method described by Budd and 
colleagues (1994) and Rodbell (1960) and further modified by Headland (2007) 
for adipose tissue from pigs. The optimized method will then be used in the 
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human fat explants (if applicable). Thus, effect of SCE on lipolysis in different 
species will be determined. 
 
4.3 Methodology  
All work was carried out aseptically, using sterile consumables washed 
repeatedly with ethanol (70%) to maintain sterility. In the cell culture laboratory, 
all work was carried out in a sterile laminar flow hood on a heating block set to 
50ºC. This was found to maintain the media temperature within the plates at 37ºC 
(Headland, 2007). 
 
4.3.1 Sample Preparation 
4.3.1.1 Rat Adipose Tissue 
Male Sprague-Dawley rats weighing 350 ± 400g were obtained from Harlan, UK 
and housed in pairs. Normal AIN diet was given ad libitum and the rats also had 
free access to water. The temperature of the housing was maintained at 21 
±1ºCand the rats were exposed to a 12hours light cycle (lights on at 0700hrs; 
lights off at 1900hrs). Rats were terminated by increasing CO2 exposure in a 
closed chamber and the neck was quickly broken to ensure minimum suffering to 
the animals. The abdomen was aseptically wiped and opened and epididymal or 
perirenal adipose tissue from both sides removed. 
 
4.3.1.2 Human Adipose Tissue 
4.3.1.2.1 Selection and Withdrawal of Participants 
Patients (all non-smoking) with a BMI over 40, or over 35 with a co-morbidity, 
referred to the obesity clinic at Derby were selected. 
Enrolment 
All patients approached to participate in the study had been referred to the 
Bariatric Clinic, Derby Royal Hospital for bariatric surgery.  A Patient Information 
Sheet was given to each patient several weeks before consent was obtained.  
Patients returned for a pre-operative assessment prior to surgery, at which time 
written informed consent was obtained.  A Unique Patient ID was allocated to all 
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patients in the Consent form which was used to identify their data. Patient 
enrolment and obtaining informed consent were carried by clinicians involved in 
the study including Ms Kwak, Prof Larvin, Dr Tan, Mr Leeder and Mr Ahmed. 
Inclusion criteria 
Patients who were undergoing bariatric surgery and were above 16 years of age 
were included. 
Exclusion criteria 
Patients who were undergoing emergency surgery were excluded, since they 
were unable to give informed consent and may have mental incapacity. 
Participants who might not adequately understand verbal explanations or written 
information given in English were also excluded. 
 
4.3.1.2.2 Procedures for Obtaining Adipose Tissue Samples 
During Laparoscopic (keyhole) Bariatric surgery it is often necessary to remove 
small segments of intra-abdominal fat in order to gain access to the operative 
area.  This visceral adipose tissue may consist of omentum tethered in the upper 
abdomen, or perigastric adipose.  Division of adherent fat is a routine part of 
surgery, and carries very little risk. It is usually affected by diathermy 
(electrocautery), or by scissors followed by diathermy. Adipose tissue contains 
small blood vessels and diathermy is usually highly effective in securing 
haemostasis.   
Intra-operatively, after obtaining liver retraction, a small sample (up to 30 g, the 
weight of a typical omental adipose tissue from these patients would be several 
kilos) of omental fat was removed to facilitate the pars flaccida dissection. An 
omental adipose tissue sample may be obtained here or during the placing of the 
gastric band reservoir. No additional incisions were necessary for the purposes of 
this study. 
 
4.3.1.2.3 Transport and Storage of Tissues 
After the adipose tissue sample was collected, it was directly placed in a sterile 
VSHFLPHQ SRW LQ ZDUP 0 PHGLD VROXWLRQ ODEHOOHG ZLWK WKH UDW RU SDWLHQW¶V
identification reference allocated on their consent form.  The sample was 
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transported immediately to the Tissue Culture Laboratory either in the Division of 
Nutritional Sciences, School of Biosciences (rat adipose tissue explants) or 
Clinical Sciences, School of Graduate Entry Medicine and Health (GEM), Derby 
(human adipose tissue explants).   
 
4.3.1.3 Preparation of SCE 
SCE was prepared from dried S.crispus leaves as described in Chapter 3, 
section 3.2.1 with the exception that water was replaced with Phosphate Buffered 
Saline solution. The concentrations used were based on the phenolic content, as 
measured in gallic acid equivalents (refer to the section that describes the 
phenolic assay). 
 
4.3.2 Media Preparation 
All media were prepared at least 1 day prior to use. Preparation was according to 
WKHPDQXIDFWXUHU¶VLQVWUXFWLRQVEXWPRGLILHGVOLJKWO\7UDQVSRUWPHGLDDQGFXOWXUH
media were prepared as shown in Table 2.0, while Krebs-Ringer Bicarbonate 
(KRB) media was prepared as shown in Table 2.1. Both culture and KRB media 
were left to stir overnight at room temperature, after all the constituents were 
added and pH adjusted, in order to make sure that the bovine serum albumin 
(BSA) was mixed thoroughly. The next day, the media was sterile-filtered using a 
0.22µm pore sized filter and kept at 4 ºC until needed. 
 
Table 4.1 Preparation of M199 Media 
 Transport Media Culture Media 
Powdered media (for 1 litre) M199 (9.5g) M199 (9.5g) 
HEPES 25mM - 
Sodium hydrogen carbonate  2.2 g/L 
Penicillin-Streptomycin 10 ml/L 10 ml/L 
Gentamycin 1ml/L 1 ml/L 
pH (adjusted with 1N NaOH or 1N HCl  7.4 7.4 
Bovine serum albumin (fatty acid free)  1 g/L 
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Table 4.2 Preparation of KRB Media 
 Concentration 
Powdered media (for 1 litre) KRB (with glucose, 9.5g)  
Bovine serum albumin (fatty acid free) 3 g/L 
pH (adjusted with 1N NaOH or 1N HCl  7.4 
 
 
4.3.3 Tissue Preparation 
Adipose tissue was aseptically removed from the body as a whole and 
immediately immersed in 20ml pre-warmed (37°C) transport media (see Table 
4.1). The transport media was maintained at 37°C by keeping it in a sterile tube 
that was immersed in warm water (40°C) contained in a thermos flask. Following 
transfer to the culture lab, the tube was kept in a water bath at 37°C. 
Adipose tissue was then transferred to a sterile culture dish containing 12.5ml of 
pre-warmed transport media (on the hot plate). The fat was then cleaned of 
connective tissues and blood vessels using scissors and forceps before being 
chopped into small pieces (approximately 2mm cubes). The tissue was then 
transferred to a second sterile culture dish containing pre-warmed (37°C with 5% 
CO2 in air and 100% humidity) culture media (see Table 4.1) to wash. 
 
4.3.4 Pre-incubation (if needed) 
After washing, approximately 100 to 300mg of chopped tissue was placed into a 
100mm culture dish containing 12.5ml pre-warmed culture media and incubated 
at 37°C and 5% CO2 in air, for the amount of time studied (0 or 22 hours).  
 
4.3.5 Acute Lipolysis Treatment 
The second phase of incubations was for the measurement of lipolysis. After 
22hours of pre-incubation, adipose explants were washed in plates containing 
12.5ml pre-warmed KRB media (Table 4.2). Then the adipose explants were 
again transferred to a well on a 12 well plate containing 2ml of pre-warmed KRB 
media including any treatments needed for the experiment (e.g. isoproterenol, 
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IP). The plate was then placed in an incubator at 37°C and 5% CO2 in air for 4 
hours. 
After the 4 hour incubation, aliquots of media were removed from each well 
separately with disposable plastic pipettes and transferred to separate and 
labelled 1.5ml eppendorf tubes before being stored at -40°C until required for 
glycerol quantification (refer to method 5.2.7). All the fat explants were removed 
from each well separately using forceps and transferred to another 1.5ml 
eppendorf tube and also stored frozen at -40°C until required for Folch Lipid 
Extraction (refer to method 4.2.8). 
 
4.3.6 Chronic Lipolysis Treatment 
For chronic incubations, treatments were added during pre-incubation in culture 
media, as well as during the 4 hours lipolysis incubation in KRB media (as in 
section 4.2.5). 
 
4.3.7 Glycerol Quantification 
Glycerol release into the KRB media was measured using a triglyceride assay kit 
75 6LJPD 8. DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV IRU IUHH
glycerol quantification, but modified and optimized for use on a 96-well microplate 
format. Triglyceride Reagent (200µl) was added to 50 µl of sample (KRB media) 
in each well of a 96-well plate. A standard curve was set up on each plate to 
enable calculation of the concentration of glycerol present. 
The free glycerol determination kit measures endogenous glycerol according to 
the following enzymatic reactions (see Figure 4.1). Glycerol was phosphorylated 
by ATP to form G-1-P and ADP, catalyzed by GK. G-1-P was then oxidized by 
glycerol phosphate oxidase (GPO) to form DAP and H2O2. POD catalysed the 
coupling of H2O2 with 4-AAP and ESPA to produce a quinoneimine dye with an 
absorbance maximum at 540nm. The increase in absorbance at 540nm is directly 
proportional to the free glycerol concentration of the sample. Absorbance was 
measured at 550nm as no 540nm filter was available. 
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Figure 4.1 Glycerol assay enzymatic reactions 
                                              GK 
     Glycerol + ATP                                     G-1-P + ADP 
                                         GPO 
     G-1-P + O2                                            DAP + H2O2 
                                                POD 
     H2O2 + 4-AAP + ESPA                         Quinoneimine dye + H2O 
 
 
4.3.8 Folch Lipid Extraction 
The amount of lipid in adipose explants from each well was determined so that 
glycerol concentration released could  be corrected. This method was modified 
from the Folch extraction method (Folch et al., 1957). Adipose tissue explants 
were placed in a 50ml conical tube and weighed. Methanol (5ml) was added to 
the tube and tissue was homogenized (Polytron PTA 10-35, Kinematica, 
Switzerland) for 30secs. Chloroform (10ml) was then added and the sample was 
homogenized again for 30secs followed by the addition of 3.75ml of Folch wash 
(0.88% KCl). The tube was then vortexed and left for 30mins at room 
temperature, prior to centrifugation (GS-6R, Beckman, USA) at 3000rpm for 
10mins, to aid separation. The upper organic phase was removed and the lower 
organic phase was injected with nitrogen gas at 2.5G for 45mins. The sample 
was then dried in an oven at 50°C until the weight became constant. The tube 
was then reweighed and the total amount of lipid present was calculated. 
 
4.3.9 Statistical Analysis 
Values for glycerol release (µg per gram lipid) were expressed as means ± SEM. 
The data were analyzed using Genstat 10.0 statistical software. General Analysis 
of Variance with No Blocking was used. Significance was taken as p<0.05. 
 
 
 
 
 92 
 
4.4 Results 
4.4.1 Optimization of Rat Adipose Tissue Explants 
4.4.1.1 Adipose Depot Response to IP 
Perirenal and epididymal adipose tissue explants response to IP was compared 
with identify which tissue depot to use. Figure 4.2 shows the glycerol release of 
epididymal and perirenal adipose tissue after incubation in KRB Media for 4 
hours without pre-incubation (n=2 rats, samples in triplicate). Both epididymal 
and perirenal fat explants were found to respond to IP (P=0.122, ANOVA), but 
the baseline lipolysis was lower for epididymal, resulting in a greater-fold 
response to IP.  Epididymal fat was therefore chosen to be used for all 
subsequent studies.  
 
4.4.1.2 Linearity of Glycerol Release 
To optimize the method used for fat explants, we have to determine whether 
glycerol concentration (as an indicator of lipolysis) was linear over time. In this 
experiment, we measured the glycerol released into KRB media from rat 
epididymal adipose tissue explants during different lengths of incubation time (2, 
3 and 4 hrs) in the presence or absence of Isoproterenol (IP 10µM), without pre-
incubation (n=1 rat, treatments in triplicate, see Figure 4.3).  There was 
significant interaction between the length of the incubation and IP treatment (P 
<0.001, ANOVA) due to the divergence of the basal and IP stimulated response. 
Both basal and IP stimulated lipolysis increased over time in a linear manner and 
at all time points IP stimulated lipolysis was greater than basal lipolysis (P 
<0.001, ANOVA), but particularly at the longer incubation times. A 4 hr incubation 
period was adopted for all subsequent studies. 
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Figure 4.2 Glycerol Release in Different Adipose Depots After Treatment 
with IP in the Rat Adipose Tissue Explants 
 
White box indicates basal (Control) and grey box indicates treatment with IP (10µM). Values are 
means ±sem, n=2 rats, treatments in triplicate. Depot X IP = 0.149, ANOVA. IP increased lipolysis 
compared with basal (P <0.001, ANOVA).  
 
Figure 4.3 Linearity of Glycerol Release During Basal and IP Stimulated 
Lipolysis in Rat Epididymal Adipose Tissue Explants 
 
White box indicates basal (Control) and grey box indicates treatment with IP (10µM). Values are 
means ±sem, n=1 rat, treatments in triplicate. Time X IP = P < 0.001, ANOVA. IP significantly 
increased lipolysis compared with basal (P <0.001, ANOVA) 
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4.4.1.3 Viability of Explants in M199 for up to 48 hours 
 
Another part of optimization is to ascertain whether explants were viable in M199 
culture for up to 48hrs or not. Epididymal explants were pre-incubated for various 
lengths of time (0, 24 and 48hrs), followed by the standard lipolysis incubation 
with and without IP (10uM, 4hrs incubation, n=3 rats, treatments in triplicate, see 
Figure 4.4). There was no interaction between the length of time for pre-
incubation and the subsequent IP treatment (P=0.66, ANOVA). There was a 
significant stimulation of lipolysis by IP treatment (P=0.017, ANOVA). There was 
no significant effect of different pre-incubation time length (P=0.274, ANOVA), but 
a 24hrs pre-incubation appeared to be slightly better than 48hrs. However 22hrs 
of pre-incubation was slightly more convenient and was therefore used for 
subsequent studies that required pre-incubation. 
 
 
Figure 4.4 Effect of Length of Pre-incubation Basal and IP stimulated 
Lipolysis in the Rat Epididymal Adipose Tissue Explants 
 
White box indicates basal (Control) and grey box indicates treatment with IP (10µM). Values are 
means± sem, n=3 rat, treatments in triplicate. Time X IP, P=0.66, ANOVA. IP significantly increased 
lipolysis when compared with basal (P=0.017, ANOVA) 
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4.4.2 Acute Effect of SCE in the Rat Epididymal Adipose Tissue Explants 
After the experimental procedures with rat epididymal adipose tissue explants 
were optimized, SCE was tested in the system to investigate the direct effects on 
lipolysis. Figure 4.5 shows the effect of SCE (4hrs) treatment in rat epididymal fat 
explants without pre-incubation in the absence or presence of IP (n=2 rats, 
treatments in triplicate). There was a significant interaction between SCE and IP 
treatments (P<0.001, ANOVA), due to IP stimulating lipolysis and SCE 
decreasing lipolysis but only in the presence of IP. 
 
4.4.3 Chronic Effect of SCE in the Rat Epididymal Adipose Tissue Explants 
The chronic effects of SCE were also investigated. Figure 4.6 shows the effect of 
SCE during pre-incubation (22hrs) and lipolysis (4hrs) treatment on basal and IP 
stimulated lipolysis by rat epididymal fat explants (n=2 rats, treatments in 
triplicate). Once again, IP significantly increased lipolysis compared with basal 
(P<0.001, ANOVA), but there was no interaction between SCE and IP treatments 
(P=0.529, ANOVA) and there was no effect of SCE on lipolysis (P=0.164, 
ANOVA). 
 
4.4.4 Chronic Effect of SCE in the Human Omental Adipose Tissue Explants 
To further investigate direct effects of SCE on lipolysis, we also studied its effects 
in human omental adipose tissue explants. Figure 4.7 shows the effect of chronic 
treatment with SCE on basal and IP stimulated lipolysis (4hrs) (n=2 humans, 
treatments in triplicate). As in the rat explants, IP significantly increased lipolysis 
compared with basal (P<0.001, ANOVA), but there was no interaction between 
SCE and IP treatments (P=0.693, ANOVA) and no effect of SCE on lipolysis in 
the human omental adipose tissue explants (P=0.126). 
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Figure 4.5 Acute Effect of SCE in the Rat Epididymal Adipose Tissue 
Explants 
Values are means ±sem, n=2 rats, treatments in triplicate. SCE decreased lipolysis compared with 
control and IP (P<0.001, ANOVA). IP increased lipolysis compared with basal (P<0.001, ANOVA), 
SED 4.87. 
Figure 4.6 Chronic Effect of SCE in the Epididymal Rat Adipose Tissue 
Explants 
Values are means ±sem, n=2 rats, treatment in triplicate. SCE does not have any significant effect 
on lipolysis compared with IP (P=0.529, ANOVA). IP induced lipolysis compared with basal 
(P<0.001, ANOVA), SED 11.17 
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Figure 4.7 Chronic Effect of SCE in the Human Omental Adipose Tissue 
Explants 
Values are means ±sem, n=2 humans, treatments in triplicate. SCE does not have any significant 
effect on lipolysis compared with IP (P=0.693, ANOVA). IP induced lipolysis compared with basal 
(P<0.001, ANOVA). 
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4.5 Discussion 
Adipose tissue is very amenable to study in vitro (Vernon, 2000). The reason for 
developing the fat explant system instead of using the adipocyte or cell lines 
(which are extensively used) to study adipose tissue metabolism is because the 
fat explants system contains the whole array of adipose cell types ranging from 
immature to mature cells which are well known to discrete different types of 
hormones at different stages. Mature adipocytes are very fragile due to the large 
volume of lipid they contain, thus during the isolation process, they are verly likely 
to burst. Therefore, after isolation, the cell population being studied may 
predominantly be immature adipocytes. Another problem is the use of 
collagenase to yield free adipocytes which may also strip the adipocyte of the 
extracellular domains of membrane bound receptors. According to Vernon 
(2000), excessive enthusiasm with the collagenase digestion can also lead to a 
diminished responsiveness in adipocytes. 
In these experiments, we have optimized the rat adipose tissue explants and 
human adipose tissue explants, based on the pig adipose tissue explants system 
developed by Headland (2007). When developing the rat adipose tissue explants, 
we had to take into consideration that the amount of fat available from a rat is a 
lot less than the fat available in the pig, so had to adjust the size of well and 
amount of fat (0.1 to 0.3g per well in a 12 well plate and maximum of 24 wells). It 
also appeared that the basal concentration and response to IP of adipose tissue 
depots in the rat and pig are different. The amount of human fat taken from an 
obese patient was similar to that available from rats. This is the reason for 
adopting the same method as the rat adipose tissue explants for the human 
adipose tissue explants.  
 
4.5.1 Optimization of Rat Adipose Tissue Explants 
 The rat adipose tissue explants is set at the best parameters to maximize the 
potential of observing glycerol release in response to different treatments. To 
confirm this, we set out to measure the optimum number of hours of incubation in 
the KRB media for lipolysis, the optimum adipose tissue depot and the optimum 
number of hours of pre-incubation in the M199 media. We found that in the rat 
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adipose tissue explants, the glycerol is released into the media in a linear manner 
(see Figure 4.3). This is similar to pig adipose tissue explants (Headland, 2007). 
However, unlike in pigs, different adipose tissue depots and pre-incubation times 
did not seem to affect the amount of glycerol released into the media (see Figure 
4.2 and 4.4). Hence, due to convenience and safety issues, a 22hrs pre-
incubation followed by a 4hrs lipolysis incubation of epididymal fat explants was 
used for subsequent experiments. 
 
4.5.2 SCE Regulation of Lipolysis in the Rat Epididymal Adipose Tissue 
Explants 
To date there are no other studies investigating the in vitro effect of S. crispus 
extract. Results described in the previous chapter indicate that glycerol 
concentration was increased in the plasma of SCE treated mice. The amount of 
fat available in each adipose tissue depot in the mice is much too little to be 
studied. Thus, in this study we used adipose tissue explants from Sprague-
Dawley rats, as rats are genetically similar to mice (Serikawa et al., 1998). We 
hypothesized that SCE would have a direct stimulatory effect on lipolysis in the 
rat adipose tissue explants. 
We investigated the glycerol release following both acute and chronic incubations 
with SCE. In the acute study, SCE inhibited lipolysis in the presence of IP (see 
Figure 4.5). However, there was no effect of SCE after chronic incubation (see 
Figure 4.6). These results show that SCE may have a direct, short-term inhibitory 
effect on lipolysis, but the effect is lost after a prolonged incubation.  
 
4.5.3 SCE Regulation of Lipolysis in the Human Omental Adipose Tissue 
Explants 
We also investigated the chronic effect of SCE in the human omental adipose 
tissue explants and found that there was no significant effect (see figure 4.7). 
This is consistent with the results found in the rat epididymal adipose tissue 
explants.  
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4.6 Conclusion 
SCE does not appear to have any direct effect on lipolysis in the rat epididymal 
adipose tissue explants and human omental adipose tissue explants, other than 
the results following short-term incubation in the rat epididymal adipose tissue 
explants. This indicates that the effect of SCE on plasma glycerol concentrations 
found in the previous in vivo experiments might be due to indirect effects. As the 
finding is not of particular interest to obesity researchers (adipose tissue lipolysis 
was not increased) investigation on the SCE is now adjourned to further analyze 
the effect of individual polyphenols on the rat epididymal adipose tissue explants 
and human omental adipose tissue explants that we have developed. 
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Chapter 5 - In vitro Effects of Individual 
Polyphenols in the Rat Epididymal Adipose Tissue 
Explants  
 
 
5.1 Introduction 
Dietary polyphenols are the most abundant antioxidants in human diets. They 
represent a group of secondary metabolites which widely occur in vegetables, 
fruits, tea, extra virgin olive oil, chocolate and other cocoa products. Consumption 
of polyphenols in foodstuffs and drinks has been associated with the prevention 
of some diseases (Rawel & Kulling, 2007; Han et al., 2007). Food and drinks 
containing high concentrations of dietary polyphenols such as green tea, S. 
matsudana leaves, liquorice and apple have been linked with anti-obesogenic 
effects (Wolfram et al., 2006; Lin and Lin-Shiau, 2006; Han et al., 2003 (a); Aoki 
et al., 2007; Nakazato et al., 2006).  
A number of studies have been carried out to investigate the anti-obesity effects 
of individual polyphenols, including apigenin and luteolin (Han et al., 2003b), 
myrisetin and quercetin (Kwon et al., 2007), epigallocatechin gallate (EGCG) 
(Wolfram et al., 2006) and kaempferol (Yu et al., 2006). All the published work 
investigating effects of individual polyphenols on lipolysis are mainly carried out in 
vivo or using isolated adipocytes or cell lines except for the study by Headland 
and colleagues (2007) where pig adipose tissue explants used to test the effects 
of individual polyphenols (quercetin, phloridzin, resveratrol, EGCG and gallic 
acid). However, there appear to be no studies that compared similar effects in the 
rat adipose tissue explant. The molecular structures of individual polyphenols, IP 
and Adenosine is shown in Figure 5.9 and 5.10. 
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5.2 Hypothesis and Aim 
The hypothesis of this study is that the effects of individual polyphenols on rat 
adipose tissue explants are similar to that found in the pig adipose tissue 
explants and other studies using rat adipocytes or cell lines. We aim to 
investigate the effects of a range of polyphenols on lipolysis using the rat adipose 
tissue explants. 
 
5.3 Methodology  
5.3.1 Preparation of Individual Polyphenols  
Individual polyphenols (quercetin, phloridzin, resveratrol and EGCG) were all 
obtained from Sigma (UK) and verbascoside was obtained from Extrasynthese 
(France). Polyphenols in the form of powder were weighed and diluted with PBS 
to obtain the required concentration.  
 
5.3.2 Rat Epididymal Adipose Tissue Explants  
Methods used for the preparation and culture of rat fat explants are described in 
section 4.2. Samples were obtained as described in section 4.2.1.1.  
 
5.3.3 Statistical Analysis 
Values for glycerol release (µg per gram lipid) were expressed as means ± SEM. 
The data were analyzed using Genstat 10.0 statistical software. General Analysis 
of Variance was used with No Blocking. Significance was taken as p<0.05. 
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5.4 Results 
5.4.1 Acute Effects of Individual Polyphenols on Lipolysis in the Rat 
Epididymal Adipose Tissue Explants 
To investigate the acute lipolytic effects of individual polyphenols, rat epididymal 
adipose tissue explants were pre-incubated in M199 media for 22hrs before 
being treated with EGCG, Phloridzin, Quercetin, Resveratrol or Verbascoside for 
4hrs in the presence or absence of isoproterenol (IP) in KRB Media. As expected, 
treatment with IP significantly increased lipolysis in all studies (P<0.001), but the 
effects of individual polyphenols varied.  
Figure 5.1 shows an inhibitory effect of EGCG on lipolysis, particularly when IP 
was added (n=2 rats, treatments in triplicate). The significant interaction between 
EGCG and IP (P=0.005) indicated that the inhibitory effect of EGCG was much 
more pronounced when IP was added compared with when it was absent.  
 
Figure 5.1 Acute (4hr) Effects of EGCG on Lipolysis in the Rat Epididymal 
Adipose Tissue Explants 
 
Values are means ±sem, n=2 rats, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA) whereas EGCG inhibited lipolysis particularly when IP was present 
(P=0.005 for EGCG X IP interaction). 
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In another study (n=2 rats, treatments in triplicate), Phloridzin tended to inhibit 
lipolysis, both with and without IP (P=0.055). This can be seen in Figure 5.2.  
 
 
Figure 5.2 Acute (4hr) Effects of Phloridzin on Lipolysis in the Rat 
Epididymal Adipose Tissue Explants 
 
Values are means ±sem, n=2 rats, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA) and Phloridzin tended to inhibit lipolysis, both with and without IP 
(P=0.055 for Phloridzin X IP interaction, ANOVA). 
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Acute treatment with Quercetin (n=2 rats, treatments in triplicate) had no 
significant effect on lipolysis, when IP was either added or not (P=0.773 for 
Quercetin and P=0.13 for Quercetin X IP interaction, ANOVA), although it 
appeared to result in a numerical increase in lipolysis in the absence of IP.  
 
 
 
Figure 5.3 Acute (4hr) Effects of Quercetin on Lipolysis in the Rat 
Epididymal Adipose Tissue Explants 
 
Values are means ±sem, n=2 rats, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA). Quercetin does not have significant effect on lipolysis both with and 
without IP (P=0.773 for Quercetin and P=0.13 for Quercetin X IP interaction, ANOVA) SED 18.98. 
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Interestingly, acute treatment with Resveratrol (n=2 rats, treatments in triplicate) 
had opposite effects on lipolysis, depending upon whether IP was added or not 
(P=0.013 for Resveratrol x IP interaction). Resveratrol alone (without IP) 
increased lipolysis, particularly at 100µM, but the effect was reversed when IP 
was added, with 100µM Resveratrol clearly inhibiting lipolysis.  
Verbascoside (n=2 rats, treatments in triplicate) had a similar effect to EGCG, 
significantly inhibitinglipolysis, particularly when IP was added (P<0.001 for 
Verbascoside x IP interaction).  
 
 
Figure 5.4 Acute (4hr) Effects of Resveratrol on Lipolysis in the Rat 
Epididymal Adipose Tissue Explant 
 
Values are means ±sem, n=2 rats, treatments in triplicate.  IP increased lipolysis compared with 
basal (P<0.001, ANOVA) while Resveratrol increased lipolysis during the basal state but decreased 
it when IP was added (P=0.013 for Resveratrol X IP interaction, ANOVA) SED 31.3. 
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Figure 5.5 Acute (4hr) Effects of Verbascoside on Lipolysis in the Rat 
Epididymal Adipose Tissue Explants 
 
Values are means ±sem, n=2 rats, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA) whereas verbascoside inhibited lipolysis particularly when IP was added 
(P<0.001, ANOVA), SED 8.35. 
 
In order to further investigate the effects of individual polyphenols on lipolysis, 
longer incubation times (chronic effects) were used. EGCG, Phloridzin and 
Resveratrol were chosen because of their different acute effects on lipolysis. 
 
5.4.2 Chronic Effects of Individual Polyphenols in the Rat Epididymal 
Adipose Tissue Explants 
A 26hr chronic incubation of RES with EGCG, Phloridzin and Resveratrol was 
achieved by pre-incubating for 22hrs in the M199 media containing each 
polyphenol, followed by 4hrs in the KRB media. This was 22hrs longer exposure 
compared with the acute incubation studies described earlier. In all chronic 
studies, treatment with IP (for 4hrs again) significantly increased lipolysis 
(P<0.001).  Figure 5.6 shows the chronic effects of EGCG (n=2 rats, treatments 
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in triplicate) which were similar to the acute effects, with EGCG significantly 
inhibiting lipolysis (P<0.001), but this time there was no significant interaction 
between EGCG and IP (i0.739). The greatest inhibitory effect was observed with 
100µM EGCG. 
 
Figure 5.6 Chronic (26hr) Effects of EGCG on Lipolysis in the Rat 
Epididymal Adipose Tissue Explant 
 
Values are means ±sem, n=2 rats, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA) while EGCG significantly inhibited lipolysis, both with and without IP 
(P<0.001, ANOVA). 
 
Unlike in the acute study where Phloridzin tended to inhibit lipolysis (Figure 5.2), 
chronic incubation with Phloridzin (n=2 rats, treatments in triplicates) had no 
significant effect (Figure 5.7, P=0.3  and PxIP=0.785).  
Resveratrol, which increased lipolysis at the highest EGCG concentration after 
acute incubation in the absence of IP, had an inhibitory effect (P<0.001) on 
lipolysis following chronic incubation (Figure 5.8), both with and without IP, with 
100µM inducing the greatest effect. 
 109 
 
Figure 5.7 Chronic (26hr) Effects of Phloridzin on Lipolysis in the Rat 
Epididymal Adipose Tissue Explant 
Values are means ±sem, n=2 rats, treatments in triplicate. Phloridzin does not have any significant 
effect on lipolysis (P=0.3, ANOVA). IP increased lipolysis compared with basal (P<0.001, ANOVA), 
SED 16.62. 
Figure 5.8 Chronic (26hr) Effects of Resveratrol on Lipolysis in the Rat 
Epididymal Adipose Tissue Explant 
Values are means ±sem, n=2 rats, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA) whereas Resveratrol inhibits lipolysis both with and without IP (P<0.001, 
ANOVA), SED 9.5. 
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Figure 5.9 Polyphenol Structures 
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Figure 5.10 Isoproterenol and Adenosine Structures 
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5.5 Discussion 
 
5.5.1 Effects of EGCG on Lipolysis in the Rat Epididymal Adipose Tissue 
Explants 
EGCG is a major polyphenolic compound found in green tea which is produced 
from dried fresh leaves of the plant Camellia sinensis L. Ktze. (Bettuzzi et al., 
2006; Demeule et al., 2002). The molecular structure of EGCG is shown in Figure 
5.9. Other catechins found in lower abundance in green tea include (-)-
epicatechin-3-gallate (ECG), (-)epigallocatechin (EGC), (-)-epicatechin (EC) and 
(+)-catechin. However, EGCG is the main catechin in green tea which is thought 
to be responsible for many of the anti-obesity effects observed in vivo and in vitro 
(Nagle et al., 2006; Wolfram et al., 2006b). However, all of the in vitro studies 
investigating direct effects of EGCG on lipolysis were done in isolated adipocytes. 
In this study, we investigated the direct effect of EGCG on lipolysis in the rat 
adipose tissue explant during acute (4hr) and chronic (26hr) incubation. In all 
experiments, EGCG was found to consistently inhibit lipolysis and the effects 
were greatest at 100µM. More than 50% inhibition was found following the acute 
(4hr) incubation compared with approximately 50% following the chronic (26hr) 
incubation. Comparisons of results with other fat explant studies is only possible 
for pig adipose tissue explants (Headland, 2007) but we have to note that all 
studies done in the pig adipose tissue explants has been done in the presence of 
adenosine aminase (ADA), an enzyme that remove adenosine in the explants 
and thus increase basal lipolysis.  
Since no other studies appear to have been done using adipose tissue explants, 
studies using isolated rat adipocytes and cultured adipocytes (3T3-L1 and 
C3H10T1/2) will also be included as a comparison. Interestingly, studies done in 
adipocytes have come to different conclusions on the effect of EGCG on lipolysis, 
with EGCG found to inhibit (Kimura et al., 1983 a&b; Wolfram et al., 2006b), 
increase (Lee et al., 2009) or have no effect at all (Mochizuki & Hasegawa, 
2004). The findings of these studies are compared with below.  
EGCG has previously been shown to inhibit lipolysis in pig fat explants after a 
chronic (24hr) incubation in both perirenal and subcutaneous fat explants, 
particularly at 100µM (Headland, 2007). Studies by Kimura and colleagues (1983 
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a&b) and Ying Wang and colleagues (Wolfram et al., 2006a) in adipocytes 
support the findings in our study. In the study by Kimura and colleagues (1983a), 
isolated adipocytes from the epididymal adipose tissue of young male Wistar-
King strain rats were treated with 0.5µg/ml adrenaline (as positive control) or pure 
EGCG (5, 20 and 100µg/ml equal to 10.91, 43.63 and 218.15µM) for 2 hours 
(acute incubation). Results were then compared with control (0.5µg/ml 
adrenaline). No effects were found after treatment with 5 and 20µg/ml EGCG, but 
100µg/ml significantly inhibited (include p-value) lipolysis by approximately 50%.  
A similar study was carried out by Kimura and colleagues (1983b), but this time 
using adrenocorticotropic hormone (ACTH) as the positive control instead of 
adrenaline. Once again, 100µg/ml EGCG significantly inhibited lipolysis, but this 
time by approximately 20%.  
Ying Wang and colleagues (Wolfram et al., 2006a) also demonstrated inhibition 
of lipolysis in differentiated C3H10T1/2 preadipocyte cultures, after 5 (acute) and 
24hrs (chronic) incubation with 50µM EGCG.  
In contrast, Lee and colleagues (2009) found that 3T3-L1 adipocytes treated with 
10µM EGCG for 24hrs (chronic incubation) significantly increased lipolysis by 
27% (P<0.05). However, no effect was observed by Mochizuki and Hasegawa 
(2004) when 3T3-L1 adipocytes were treated with higher concentrations of 
EGCG (21.8 and 43.6µM) for 4 hrs (acute incubation). Hence there are 
inconsistent effects of EGCG described in the literature, particularly when 
comparing isolated primary adipocytes, differentiated 3T3-L1 adipocytes and 
FXOWXUHGIDWH[SODQWV:K\WKLVVKRXOGEHLVQ¶WFOHDU 
Thus, the results observed here in fat explants would suggest that the 
mechanism for the reduction of white adipose tissue (WAT) observed in in vivo 
studies (Bose et al, 2008; Huang et al., 2009; Klaus et al., 2005; Wolfram et al., 
2005) was not mediated via a direct increase in lipid mobilization. Instead, the 
reduction could be mediated via induction of adipocyte cell apoptosis as 
suggested by Wolfram and colleagues (2005) and Hwang and colleagues (2005). 
 
 
 114 
 
5.5.2 Effects of Phloridzin on Lipolysis in the Rat Epididymal Adipose 
Tissue Explants 
3KORULG]LQ SKORUHWLQ ¶-O-glucose) is the glucosidic form of the flavonoid, 
phloretin. Phloretin is found exclusively in apples and in apple-derived products 
(Crespy et al., 2002); its concentration is highly dependent on the variety of apple 
(Escarpa & Gonzalez, 1998). The molecular structure of Phloridzin is presented 
in Figure 5.9. It is sometimes referred to as phlorizin, phlorrhizin, phlorhizin or 
phlorizoside (Gosch et al., 2010). Since its discovery in 1835, phloridzin has been 
used for a variety of purposes in experimental medicine and biology. Most studies 
relate to diabetes, obesity, stress hyperglycemia, antioxidative activity, 
membrane permeability, beverages, food additives, pharmaceuticals and 
cosmetics (Ehrenkranz, 2005 & 2006; Gaudout et al., 2006; McCrimmon et al., 
2002; Rezk et al., 2002; Sukhorukov et al., 2001 and Valenta et al., 2001). 
Two previous studies investigated the effects of Phloridzin on lipolysis ( 
Headland, 2007 and Kuppusamy & Das, 1992). Headland (2007) studied the 
effect of a chronic 24hr incubation of Phloridzin in pig fat explants from two 
different adipose tissue depots. In the subcutaneous adipose tissue, Phloridzin 
was found to increase lipolysis at 25µM but had no significant effect at 100µM. In 
contrast, although it appeared to increase lipolysis numerically, Phloridzin had no 
statistically significant effect on lipolysis in the perirenal adipose tissue. The 
results in the pig perirenal adipose tissue explants agree with what we have 
found in the rat epididymal adipose tissue, following both acute and chronic 
incubation with Phloridzin. In another study, Kuppusamy and Das (1992) 
investigated the effect of an acute (10mins) incubation of isolated adipocytes with 
250µM of Phloridzin and found that there were no significant effects. This result 
also supports our findings. Despite appearing to have an inconsistent effect in pig 
subcutaneous fat explants and no effect in pig perirenal fat explants, rat 
epididymal fat explants and isolated rat adipocytes, Ehrenkraz and colleagues 
(2005) described an anti-obesity effect of Phloridzin.  The findings from in vitro 
studies simply indicate that the mechanism of action for Phloridzin is not via a 
direct effect on lipolysis in the WAT. 
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5.5.3 Effects of Quercetin on Lipolysis in the Rat Epididymal Adipose 
Tissue Explants 
Quercetin is one of the most abundant flavonol-type flavonoids present in several 
components of the human diet (Bravo, 1998). In the acute (4hr) incubation in rat 
adipose tissue explant, there was no significant effect of quercetin when IP was 
added, but it appeared to numerically increase lipolysis in the absence of IP, but 
this was not statistically significant (P=0.773). Using adipocytes isolated from 
epididymal adipose tissue of male Wistar rats Kuppusamy and Das (1992) found 
that treatment with 250µM quercetin and epinephrine for 10 mins (acute effect) 
increased lipolysis by nearly 198% when compared with control.  Kuppusamy and 
Das (1994) suggest that quercetin has some structural feature which leads to it 
having a synergistic effect on lipolysis with epinephrine. In a subsequent study 
.XSSXVDP\DQG'DVWKH\VXJJHVWWKDWTXHUFHWLQPD\EHDFWLQJDVDȕ-
adrenoceptor agonist, thereby increasing lipolysis through the stimulation of 
cAMP. 
However, chronic (24hr) incubation with Quercetin shows different results found 
in the pig adipose tissue explants and cultured adipocyte cell lines. In the study 
by Headland (2007), quercetin especially at 100µM was found to significantly 
inhibit lipolysis both in the subcutaneous and perirenal pig adipose tissue explant 
after a chronic incubation (24hr). In another chronic incubation (24, 48 and 72hr) 
with 100µM Quercetin, Hsu and Yen (2006) found that Quercetin potently 
induced cell apoptosis in 3T3-L1 pre-adipocytes and effect was increased with 
longer incubation time. Quercetin was also found to have the highest inhibition of 
cell population growth when compared with Naringenin, Rutin, Hesperidin, 
Resveratrol and Naringin.  
A consiVWHQW LQKLELWLRQ DIIHFW ZDV REVHUYHG DIWHU FKURQLF KU LQFXEDWLRQ RI
cultured 3T3L-1 cells and pig adipose tissue explants compared with acute 
(10min and 4hr) incubation. Thus, it is doubted whether quercetin may be acting 
DV D ȕ-adrenoceptor agonist as suggested by Kuppusamy and Das (1994) or 
ZKHWKHUWKH\DUHDFWLQJDVDȕ-adrenoceptor antagonist instead. 
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5.5.4 Effects of Resveratrol on Lipolysis in the Rat Epididymal Adipose 
Tissue Explants 
5HVYHUDWURO¶-trihydroxystilbene) is a naturally occurring polyphenol found in 
red wine, grape juice and the root of Polygonum cuspidatum (Siemen and 
Creasy, 1992; Nonomura et al., 1963). Moreover, the pure compound is now 
available in tablets and is suggested as a dietary supplement (Szkudelska et al., 
2009a). In our studies, acute (4hr) incubation with Resveratrol was found to 
increase lipolysis in the absence of IP, but to inhibit lipolysis in the presence of 
IP. However, chronic (26hrs) incubation with Resveratrol resulted in a consistent 
inhibition of lipolysis both in the absence and presence of IP. Different results 
were found in pig adipose tissue explant by Headland (2007). Although 24hr 
treatment with 10, 50 or 100µM Resveratrol numerically increased lipolysis in 
both subcutaneous and perirenal adipose tissue explants, the differences were 
not statistically significant.  
The observed effects in rat adipose tissue explant agree with those of Skudelska 
and colleagues (2009a), who showed that 10 and 100µM resveratrol significantly 
enhanced lipolysis (approximately 900nmol/106 cells/90min at 10µM and 
1200nmol/106 cells/90min at 100µM) in isolated rat adipocytes incubated for 
90mins with epinephrine. Incubations of adipocytes for 30min with 0.5µM 
epinephrine and 1, 10 and 100µM Resveratrol also resulted in enhanced 
accumulation of cAMP compared with cells exposed to epinephrine alone. The 
increase in cAMP found in adipocytes incubated with resveratrol is proposed to 
be responsible for enhanced lipolytic rate (Skudelska et al., 2009a).   
However, in another study where a lower concentration of Resveratrol (25µM) 
was used, no significant effect was found on lipolysis in 3T3-L1 adipocytes 
treated for 24 and 48hrs chronic incubation (Rayalam et al., 2007). Moreover, 
100µM Resveratrol was also found to significantly increase adipocyte apoptosis 
by 76% and decreased lipid accumulation in maturing pre-adipocytes by 43% 
after a 48hrs chronic incubation (Rayalam et al., 2008a).  
Thus, these results suggest that the effects of Resveratrol on lipolysis are 
LQFRQVLVWHQW SDUWLFXODUO\ LI FKURQLF KU LQFXEDWLRQ ZLWK KLJK FRQFHQWUDWLRQ
(250µM) was followed. Instead, an acute incubation with a medium concentration 
(100µM) gives more consistent results on lipolysis. 
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 5.5.5 Effects of Verbascoside on Lipolysis in the Rat Epididymal Adipose 
Tissue Explants 
Verbascoside is a polyphenol found in the S. crispus extract (Abou Muamer et al., 
2003, unpublished). Even though we found that direct incubation of rat fat 
explants with SCE had no significant effect on lipolysis (see previous chapter), 
we set out to investigate whether an individual active component of SCE had any 
effect. Interestingly, after an acute (4hr) incubation, verbascoside was found to 
significantly inhibit lipolysis, but there appear to be no published studies with 
which to compare. Our theory is that verbascoside might inhibit lipolysis through 
the same mechanism as EGCG since the total of hydroxyl group in the 
verbascoside structure is nine, just one less than eight in the EGCG structure. 
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5.6 Conclusion 
These studies investigated the effects of various individual polyphenols on basal 
and IP stimulated lipolysis in rat adipose tissue explant and then compared the 
findings with similar studies in our lab using pig adipose tissue explants where 
individual polyphenols were incubated with ADA (Headland, 2007), as well as 
published studies using isolated rat adipocytes and cultured adipocyte cell lines 
(3T3-L1 and C3H10T1/2).  
Interestingly, there was both consistency and inconsistency dependent upon the 
polyphenol being studied and the length of incubation. Hence, the effects of an 
acute (<4hrs) incubation with EGCG, Phloridzin or Resveratrol on lipolysis in rat 
adipose tissue explant are similar to those observed in isolated rat adipocytes 
subjected to the same polyphenols and length of incubation. Conversely, the 
effects observed after an acute incubation with EGCG or chronic incubation with 
EGCG or Resveratrol on lipolysis in rat adipose tissue explant are completely 
different to those observed in cultured adipocyte cell lines.  
Thus, these findings are contrary to the hypothesis as our rat adipose tissue 
explant system shows similar responses to individual polyphenols as isolated 
adipocyte, but different to cultured adipocyte cell lines and the pig adipose tissue 
explants. Adipose tissue explants and isolated adipocytes will contain adipocytes 
at more mature stages of development than the cultured adipocyte cell lines, 
which may then account for some of the apparent differences in lipolytic 
responsiveness. 
It is worth noting that the effects of the individual polyphenols in the rat fat 
explants appear to show some structure-activity relationship. The polyphenols 
(EGCG and Verbascoside) with the highest numbers of hydroxyl groups on the 
benzene rings (8 or 9) were found to inhibit lipolysis, while polyphenols with 5 to 7 
hydroxyl groups (Phloridzin and Quercetin) had no significant effect and the 
polyphenol with just 3 hydroxyl groups (Resveratrol) increased lipolysis, although 
the effect was only observed in the acute (4hr) study. Although the main focus of 
these studies was the effect of individual polyphenols on adipose tissue lipolysis, 
we should not ignore their effects on adipogenesis and lipid accumulation 
(lipogenesis) as these effects may also be important in treating obesity. Further 
studies should compare the different lipolytic effects across species, especially to 
compare with human adipose tissue/ cells. 
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Chapter 6 - In vitro Effects of Individual 
Polyphenols in the Human Omental Adipose Tissue 
Explants 
 
 
6.1 Introduction 
In humans, fat mobilization is regulated by various mechanisms. It is acutely 
stimulated by catecholamines (epinephrine and norepinephrine) and natriuretic 
SHSWLGHV +XPDQ IDW FHOOV H[SUHVV ȕ1 ȕ2 DQG Į2-adrenergic receptors (Lafontan 
M. $FWLQJ WKURXJKELQGLQJ WRȕ1- RUȕ2 adrenoreceptors, catecholamines 
stimulate adenylate cyclase and promote cAMP production from ATP (see Figure 
&RQYHUVHO\VHOHFWLYHVWLPXODWLRQRI IDWFHOOĮ1-adrenergic receptors inhibits 
lipolysis as activation of the Gi-coupled receptors leads to a decrease in 
intercellular cAMP concentration (Lafontan M., 2008; Langin D., 2006). The 
activation of Gi protein is the best-known mechanism that mediates lipolytic 
activation (Carmen & Victor, 2006). Several other antilipolytic pathways including 
Į2-adenosine-receptors, EP3-prostaglandin, E2 receptors and neuropeptide 
Y/peptide YY (NPY-1) receptors have all been identified in human fat cells 
(Lafontan, 2008). These receptors are also coupled to adenylate cyclase through 
Gi inhibitory GTP-binding proteins, and their stimulation reduces cAMP 
concentrations and inhibits lipolysis.  
A possible explanation for the existence of two opposite mechanisms that affect 
lipolysis in the same cell may be that, in this way, the Į2 receptors exert a 
permanent basal inhibition of lipolysis (Lafontan et al., 1997). Adenosine is 
another lipolysis inhibitor that has a Gi protein coupled receptor in the adipocyte 
(Schwabe et al., 1975). Adenosine is released from adipose tissue and acts on 
four G protein-FRXSOHG UHFHSWRUV WKHDGHQRVLQHĮ1 UHFHSWRU WKHDGHQRVLQHĮ2A 
UHFHSWRUWKHDGHQRVLQHĮ2B UHFHSWRUDQGWKHDGHQRVLQHĮ3 receptor (Fredholm et 
al., 2001 a&b). There is pharmacological evidence that the receptor responsible 
for the DQWLOLSRO\WLF HIIHFW LV WKH DGHQRVLQH Į2 receptor (Fatholahi et al, 2006; 
Schoelch et al., 2004; Xu et al., 1998) and basal concentrations of endogenous 
adenosine are sufficient to cause inhibition of lipolysis (Lönnroth et al., 1989). 
However, lipolysis can also be maximally stimulated by lowering media 
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adenosine concentrations with ADA (Frühbeck et al., 2001). An activation of 
OLSRO\VLV PD\ DOVR WDNH SODFH WKURXJK 71)Į PHGLDWHG GHFUHDVH RI *L
concentration coupled to adenosine receptor which blocks the continuous 
lipolysis inhibition signal (Gasic et al., 1999).  
6.2 Hypothesis and Aim 
Since the development of adipose tissue cells of humans are more similar to the 
pig than to the rat, in this experiment, the hypothesis is that the human adipose 
tissue explants will have similar responses towards individual polyphenols as 
found in the pig adipose tissue explants (Headland K., 2007). We aim to treat the 
human adipose tissue explants with individual polyphenols in the presence and 
absence of IP and ADA and later compare the results across human, rat and pig. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Model for stimulatory pathways in human adipose tissue 
lipolysis. AC, adenylyl cyclase; AR, adrenoreceptor; ATGL, adipose 
triglyceride lipase; DG, diglyceride; FA, fatty acid; Gs, stimulatory GTP-
binding protein; Gi, inhibiting GTP-binding protein; HSL, hormone-sensitive 
lipase; MG, monoglyceride; MGL; monoglyceride lipase; PKA, protein 
kinase A; TG, triglyceride (Figure modified from Langin D., 2006) 
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6.3 Methodology  
6.3.1 Preparation of Individual Polyphenols  
Individual polyphenols: phloridzin, resveratrol and EGCG were all obtained from 
Sigma (UK). Polyphenols in the form of powder were weighed and diluted with 
PBS to obtain the concentration needed.  
 
6.3.2 Human Omental Adipose Tissue Explants 
Methods used for isolation and culture of explants in these experiments were 
explained in detail in section 4.2. Samples were obtained as explained in section 
4.2.2.2.  
 
6.3.3 Statistical Analysis 
Values for glycerol release (µg per gram lipid) were expressed as means ± SEM. 
The data were analyzed using Genstat 10.0 statistical software. General Analysis 
of Variance with No Blocking was used. Significance was taken as p<0.05. 
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6.4 Results 
6.4.1 Chronic Effect of Individual Polyphenols with ADA  
A 26hr chronic incubation of human omental adipose tissue explants with EGCG, 
Phloridzin and Resveratrol was achieved by pre-incubating for 22hr in the M199 
media, followed by 4hr incubation in the KRB media. ADA was added in the KRB 
media to remove adenosine. In all chronic studies, treatment with IP (for 4hrs 
again) significantly increased lipolysis (P<0.001). Figure 6.2 shows an inhibitory 
effect of EGCG on lipolysis, particularly when IP was added (n=2 humans, 
treatments in triplicate). The significant interaction between EGCG and IP 
(P<0.001) indicated that the inhibitory effect of EGCG was much more 
pronounced when IP is not added compared with when it was present. The 
greatest inhibitory effect was observed with 100µM EGCG. 
 
 
Figure 6.2 Chronic (26hr) Effects of EGCG on Lipolysis in the Human 
Omental Adipose Tissue Explants 
 
Values are means ±sem, n=2 humans, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA) whereas EGCG inhibited lipolysis particularly when IP was present 
(P<0.001 for EGCG X IP interaction). 
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In another study (n=2 humans, treatments in triplicate), there was a significant 
interaction between IP and Phloridzin (P=<0.001). Phloridzin was found to slightly 
increase basal lipolysis at 100µM (Figure 6.3), but inhibit lipolysis when IP was 
added.  
Interestingly, chronic 26hr treatment with Resveratrol (n=2 humans, treatments in 
triplicate) had opposite effects on lipolysis (Figure 6.4), depending upon whether 
IP was added or not (P<0.001 for Resveratrol x IP interaction). Resveratrol alone 
(without IP) increased lipolysis, particularly at 50 and 100µM, but the effect was 
reversed when IP was added, with 100µM Resveratrol clearly inhibiting lipolysis. 
 
 
Figure 6.3 Chronic (26hr) Effects of Phloridzin on Lipolysis in Human  
Omental Adipose Tissue Explants 
 
Values are means ±sem, n=2 humans, treatments in triplicate. IP increased lipolysis compared with 
basal (P<0.001, ANOVA) while Phloridzin increased lipolysis during the basal state but decreased it 
when IP was added (P<0.001 for Resveratrol X IP interaction, ANOVA) SED 6.09. 
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Figure 6.4 Chronic (26hr) Effects of Resveratrol on Lipolysis in Human 
Omental Adipose Tissue Explants 
 
Values are means ±sem, n=2 humans, treatments in triplicate.  IP increased lipolysis compared 
with basal (P<0.001, ANOVA) while Resveratrol increased lipolysis during the basal state but 
decreased it when IP was added (P=<0.001 for Resveratrol X IP interaction, ANOVA) SED 6.09. 
 
6.4.2 Chronic Effects of Individual Polyphenols With and Without ADA 
To check whether adenosine is involved in the effects found with the chronic 26hr 
incubation with individual polyphenols, the human adipose tissue explants were 
incubated with Phloridzin or Resveratrol, with and without IP and ADA. As before, 
IP and ADA were added during the 4hr incubation in the KRB media. In all 
experiments, treatment with IP significantly increased lipolysis (P<0.001).  
Figure 6.5 shows that Phloridzin tended to inhibit lipolysis (P=0.049) whether or 
not IP and/or ADA was added (n=2 humans, treatments in triplicate). This is 
different from the results found in the previous chronic 26hr incubation with 
Phloridzin in the presence of ADA where it was found to significantly increase 
lipolysis. However, the inhibiting effect in the presence of IP continued to be 
consistent and was independent of ADA. 
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Human adipose tissue explants were also incubated with Resveratrol at 50 and 
100µM in the presence or absence of IP and ADA. Experiments were done 
separately for each concentration as the amount of adipose tissue obtained from 
a single patient is only enough to analyze 8 different treatment groups (in 
triplicate). Each experiment was done on human adipose tissue from 2 individual 
patients and treatments were done in triplicate. In all experiments, IP significantly 
increased lipolysis (P<0.001). 
Figure 6.6 shows the effect of 50µM Resveratrol on lipolysis. There was a 
significant ADA x IP x Resveratrol interaction (P=0.006). Resveratrol was found 
to increase basal lipolysis (without IP) and lipolysis was induced even more when 
ADA was present. However, when IP was added to the media, Resveratrol 
inhibited lipolysis, with no apparent effect of ADA. Similar effects were also found 
when 100 M Resveratrol was added (Figure 6.7).  
As before, there was a significant ADA x IP x Resveratrol interaction (P=0.002), 
with Resveratrol increasing basal lipolysis (without IP) and ADA further increasing 
lipolysis. Once again, when IP was added to the media, Resveratrol inhibited 
lipolysis, with no apparent effect of ADA. Interestingly, 50µM Resveratrol on its 
own seems to stimulate basal lipolysis more than 100µM Resveratrol, whereas 
there was a bigger inhibitory effect on IP-stimulated lipolysis with 100µM 
Resveratrol. 
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Figure 6.5 Chronic (26hr) Effects of Phloridzin on Lipolysis in Human Omental Adipose Tissue Explants in the Presence and Absence 
of ADA and IP.  
 
  
 
 
 
 
 
 
 
 
 
 
Values are means ±sem, n=2 humans, treatments in triplicate. IP increased lipolysis compared with basal (P<0.001, ANOVA) while Phloridzin significantly inhibited lipolysis 
independent of IP and ADA (P=0.049, ANOVA).  
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Figure 6.6 Chronic (26hr) Effects of 50µM Resveratrol on Lipolysis in the Human Omental  Adipose Tissue Explant in the Presence 
and Absence of ADA 
 
 
 
 
 
 
 
 
 
 
 
Values are means ±sem, n=2 humans, treatments in triplicate.  IP increased lipolysis compared with basal (P<0.001, ANOVA). Resveratrol increased lipolysis during the basal 
state especially when incubated with ADA but decreased it when IP was added (P=0.006 for Resveratrol X IP X ADA interaction, ANOVA) SED 7.97. 
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Figure 6.7 Chronic (26hr) Effects of 100µM Resveratrol on Lipolysis in the Human Omental Adipose Tissue Explant in the Presence 
and Absence of ADA 
 
 
 
 
 
 
 
 
 
 
 
Values are means ±sem, n=2 humans, treatments in triplicate.  IP increased lipolysis compared with basal (P<0.001, ANOVA). Resveratrol increased lipolysis during the basal 
state especially when incubated with ADA but decreased it when IP was added (P=0.002 for Resveratrol X IP X ADA interaction, ANOVA) SED 5.48. 
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6.5 Discussion 
In all experiments, ADA was included to remove adenosine and prevent the tonic 
inhibition of lipolysis in adipose tissue explants. The addition of ADA also makes 
the lipolysis results comparable to results obtained previously in our lab in pig 
adipose tissue explants (Headland, 2007). 
 
6.5.1 Effects of EGCG on Lipolysis in the Human Omental Adipose Tissue 
Explants  
In this study, we investigated the direct effect of EGCG on lipolysis in human 
adipose tissue explants during chronic (26hr) incubation. Similar to the results 
previously found in the rat adipose tissue explants (26hr without ADA) and pig 
adipose tissue explants (24hr with ADA) by Headland (2007), EGCG was found 
to consistently inhibit lipolysis and the effects were greatest at 100µM. In the 
human adipose tissue explants, more than 50% inhibition was found following the 
chronic (26hr) incubation both with and without IP added.  
EGCG has previously been shown to inhibit lipolysis in pig fat explants after a 
chronic (24hr with ADA) incubation in both perirenal and subcutaneous fat 
explants, particularly at 100µM (Headland, 2007). In the present study, 100µM 
EGCG inhibited lipolysis more than 50µM EGCG when IP was added, but when 
IP was not present both 50 and 100µM EGCG inhibited lipolysis to the same 
concentration. This is probably because inhibition is less pronounced during 
basal lipolysis, which is much lower than IP stimulated lipolysis. 
Thus, the results observed here in human fat explants would suggest that the 
effect of EGCG on lipolysis inhibition is consistent in pig, rat and human fat 
explants.  The reduction of WAT observed in in vivo studies could be mediated 
via induction of adipocyte cell apoptosis and inhibition of of adipocyte 
differentiation, as suggested by Wolfram and colleagues (2005) and Hwang and 
colleagues (2005) when the effect of EGCG was analyzed in an in vitro cultured 
adipocytes assay. 
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6.5.2 Effect of Phloridzin on Lipolysis in the Human Omental Adipose 
Tissue Explants 
Compared with EGCG, Phloridzin has a rather inconsistent effect on lipolysis in 
the human adipose tissue explants. When the effect of chronic (26hr) incubation 
with Phloridzin was investigated the first time (in the presence of ADA), it was 
found to stimulate lipolysis when IP was not present, but decrease lipolysis when 
IP was present. However, in another experiment to investigate the effect of 
chronic (26hr) incubation in the presence and absence of ADA and IP, Phloridzin 
was found to significantly inhibit lipolysis both with and without IP added. It 
appears that the induction of basal lipolysis found at 50 and 100µM in the earlier 
experiment, was not repeated when 100µM Phloridzin was used subsequently, 
although the inhibitory effect of Phloridzin when IP was present was consistent in 
both experiments. 
The results found in the human adipose tissue explants do not agree with 
previous findings in pig and rat adipose tissue explants. In pig subcutaneous 
adipose tissue explants, 24hr incubation with Phloridzin was found to increase 
lipolysis at 25µM, but had no significant effect at 100µM (Headland, 2007). 
Moreover, although it appeared to increase lipolysis numerically, Phloridzin had 
no statistically significant effect on lipolysis in pig perirenal adipose tissue 
explants. A similar result was found in rat epididymal adipose tissue explants 
(see chapter 4), where no significant effects were found following both acute (4hr) 
and chronic (26hr) incubation with Phloridzin. 
Thus, the effects of Phloridzin in human, rat and pig fat explants were 
inconsistent. Although it is not known why the effect is different across species, it 
must be noted that the effect of Phloridzin in inducing and inhibiting lipolysis in 
the human adipose tissue explants was not greater than 40% when compared 
with control. 
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6.5.3 Effect of Resveratrol on Lipolysis in the Human Omental Adipose 
Tissue Explants 
More interesting and consistent results were found in this study when Resveratrol 
was incubated for 26hr in the presence of ADA in the first experiment, and when 
50µM or 100µM Resveratrol (26hr incubation) was used in the presence and 
absence of ADA and IP in subsequent experiments.  
During the first study, Resveratrol at 50 and 100µM was found to increase 
lipolysis when IP was not present, but significantly decreased lipolysis when IP 
was present, especially at 100µM. Subsequent experiments were carried out 
where effects of the presence and absence of ADA were also investigated.  
Interestingly, Resveratrol (at both 50 and 100µM) induced greater lipolysis when 
ADA was present, but only when IP was absent. When ADA and IP was not 
present (basal conditions), 50µM Resveratrol was seen to induce lipolysis to a 
greater extent than 100µM Resveratrol. In all experiments, when IP was present 
Resveratrol inhibited lipolysis and was independent of ADA, with greater 
inhibition found at 100µM compared with 50µM Resveratrol.  
The results in this study are not supported by the findings in the rat (26hr) or pig 
(24hr) adipose tissue explants (Headland, 2007), but do agree with results found 
in the acute (4hr) incubation with 100µM Resveratrol in rat adipose tissue 
explants (refer to Chapter 5), where Resveratrol was found to increase lipolysis in 
the absence of IP, but inhibit lipolysis in the presence of IP.  
Chronic (22hrs) incubation with Resveratrol resulted in a consistent inhibition of 
lipolysis both in the absence and presence of IP in the rat fat explants. In pig 
adipose tissue explants, there was no significant effect of treatment with 10, 50 or 
100µM Resveratrol on lipolysis in subcutaneous and perirenal adipose tissue 
explants (Headland, 2007).  
The effects of Resveratrol on lipolysis in the human adipose tissue explants was 
found to be different when compared with the effects found in the pig and rat 
adipose tissue explants when incubated for 24 and 26hr. The effects of 
Resveratrol on lipolysis in the human adipose tissue itself are also dependent on 
the presence and absence of ADA and IP.  
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Thus, it is unclear whether Resveratrol is acting as a beta-adrenergic receptor 
agonist or as an adenosine receptor antagonist, both of which could result in the 
induction of lipolysis. Thus, we suggest that Resveratrol may have a mixed 
agonist/ antagonist effect, although whether this relates to beta-adrenergic or 
adenosine receptors (or both?) is far from clear.  
 
6.6 Conclusion 
These studies investigated the effects of EGCG, Phloridzin and Resveratrol on 
basal and IP stimulated lipolysis in human omental adipose tissue explants in the 
presence and absence of ADA and then compared the findings with similar 
studies in our lab using the rat epididymal adipose tissue explants (results in the 
previous chapter 5) and pig fat explants (Headland, 2007). 
With similar concentrations and incubation times, only EGCG was found to have 
consistent effects across the species, whereas Phloridzin and Resveratrol 
showed different effects in different species. These results suggest that individual 
polyphenols may act through different mechanisms in adipose tissue across 
different species. Thus, the hypothesis was not supported. However, we have to 
note that the age of rat, pig and human were not the same and this might affect 
the composition of adipocytes (pre-adipocytes, adipocytes and mature cells) in 
the adipose tissues resulting in the different effects on lipolysis found. 
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Chapter 7 ± Regulation of Lipolysis in Rat, Human 
and Pig Adipose Tissue Explants: A Comparison 
 
 
7.1 Introduction 
A lot of experimental medical research into the regulation of lipolysis were carried 
out using laboratory animals, based on the assumption that factors regulating 
their metabolism are identical or at least similar to those present in humans. 
However, findings from numerous studies have established that species 
differences exist, particularly for adipose tissue responsiveness to certain 
hormones, such as insulin (Steinke et al., 1965; Di Girolamo & Rudman, 1966; 
Gries & Steinke; 1967). It is also well known that adipose tissue of animals of 
various classes responds to lipolytic and anti-lipolytic substances in different 
ways, as described for ruminants (Menahan, 1966; Khachadurian et al., 1966; 
Metz & van den Bergh, 1972) and for birds (Carlson et al., 1964; Goodridge, 
1968; Langslow, 1972).  
Moreover, in animals of the same order, and even within the same family, the 
effect of lipolytic hormones was found to vary (Rudman & del Rio, 1969; Boberg 
et al., 1970). For example, catecholamines were shown to be lipolytic in rat and 
dog adipose tissue, but not in rabbit or guinea pig adipose tissue (Mersmann et 
al., 1974). The lipolytic response to other hormonal substances such as 
adrenocorticotropin, thyrotropin, melanocyte-stimulating hormone, vasopressin 
and glucagon, was shown to also be species specific (Rudman & DiGirolamo, 
1967). 
The differences found in the regulation of lipolysis between species may be 
attributed to the properties of adipocytes in situ. For example, in contrast to mice, 
KXPDQ DGLSRF\WHV SRVVHVV Į2-adrenergic receptors and natriuretic peptide 
receptors, and some receptors for thyrotropin (Wang et al., 2008). Conversely, 
human adipocytes have a negligible response to ȕ3 adrenergic agonists 
(Rosenbaum et al., 1993), in contrast to the large response seen in rodent 
adipocytes. Growth hormone provokes intense lipolysis in mice but has little or no 
effect in humans (Arner, 2005; Djurhuus, 2004). Furthermore, differences 
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between omental and subcutaneous fat depots are less marked in rodents 
compared with humans (Arner, 2005).   
 
7.2 Hypothesis and Aim 
The response to treatment with individual polyphenols was found to be different 
between human, rat and pig fat explants.  In this study, the hypothesis was 
therefore, that basal and stimulated lipolysis in rat, human and pig adipose tissue 
explants are different to each other. The aim was to analyze all the basal and 
stimulated lipolysis data taken from the previous chapters. Note that all the pig 
adipose tissue explant studies were performed by a previous PhD student in the 
Division (Headland, 2007). Additionaly, in the human adipose tissue explants, we 
LQYHVWLJDWHG ZKHWKHU SDWLHQWV¶ %0, RU DJH LPSDFWHG XSRQ OLSRO\VLV ZKHQ EDVDO
and IP-stimulated concentrations of lipolysis were correlated with BMI and age of 
the patients.   
 
7.3 Methodology  
7.3.1 Adipose Tissue Explants  
Methods used for isolation and culture of adipose tissue explants in this 
experiment have been explained in detail in Chapter 4, section 4.2 for rat and 
human adipose tissue explants and in Chapter 2, section 2.1 in the PhD thesis 
written by Headland (2007) for pig adipose tissue explants. 
 
7.3.3 Statistical Analysis 
Values for glycerol release (µg per gram lipid) were expressed as means ± SEM. 
The data were analyzed using Genstat 10.0 statistical software. General Analysis 
of Variance with No Blocking was used. Significance was taken as P<0.05. 
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7.4 Results 
7.4.1 Basal Lipolysis in the Rat, Human and Pig Adipose Tissue Explants 
Figures 7.1, 7.2, 7.3, 7.4 and 7.5 show the basal and IP stimulated lipolysis in rat 
epididymal adipose tissue explants (n=18 rats, treatments in triplicate), rat 
perirenal adipose tissue explants (n=2 rats, treatments in triplicate), human 
omental adipose tissue explants (n=18 humans, treatments in triplicate), pig 
perirenal (n=3 pigs, treatments in triplicate) and subcutaneous (n=3 pigs, 
treatments in triplicates) adipose tissue explants.  
Epididymal rat and omental human adipose tissue explants were pre-incubated 
for 22hrs in M199 media and then for 4hrs in the KRB media with or without 
10µM IP. Pig perirenal and subcutaneous adipose tissue explants were pre-
incubated for 20hrs in M199 media and then for 3hrs in the KRB media with or 
without 10µM IP. All adipose tissue explants were derived from intra-abdominal 
adipose tissue depots except for the pig subcutaneous adipose tissue. Data for 
pig perirenal and subcutaneous adipose tissue explants were obtained from the 
work previously done by Headland (2007) in our lab. 
In all experiments, 10µM IP significantly increased lipolysis (P<0.001, ANOVA) 
but the concentrations and percentage increase from basal varied between 
species and adipose tissue depot. The highest concentrations of IP-stimulated 
lipolysis were in the rat epididymal adipose tissue explants (425.2µg glycerol/g 
lipid), followed by the pig perirenal (353.6µg/g lipid), rat perirenal adipose tissue 
explants (311.56 µg glycerol/g lipid), human omental (136.7µg/g lipid) and lastly, 
pig subcutaneous (133.6µg/g lipid) adipose tissue explants. 
A slightly different order was observed for the basal lipolysis concentrations. Rat 
perirenal was found to be the highest with mean glycerol release of 206.38 µg/g 
lipid, followed by rat epididymal at 195.1µg/g lipid, pig subcutaneous at 54.151 
µg/g lipid, pig perirenal at 44.31 µg/g lipid and lastly human omental at 19.33 
µg/g lipid. The highest % response to IP stimulation was found in the pig 
perirenal (698% increase), followed by the human omental (607% increase), pig 
subcutaneous (164.7% increase), rat epididymal (117.9% increase) and rat 
perirenal (51%) adipose tissue explants. 
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Figure 7.1 Basal and IP-stimulated Lipolysis in Human Omental Adipose 
Tissue Explants (n=18)  
 
IP significantly increased lipolysis (P<0.001, ANOVA) 
 
Figure 7.2 Basal and IP-stimulated Lipolysis in Rat Epididymal Adipose 
Tissue Explants (n=18) 
 
IP significantly increased lipolysis (P<0.001, ANOVA) 
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Figure 7.3 Basal and IP-stimulated Lipolysis in Rat Perirenal Adipose 
Tissue Explants (n=2) 
 
IP significantly increased lipolysis (P<0.001, ANOVA) 
 
Figure 7.4 Basal and IP-stimulated Lipolysis in Pig Perirenal Adipose 
Tissue Explants (n=3) 
 
IP significantly increased lipolysis (P<0.001, ANOVA) 
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Figure 7.5 Basal and IP-stimulated Lipolysis in the Pig Subcutaneous 
Adipose Tissue Explants (n=3) 
 
IP significantly increased lipolysis (P<0.001, ANOVA) 
 
 
 
 
7.4.2 Adenosine Regulation of Lipolysis in the Rat Epididymal, Human 
Omental and Pig Perirenal Adipose Tissue Explants 
Adenosine is an inhibitor of lipolysis via binding to adenosine receptor (Figure 
6.1) which results in subsequent inhibition of adenylate cyclase and 
phosphorylation of hormone sensitive lipase. In this experiment, we investigated 
the effects of 0.75U adenosine deaminase (ADA) to remove adenosine, and the 
non-metabolisable adenosine analogue, N-6-phenyllisopropyl adenosine (PIA, 
100nM), both separately and combined in the presence or absence of 10µM IP, 
when added to rat epididymal (n=2 rats, all treatments in triplicate), human 
omental (n=2 humans, all treatments in triplicate) or pig perirenal (n=3 pigs, all 
treatments in triplicate) adipose tissue explants. Data for pig perirenal adipose 
tissue explants were again taken from the work done previously by Headland 
(2007) in our lab. Results are shown in Figures 7.6, 7.7 and 7.8. 
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In all experiments, IP significantly increased lipolysis (P<0.001, ANOVA). As 
expected, lipolysis also increased with the addition of 0.75U ADA, but in all 
species this was only in the absence of IP, with no additional effect of combining 
IP and ADA (P<0.001, and P=0.025, for ADA x IP interaction in the rat and 
human respectively). Interestingly, PIA significantly reduced lipolysis in the 
human and pig adipose tissue explants (P<0.006 in human and P=0.008 in pig), 
but had no effect in the rat adipose tissue explants (P=0.298).  
 
 
Figure 7.6 Adenosine Regulation of Lipolysis in Rat Epididymal Adipose 
Tissue Explants 
 
Values are means ±sem, n=2 rats, treatments in triplicate. Effect of ADA is dependent on IP (ADA 
X IP interaction, P<0.001, ANOVA). IP significantly increased lipolysis (P<0.001, ANOVA). PIA 
does not have any significant effect on lipolysis (P=0.298, ANOVA). 
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Figure 7.7 Adenosine Regulation of Lipolysis in the Human Omental 
Adipose Tissue Explants 
 
Values are means ±sem, n=2 humans, treatments in triplicate. Effect of ADA is dependent on IP 
(ADA X IP interaction, P=0.025, ANOVA). IP significantly increased lipolysis (P<0.001, ANOVA). 
PIA significantly inhibits lipolysis (P<0.006, ANOVA). 
Figure 7.8 Adenosine Regulation of Lipolysis in the Pig Perirenal Adipose 
Tissue Explants 
 
Values are means ±sem, n=3 pigs, treatments in triplicate. Both ADA and IP significantly increase 
lipolysis (P<0.001, ANOVA for both). IP significantly increased lipolysis (P<0.001, ANOVA). PIA 
significantly inhibits lipolysis (P=0.008, ANOVA). 
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7.4.3 Lipolysis in the Human Omental Adipose Tissue Explants According 
to BMI and Age 
In all experiments, omental adipose tissue explants (n=18, treatments in 
triplicate) were pre-incubated for 22hrs in M199 media and then treated with 
10µM IP for 4hrs in the KRB media. Lipolysis results were then compared with 
non-treated group (basal) and the effect of BMI and age were measured using a 
scatter plot shown in Figures 7.9 and 7.10.  
From the Figure 7.9, we can conclude that BMI and glycerol released in the 
media have a very weak negative correlation (F=0.999). Basal lipolysis has a 
stronger negative correlation compared with IP stimulated lipolysis. In all 
samples, IP increased lipolysis significantly (P<0.001, ANOVA) but there are no 
significant effect of BMI on lipolysis (P=0.097, ANOVA). 
Figure 7.10 shows that age also had a weak negative correlation (F=0.998). A 
stronger correlation was also found in the basal compared with IP stimulated 
lipolysis. Age did not have any effect on lipolysis (P=0.48, ANOVA). IP 
significantly increased lipolysis (P<0.001, ANOVA).  
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Figure 7.9 Changes in basal and IP-stimulated Lipolysis in the Human Omental Adipose Tissue Explants with increasing BMI. 
 
BMI and Mean Glycerol have a weak negative correlation (F=0.999). IP significantly increased lipolysis (P<0.001, ANOVA). There was a tendency for IP-stimulated lipolysis to 
decrease slightly with increased BMI (P=0.097, ANOVA). Values are means of triplicate measures from, n=18 humans.
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Figure 7.10 Changes in basal and IP-stimulated Lipolysis in the Human Omental Adipose Tissue Explants with increasing Age 
 
Age and Mean Glycerol have a weak negative correlation (F=0.998). IP significantly increased lipolysis (P<0.001, ANOVA). Age did not  effect  lipolysis (P=0.48, ANOVA). 
Values are means of triplicate measures from n=18 humans. 
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7.5 Discussion 
7.5.1 Basal Lipolysis in the Rat, Human and Pig Adipose Tissue Explants 
,VRSURWHUHQRO LV D SXUH ȕ-adrenoreceptor agonist (Mersmann, 1984a) in the 
DGUHQHUJLF FRQWURO RI DGLSRVH WLVVXH OLSRO\VLV /LSRO\VLV VWLPXODWHG E\ D ȕ-
adrenoreceptor agonist was chosen to measure lipolytic response across rat, 
KXPDQ DQG SLJ UDWKHU WKDQ DQ Į-adrenoreceptor antagonist, because rat 
DGLSRF\WHVDUHXQLTXHLQWKDWWKH\SRVVHVVȕ-adrenoreceptors but are deficient in 
IXQFWLRQDO Į-adrenoreceptors compared with human and pig adipocytes which 
KDYH ERWK Į DQG ȕ-adrenoreceptors (Carpene et al., 1983). In our studies, we 
found that IP significantly (P<0.001) increased lipolysis in rat, human and pig 
adipose tissue explants. Although the magnitude of the response to IP varied, 
this was expected as there are marked species differences in the response of 
adipose tissue to various lipolytic agents (Mersmann et al., 1974; Mersmann, 
1984a & b; Herberg et al., 1974). 
From these studies, we conclude that basal lipolysis in the rat adipose tissue 
explants is higher than in the human and pig adipose tissue explants (Figures 
7.1, 7.2 and 7.3). Herberg and colleagues (1974) compared basal lipolysis in 
isolated adipocytes from four strains of mice and compared with isolated 
adipocytes from human subcutaneous adipose tissue. They found that basal 
release of glycerol by subcutaneous adipocytes from Swiss albino mice, 
C57BL/6J-ob/+ mice, New Zealand obese mice and Australian mice (aged 6-8 
weeks and weighing around 26g) were all significantly higher than human 
adipocytes. Similarly, theophylline stimulated glycerol production was significantly 
lower in human adipocytes than in the mice adipocytes. It is also worth noting 
that the lipolytic activity (both basal and stimulated) was generally higher in 
subcutaneous than in epididymal adipose tissue explants from all strains of mice 
(Herberg et al., 1974). Similar studies by Mosinger and colleagues (1965) and 
Carlson and Hallberg (1968) on human omental and subcutaneous adipose 
tissue explants have shown that subcutaneous adipose tissue is relatively 
insensitive to lipolytic stimulation. The effect of cell size on basal lipolysis should 
also not be underestimated. A positive correlation was found between the basal 
rate of lipolysis and the fat cell size in rat and human (Holm et al., 1975; Arner, 
1988)  
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Basal lipolysis was found to be higher in pig adipose tissue explants (Headland, 
2007) than in human adipose tissue explants, but lower than rat adipose tissue 
explants. This is also true for the IP stimulated lipolysis in pig perirenal adipose 
tissue explants, but not in the pig subcutaneous adipose tissue explants, where 
IP stimulated lipolysis was similar to that in human omental adipose tissue.  
However, these results are not supported by a similar study by Mersmann 
(1984b) using isolated pig subcutaneous adipocytes (n=21) and rat epididymal 
adipocytes (n=10). In that study, when pig and rat adipocytes were stimulated 
with 1µM IP, fatty acid release (µmol 120min-1 g tissue-1) was higher in the pig 
than in the rat. It is interesting to note that the number of pigs used in the 
Mersmann (1984b) study was 7 times higher than in Headland (2007) study. This 
and other variables such as the adipocyte composition, breed, age and weight of 
the pig might contribute to the differences in IP response. 
 
7.5.2 Adenosine Regulation of Lipolysis in the Rat Epididymal, Human 
Omental and Pig Perirenal Adipose Tissue Explants 
Adenosine is known as a major regulator of adenyl cyclase which leads to 
lipolysis in the adipose tissue (Chaves et al., 2011). Recently, it was shown that 
removal of endogenous adenosine with adenosine deaminase causes lipolysis in 
DGHQRVLQH Į1 UHFHSWRU  EXW QRW DGHQRVLQH Į1 receptor (-/-) adipocytes 
(Johansson et al., 2008) and that incubation of rat isolated adipocytes with an 
DGHQRVLQH Į1 receptor antagonist induces an increase in lipolytic activity 
(Szkudelski et al., 2009). These findings provide strong evidence that the 
antilipolytic effect of adenosine involves impairment of PKA activation. In this 
study, as expected, the presence of adenosine does have an effect on the 
lipolysis rate in rat, human and pig adipose tissue explants, since the addition of 
ADA (to metabolise/remove adenosine) increased basal lipolysis. However, only 
in the pig perirenal adipose tissue explants was IP stimulated lipolysis found to be 
increased with ADA. We suggest that IP stimulation in the rat and human adipose 
tissue explants was already maximal (based on the average IP stimulated 
lipolysis in all experiments including the previous chapter 4, 5 and 6) and thus, 
lipolysis could not be increased further with the addition of ADA. It was also found 
that the non-metabolisable form of adenosine (PIA) reduced lipolysis in the 
presence of IP and ADA in the human and pig adipose tissue explants, but not in 
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the rat adipose tissue explants. The reason for this is unknown but one possible 
reason is that the concentration of PIA needed to be an effective adenosine 
receptor agonist. 
 
7.5.3 Lipolysis in the Human Omental Adipose Tissue Explants According 
to BMI and Age 
Human adipose tissue displays significant regional differences in adipocyte size, 
basal metabolic activities and hormonal responsiveness (Lafontan & Langin, 
2009). Regional differences in regulation of lipolysis have been shown in vitro 
and in vivo (Jensen, 1997; Lafontan & Langin, 2009). However, the interpretation 
of the studies is complex and generates equivocal data since it also depends on 
gender, fat depot (intra-abdominal vs peripheral depots), BMI, and the choice of 
lipolysis units used eg. glycerol per gram lipid or glycerol per esterified fatty acids 
or cell number (Lafontan & Langin, 2009; Rodbell, 1964; Tchernof et al., 2006; 
Van Harmelen et al., 1997; Reynisdottir, 1994). Age, physical activity, nutrition 
and genetic variance are also important factors for lipolysis regulation (Arner, 
2005). 
In this study, we found that although BMI and age had weak negative correlations 
with lipolysis (Figure 7.9), these were not statistically significant (P=0.097 for 
BMI, P=0.48 for age). However, the trend suggests that IP stimulated lipolysis 
decreased with increased BMI. A study by Leijonhufvud and colleagues (2010) 
also showed that lipolysis was decreased with the increase of BMI, but there was 
no change with the increase in age. In their study, Leijonhufvud and colleagues 
(2010) constructed and evaluated a simple index of lipolytic activity (ratio of 
fasting plasma glycerol and body fat %) in population based samples of 316 
teenagers (BMI 16-51) and 3039 adults (BMI 16-70). They found that in the 
adults, waist circumference and BMI but not age, plasma insulin, plasma 
noradrenaline or waist-to-hip ratio contributed independently and inversely to 
lipolytic activity. The same analysis in teenagers showed that only BMI 
contributed independently and inversely to lipolytic activity.  
Our study agrees with Leijonhufvud and colleagues (2010), indicating no effect of 
age on lipolysis (Figure 7.10). However, we have to note that age has previously 
been suggested to have important effects on lipolysis related to the action of 
catecholamines and insulin (Gregerman, 1994; Herrera & Amusquivar 2000; Toth 
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& Tchernof (2000). In previous study on elderly subjects, there was a decrease in 
catecholamine-induced lipolysis, mainly due to impaired function of the protein 
kinase A-HSL complex (Arner, 2005). The antilipolytic effects of insulin also 
decrease with aging, which was, at least in part, ascribed to loss of cell-surface 
insulin receptors (Arner, 2005). 
 
7.6 Conclusion 
The rates of lipolysis in cultured adipose tissue explants appears to differ 
between rat, human and pig. This confirmed the hypothesis. Other variables such 
as age, cell size, BMI and specific adipose tissue depot are likely to be important 
contributory factors in these apparent differences. It is not clear that either animal 
VSHFLHV LV D ³EHWWHU´ PRGHO IRU KXPDQV WKHUHIRUH IXWXUH VWXGLHV DLPHG DW
understanding human physiology and lipid metabolism should be done in human 
adipose tissue explants rather than using adipose tissue from animal models.  
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Chapter 8 ± General Discussion 
 
 
Obesity increases the risk of medical illness and premature death (Kopelman 
PG., 2000) and thus imposes an enormous economic burden on the health care 
system (Katzmarzyk & Janseen, 2004). Obesity is also associated with a reduced 
quality of life resulting from substantial limitations and restrictions in activities of 
daily living (Visscher et al., 2004). Obese individuals are less likely to obtain 
insurance, employment or promotion or enjoy personal relationships (Puhl & 
Brownell, 2001). Prevention and treatment of obesity is therefore now widely 
recognized as a priority for most health care systems. A variety of natural 
products, including crude extracts and isolated compounds from plants, can 
induce body weight reduction and prevent diet-induced obesity. Therefore, they 
have been widely used in treating obesity (Han et al., 2005; Moro and Basile, 
2000; Rayalam et al., 2008b). A wealth of information indicates numerous 
bioactive components from nature are potentially useful in obesity treatments. A 
good example of such is the polyphenols. These show strong anti-obesity activity 
and include apigenin, genistein, and the catechins (Rayalam et al., 2008a; 
Thielecke and Boschmann, 2009; Wolfram et al., 2006). 
 
During my PhD studies, I have focused on the effect of Strobilanthes crispus 
extract (SCE) as an energy expenditure and lipolysis stimulator and the effect of 
individual polyphenols as lipolysis inducers. I have first optimized the chloroform-
methanol extraction method for SCE. Chloroform-methanol was the same solvent 
used for SCE extraction during my Masters studies, where SCE was found to 
decrease abdominal fat and improved plasma lipid profile in HF diet induced 
obese rats. In Chapter 2, it has been determined that the chloroform-methanol 
extraction SCE contains polyphenols. 
. 
The SCE was then investigated in an in vivo study using mice where the 
hypothesis was that it will reduce abdominal adipose tissue weight and improve 
the lipid profile of the treated groups. The results showed that the SCE had no 
significant effect on bodyweight or abdominal adipose tissue weight but 
significantly increased plasma glycerol and liver triglycerides contents. Plasma 
and liver cholesterol concentrations were also increased but only in the HF diet 
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fed groups. The results from the lipid profile clearly indicated that the SCE was 
atherogenic. Concommitantly, SCE was found to decrease the RER value of 
treated groups at Weeks 4 and 9 and increased heat production at Week 4 
although this effect was found to be tolerated at Week 9. The decrease in RER 
value at Weeks 4 and 9 would seem to indicate lipids were being more 
preferentially used as a source of energy but the energy expenditure between 
treated and non-treated groups, on week 9, was similar as the heat production 
value was not changed. Lipid oxidation and energy expenditure appear to be a 
positive effect of SCE, although this effect was insufficient to reduce adiposity in 
the obese LDLr KO mice. However, tolerance towards heat production might be 
masking any effects and so the measurements for adipose tissue weights, lipid 
and liver lipid contents might be different if these were to be measured earlier 
(Week 4). Additionally, longer treatment time with SCE might also decreased the 
RER value further, or long enough to see a change in adiposity as the decrease 
in RER was only starting to be significant at Week 10.  
The different outcomes found when either LDLr KO mice or Sprague-Dawley rats 
were treated with SCE may be related to their different genetic background. The 
bioavailability of polyphenols through the actions of gut microbiota could also be 
different between LRLr KO mice and Sprague Dawley rats because of the 
different diets used in each case which may result in different microbiota. In a 
human study, obese people with higher Bacteroidetes in the fecal gut microbiota 
were found to lose bodyweights at a higher rate compared to obese people with 
higher Firmicutes although their calorie intake was the same (Rastmanesh, 
2011). The intestinal microbial transformation of polyphenols is subject to a wide 
inter-individual variability (Gardana et al., 2009). In vitro and humans studies 
support the hyphothesis that changes in the microbiota ratio might affect the 
normal food digestion process (Berlanga et al., 2009; Connoly et al., 2010; 
Koropatkin & Smith, 2010; Laparra et al., 2010; Salazar et al., 2009; Samuel et 
al., 2008; Sonnenburg et al., 2010) and this affects the amount of polyphenols 
absorbed in the gut lumen. Similarly in the LDLr KO mice and Sprague-Dawley 
rats, even though the percentage of fat given in the HF diet group was similar 
(LDLr KO mice given 60% kcal fat, Sprague-Dawley rats given 55% kcal fat), the 
source of fat was different. HFD given to the LDLr KO mice was mainly made 
from lard while the HFD given to Sprague-Dawley rats was mainly made from full-
cream milk powder and corn oil. 
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The effects of SCE were further investigated in vitro using cultured rat epididymal 
and human omental adipose tissue explants. We hypothesized that application of 
SCE would result in an enhancement of lipolysis in rat and human adipose tissue 
explants.  This hypothesis was not met as SCE at three different concentrations 
(0.13%, 0.013% and 0.0013%) did not appear to have any direct effect on 
lipolysis in either rat or human adipose tissue explants.  These concentrations of 
SCE when converted to Gallic Acid Equivalents represent the addition of 
1000µM, 100µM and 10µM equivalents of phenolics, respectively. A review from 
97 polyphenol bioavailability studies (Manach et al., 2005) concluded that the 
plasma concentrations of total polyphenol metabolites ranged from 0 to 4 µM with 
an intake of 50 mg aglycone equivalents, and the relative urinary excretion 
ranged from 0.3% to 43% of the ingested dose, depending on the polyphenol. 
Thus the lack of effect in the explants studies is unlikely to be due to the 
concentrations used as these were relatively high. Another possible explanation 
is that the types of polyphenols available in the SCE used in the in vitro study 
might not be similar to the types of polyphenols available in the SCE that was 
being absorbed and utilized in the in vivo study. As discussed in the introduction 
dietary polyphenols can be subject to metabolism by the gut microfloraa and also 
once absorbed into the body. Further studies on the bioavailability of constituents 
within the SCE in vivo should be done to confirm this.  
 
Another possibility is that the increase in plasma glycerol concentrations and lipid 
oxidation with SCE treatment found in the in vivo experiment may have been due 
to an indirect effect of SCE on lipolysis through the activation of PPARĮ in the 
liver instead of acting directly as a ȕ-adrenoreceptor agonist. The increase of 
plasma lipid in the in vivo study could be the result of the reduced capability of 
the liver to convert the lipids into bile acids which could then be removed out of 
the capillary system into the fecal excretion. All these actions are related to 
specific interaction of polyphenols with enzymes and receptors in various organs 
in the body and thus may be the reason of the different effects of SCE found in 
the in vivo and the in vitro system.  
 
Since polyphenols were still the main interest in this study and we had already 
developed the rat adipose tissue explants system, the effects of individual 
polyphenols on lipolysis were then studied in rat and human adipose tissue 
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explants (the latter successfully developed from the rat adipose tissue explants 
method) results were then compared with the results from a previous pig adipose 
tissue explant study (Headland, 2007). The hypothesis was that effects of 
individual polyphenols on rat and human adipose tissue explants are similar to 
that found in the pig adipose tissue explants and other studies using cultured 
adipocytes and cell lines. However, this hypothesis was not supported by the 
findings. Consistency of the effects on lipolysis was found to depend on the 
polyphenol being studied and the length of incubation. When comparisons were 
made between the lipolytic effects of individual polyphenols on the rat, human 
and pig  adipose tissue explants only EGCG was found to have consistent effects 
at similar concentrations and incubation times, whereas Phloridzin and 
Resveratrol showed different effects in different species. The consistency of 
EGCG in inhibiting lipolysis in the adipose tissue explants of all three species 
could be due to the fact that a toxic concentration had been used. EGCG Cmax 
value was found to range from 25 to 126nM in human plasma (Stalmach et al., 
2008) and the concentration that was used in the adipose tissue explants was 10 
fold higher. However, if these EGCG concentrations are toxic, then this must be 
specific to EGCG since at similar concentrations there was no effect of 
Phloridzin, and Resveratrol increased lipolysis in some experiments. When the 
molecule structures of IP (lipolysis stimulator) and Adenosine (lipolysis inhibitor) 
was compared with the molecule structures of all the individual polyphenols 
(Figure 5.9 and 5.10 in Chapter 5), there seems to be no relation between 
molecular structures and their effects as either a lipolysis stimulant or inhibitor.  
 
The results from the in vitro study of individual polyphenols showed variable 
responses in adipose tissue across different species although the differential 
effect is not really clear. For future work, it is suggested that the effect of the 
individual polyphenols on adipose cell apoptosis induction and lipogenesis 
inhibition were also studied because these mechanisms could be the factors that 
were affecting the response of lipolysis in the rat, human and pig adipose tissue 
explants. When planning future work, we have to note that the age of the rats, 
pigs and humans and also the state of health (normal rats and pigs, obese 
humans) of the species used in this study were not the same and this might affect 
the composition of adipocytes (pre-adipocytes, adipocytes and mature cells) in 
the adipose tissues, resulting in the different effects on lipolysis found. 
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Additionally, when the effects of polyphenols on lipolysis-in  rat adipose tissue 
explants was compared to similar treatments carried out on isolated adipocytes 
and cultured adipocyte cell lines, the rat adipose tissue explants response was 
found to be very similar  to the  response found in the isolated adipocytes but not 
to cultured adipocyte cell lines. It is not clear whether this is due to the higher 
proportion of mature adipocytes found in adipose tissue explants and the isolated 
adipocytes compared to the cultured adipocyte cell lines. 
Since the response to treatment with individual polyphenols was found to be 
different between human, rat and pig fat explants, the hypothesis that basal and 
stimulated lipolysis in the rat, human and pig adipose tissue explants are different 
was tested. This hypothesis was proven to be true as it was found that across 
species, basal lipolysis was found to be higher in pig perirenal adipose tissue 
explants (Headland, 2007) than in human adipose tissue explants, but lower than 
in rat adipose tissue explants. IP stimulated lipolysis was also higher than in the 
human system, in pig perirenal adipose tissue explants, but not in the pig 
subcutaneous adipose tissue explants, where IP stimulated lipolysis was similar 
to that in human omental adipose tissue. However, there was similarity across 
species in the response to ADA. The presence of adenosine does have an effect 
on the lipolysis rate in rat, human and pig adipose tissue explants, since the 
addition of ADA (to metabolise/remove adenosine) increased basal lipolysis in all 
three cases. Adenosine is known as a major regulator of adenyl cyclase which 
leads to lipolysis in the adipose tissue (Chaves et al., 2011). Recently, it was 
shown that removal of endogenous adenosine with adenosine deaminase 
enhanced OLSRO\VLVLQDGHQRVLQHĮ1 UHFHSWRUEXWQRWDGHQRVLQHĮ1 receptor (-
/-) adipocytes (Johansson et al., 2008) and that incubation of rat isolated 
DGLSRF\WHV ZLWK DQ DGHQRVLQH Į1 receptor antagonist induces an increase in 
lipolytic activity (Szkudelski et al., 2009). These findings provide strong evidence 
that the antilipolytic effect of adenosine involves impairment of PKA activation.  
The rates of lipolysis in adipose tissue explants appears to differ between rat, 
human and pig, but other variables such as age, cell size, BMI and specific 
adipose tissue depot are also likely to be important contributory factors in these 
apparent differences. It is thus QRWFOHDU WKDWHLWKHUDQLPDOVSHFLHV LVD ³EHWWHU´
model for humans. 
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In summary, SCE was found to have an effect on lipolysis in the obese LDLr KO 
mice but the mechanism for this effect is still unclear. In the future, the study 
could be extended to investigate changes in the expression of genes related in 
energy expenditure and lipolysis such as peroxisome proliferator alpha (33$5Į) 
and carnitine palmitoyltransferase (CPT1) to obtain more clues to the 
mechanism. Activation of PPARĮ leads to changes in transcription of a large 
number of genes that regulate lipoprotein metabolism including LPL and changes 
in transcription of LPL are thought to lead to enhanced lipolysis of VLDL 
triglycerides resulting in reduced plasma triglyceride levels (Shah et al., 2010). 
Fatty acid degradation occurs in the mitochondria through the process of ȕ-
oxidation and CPT-1 is the rate-limiting step for the entry of fatty acids into the 
mitochondria (McGarry et al., 1983; Mc Garry et al., 1997; Eaton et al., 2001). 
 
Future in vivo work should also consider calculating the composition of adipose 
tissue in the mice using a more sensitive tool such as the Dual Energy X-ray 
Absorptiometry (DXA) as the effect of SCE on LDLr KO mice adipose tissue 
weight might be too small to be detect using conventional methods whilst the 
CLAMS was able to detect very small changes in RER and heat production in the 
treated mice.  
 
The bioavailability of the polyphenols in the SCE should also be investigated as it 
could be different across species. It would be more interesting if humans would 
be included in this species comparison study as the final application of the SCE 
would be in the human. However, the treatment of humans with a chloroform-
methanol extract might not be approved as chloroform is considered a toxic 
material. In this case, the polyphenol contents of SCE should be analyzed and 
identified. Other non-toxic methods of extraction can then be applied to extract 
the identified polyphenols. These polyphenols can then be used for human study 
although it may be subjected to an in vitro study first. 
Since most of the polyhenols studied in the rat and human adipose tissue 
explants had inconsistent effects on lipolysis, except for EGCG, studies on the 
metabolized forms of polyphenols might be carried out to compare with the 
results for   the individual polyphenols. Further studies should also measure the 
effect of individual polyphenols on adipocyte cell apoptosis.  
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Appendix A 
 
Calculation of Heat from the CLAMS 
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Oxymax will calculate heat with one of two methods. Both methods calculate the 
heat before the application of any normalization or correction and, thus, reflect 
the exact heat of the subject. The method termed Internal will derive a calorific 
value (CV) based on the observed respiratory exchange ratio. This calorific value 
is then used with the observed oxygen consumption (VO2) to calculate heat. The 
equations are: 
Heat = CV × VO2 
CV = 3.815 +1.232 × RER 
 
The constants are derived from the following data: 
 
Analysis of the oxidation of mixtures of carbohydrate and fat 
(Converted from the table of Lusk, 1928) 
 
 
 
 
 
 
 
 181 
 
 
A least squares linear fit to the data provides the formula Heat (kcal/liter of O2) = 
3.815 + 1.232*RER. 
Multiplication by VO2 in liters/unit time yields a heat value in kcal/unit time. 
 
Example calculation: assume VO2 = 4000 ml/hr/kg for a 25 gram mouse and 
RER = 0.85. 
Heat (kcal/hr) = (3.815 + 1.232 * 0.85) * 4000 ml/hr/kg * 1L/1000 ml * 1kg/1000g * 
25 g = 0.486 kcal/hr 
 
The other method, termed User Defined, allows the user to enter calorific values 
(CVx) relating to the oxygen consumption (VO2) the carbon dioxide production 
(VCO2), and the methane production (VCH4). 
Note that the methane term drops out if a methane sensor is not present. Each of 
the calorific values is entered in the form Kcal/Liter of the respective gas. The 
equation used is: 
Heat = CV1× VO2 +CV2 × VCO2 +CV3 × VCH4 
